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Abstract 
Tendon is composed of fascicles bound together by interfascicular matrix 
(IFM). Energy storing tendons are more elastic and extensible than positional tendons; 
behaviour provided by specialisation of the IFM to enable repeated interfascicular 
sliding and recoil. With ageing, IFM becomes stiffer and less fatigue resistant, 
potentially explaining why older tendons become more injury-prone. Recent data 
indicates enrichment of elastin within the IFM, but this has yet to be quantified and 
the role of elastin in IFM mechanics remains unknown. This thesis aims to quantify 
elastin content, organisation and fragmentation, and its influence on tendon mechanics, 
in both fascicular matrix (FM) and IFM of functionally distinct tendons, and how this 
changes with ageing. 
It was hypothesised that elastin is mainly localised to the IFM of energy storing 
tendons and becomes increasingly disorganised with ageing. Further, it was 
hypothesised that elastin depletion affects the mechanical properties of IFM, 
specifically fatigue resistance and recoil ability, but will not affect fascicles. 
Biochemical analyses and immunohistochemical techniques were used to 
determine elastin content and organisation in young and old equine energy storing and 
positional tendons. Elastase treatments were conducted in young and old IFM and 
fascicle samples from energy storing tendons to deplete elastin, after which failure, 
fatigue and recovery mechanical tests were performed, comparing IFM and fascicle 
mechanical properties before and after elastase treatment. 
Supporting the hypothesis, elastin localises to the IFM of energy storing 
tendons, reducing in quantity and becoming increasingly disorganised with ageing. 
Further, elastin depletion did not affect fascicle mechanics, but lead to reduced 
mechanical properties and fatigue resistance in the IFM. These changes may contribute 
to the increased injury risk in aged energy storing tendons. Full understanding of the 
processes leading to loss of elastin and its disorganisation with ageing, may aid in the 
development of treatments to prevent age related tendinopathy. 
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Chapter 1 - Introduction 
1.1. General Introduction 
Tendons provide an attachment from muscle to bone, playing an important role 
in locomotion. Their primary function is to transfer the force generated by muscle 
contraction to the skeleton, facilitating movement around joints and positioning limbs 
(Alexander 1991, Benjamin & Ralphs 1997). 
For efficient function, tendons must be strong and stiff under uniaxial tension 
but, at the same time, incorporate some viscoelasticity to optimize their stiffness to 
meet different loading conditions (Kubo et al., 2002, Ker 2007). These properties are 
conferred by the molecular composition of tendon and the interaction of structural 
molecules in the extracellular matrix (ECM). Tendons are comprised mainly of 
hierarchically organised type I collagen molecules, which results in high tensile 
strength. In addition to transferring force, some tendons have an additional role, in 
energy storage (Alexander, 1991), acting as a spring to store and release energy as they 
stretch during stance phase and recoil during the flight phase, reducing the energy cost 
of locomotion (Figure 1) (Alexander, 1991).  
The human Achilles tendon and the equine superficial digital flexor tendon 
(SDFT) (Figure 1) are two examples of energy-storing (ES) tendons. These tendons 
experience high forces during locomotion, acting with low safety margins. Thus, ES 
tendons are more compliant than the positional tendons, storing considerable potential 
energy in their elongated state (Alexander 1991, Batson et al., 2003, Lichtwark & 
Wilson 2007). On the other hand, tendons such as the human anterior tibialis and 
equine common digital extensor tendon (CDET) (Figure 1) are examples of positional 
tendons. These tendons are loaded predominantly by muscular contraction and are 
subjected to lower strains compared to ES tendons (Kear & Smith 1975). Exercise – 
induced injury of positional tendons is subsequently rare (Ely et al., 2009, Markarian 
et al., 1998). 
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The mechanical properties of tendon tissue vary according to its function, and 
so, reflect different functional behaviour between tendon types. Despite a great 
variation in SDFT strength and stiffness between individual horses (Birch 2007), the 
SDFT consistently fails at significantly higher strains than the CDET (Batson et al., 
2003). In vivo, strains of up to 16.6 per cent have been recorded in the equine SDFT 
during galloping (Stephens et al., 1989), and strains that exceed 10.3 per cent have 
been recorded during hopping in the Achilles tendon (Lichtwark & Wilson 2005). In 
positional tendons, maximum strains of 2.5 per cent have been estimated in the CDET 
(Batson et al., 2003, Birch et al., 2008b) and strains up to 3.1 per cent have been 
measured in the human anterior tibialis tendon (Maganaris & Paul 1999). Reflecting 
these different functional demands, in vitro mechanical testing to failure has shown 
that the SDFT fails at approximately 23 per cent strain (Dowling et al., 2002, Gerard 
et al., 2005, Thorpe et al., 2012). By contrast, maximum in vitro failure strains have 
been estimated at 18 per cent in the CDET (Thorpe et al., 2012). Data highlighted that 
ES tendons function with a far smaller safety margin (Batson et al., 2003). 
Figure 1: Illustration of the equine forelimb (a) and human leg (b). The superficial digital 
flexor tendon and common digital extensor tendon are identified in the equine forelimb (a). The 
positioning of the limb during movement is shown, highlighting how the SDFT is stretched during 
stance phase, and recoils during the flight phase. In the flight phase, the CDET undergoes much 
lower strains to position the limb. The equivalent energy storing Achilles tendon and positional 
anterior tibialis tendon, are indicated in the human leg (b). Adapted from Birch (2007), Betts et 
al., (2013). 
Anterior Tibialis 
tendon 
a b 
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The SDFT has a lower elastic modulus and failure stress when compared to the 
CDET, enabling it to stretch to store (Batson et al., 2003). By contrast, the CDET 
requires greater stiffness in order to efficiently reduce the muscular work required to 
keep tendon tension (Batson et al., 2003). 
Previous studies indicate that the differences in the material properties of each 
tendon type are determined by the compositional and organisational variations in the 
matrix (Birch et al., 2008a, Birch 2007). However, specifically how some of the matrix 
structural components influence the functionality and mechanical properties of 
specific tendons is yet to be determined. 
The high strains energy storing tendons must withstand make them more prone 
to highly debilitating and painful injuries, compared to tendons that function purely to 
position the limb (positional tendons) (Shepherd & Screen 2013).  
Tendon injuries, known as tendinopathies, are increasingly prevalent but 
extremely difficult to treat, mainly as we have very limited understanding of the 
aetiology and pathophysiology of these conditions (Riley 2008). It is known that the 
incidence of injury increases with age (Kannus et al., 1989), and is a  recurrent 
problem, likely due to the slow and inadequate tendon healing response. The healing 
tendon tissue has a different structure, which is likely to be weaker than the original 
tissue (Corr et al., 2009).  
Recent studies have focused on understanding the contribution of individual 
structural molecules to whole tendon mechanics, which have been useful in order to 
better understand and treat tendon disorders. This is important as tendon injury is one 
of the most common musculoskeletal injuries both in athletes and the general 
population, affecting up to one in three adults over the age of 50 (Järvinen et al., 2005, 
Tempelhof et al., 1999). 
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1.2. Epidemiology of Tendon Injuries 
Tendon injury is one of the most common musculoskeletal injuries that occur 
both to athletes and the general population (Clayton & Court-Brown 2008). However, 
it is also the most common form of musculoskeletal injury in horses (Ely et al., 2009). 
A survey of thoroughbred injuries and fatalities at British racecourses found that 
injuries to the musculoskeletal system account for 82 per cent of all injuries to 
racehorses and, of these, 46 per cent involved the flexor tendon or the suspensory 
apparatus (Williams et al., 2001). Tendons in the horse forelimbs are the most affected, 
accounting for 97-99 per cent of the tendon injuries, with the energy storing SDFT 
being injured the most (Kasashima et al., 2004). 
Humans and horses have a similar mechanism for the initiation and progression 
of tendon injury (Lui et al., 2011, Innes & Clegg 2010). The human Achilles tendon is 
the most commonly injured tendon in runners, in the same manner as the SDFT in 
horses (Knobloch et al., 2008, Thorpe et al., 2010a). On the other hand, the CDET and 
human anterior tibialis are rarely injured; this may be due to the fact that positional 
tendons experience much lower strains than those that act as energy stores. It is proven 
that the risk of tendinopathies increases significantly with ageing in both human and 
equine ES tendons (Knobloch et al., 2008, Hess 2010, Kasashima et al., 2004) and is 
more common in males (Clayton & Court-Brown 2008, Kannus et al., 1989). 
It is not fully clear why ageing is a crucial factor that predisposes humans and 
animals to tendon injuries. Some studies have suggested that this may happen due to 
an accumulation of micro-damage within the tendon ECM or may be due a reduction 
in the ability of cells in aged tendons to maintain and repair the matrix (Smith et al., 
2002a). 
Tendinopathy is the generic name for a variety of painful conditions 
developing in and around tendons in response to overuse. It is usually associated with 
histopathologic changes such as degeneration and disorganization of collagen fibres, 
increased cellularity and minimal inflammation (Khan et al., 1999, Soslowsky et al., 
2000). The recurrence of tendon injury is very common and, in some cases, the 
symptoms can last for several years. Traditional treatments for tendinopathy are 
focussed on reducing inflammation; however, these may not be the most effective 
option. Nonsteroidal anti-inflammatory medication (NSAIDS) and corticosteroids, 
used to control inflammation, purport to provide some pain relief in short term, 
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although their effectiveness is not proved in the long term (Andres & Murrell 2008, 
Almeikinders & Temple 1998). A vast range of other treatments are used to treat 
tendinopathy, such as eccentric strengthening exercises, glyceryl trinitrate patches and 
extracorporeal shock wave therapy (ESWT), however most current treatment options 
are neither effective nor evidence-based (Andres & Murrell 2008, Riley 2008). In fact, 
there is remarkably little evidence that any therapies are effective. The relationship 
between basic tendon structure and function in different tendon types is not yet 
understood. Also, little is known about how tendon mechanical properties are affected 
by ageing and injury and also by some ECM components. Such understanding is a 
fundamental first step towards understanding healthy function and the aetiology of 
tendinopathy, and thus, developing treatments able to prevent or reverse the 
degenerative process of tendinopathy and maybe even regenerate healthy tendon.  
Various animal models have been developed in order to study the aetiology of 
tendinopathy. Most in vivo animal models available at present are small animal, and 
rely on either prolonged mechanical stimuli to induce overuse injury to the tissue 
(Huang et al., 2004, Jelinsky et al., 2008) or inflammatory drug treatments (Sullo et 
al., 2001). An in vivo approach provides the ability to examine how various repair 
mechanisms and signals from other areas of the body interact with the injured tendon. 
However, the interaction of all factors is very complex, and it is very difficult to 
investigate some of the basic molecular biology. Furthermore, reproducibility of the 
injuries provoked in small animals, such as rats, rabbits and mice, is variable between 
different animals, and dependent on the tendons used. Also, particularly in rodent 
models, damaged tendons seem to heal when overuse training is interrupted, in contrast 
with what happen in human clinical situations (Sullo et al., 2001, Huang et al., 2004, 
Jelinsky et al., 2008). In contrast, in vitro models of tendinopathy have utilised tendon 
explants from a wider variety of species and investigated the influence of mechanical 
or chemical injury in culture. Such models are generally easier to control and the 
molecular mechanisms occurring in response to injury are more easily investigated 
(Spiesz et al., 2015). However, whilst a simpler investigation of many different cellular 
processes, such as DNA synthesis, mitosis, gene expression, and cell differentiation is 
enabled, the study of cells outside their normal environment ultimately limits the 
translatability of the findings. Taken together, it has become clear that one perfect 
model of tendinopathy does not exist. Instead, finding appropriate treatments for 
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tendinopathy will likely arise from a culmination of experiments carried out in these 
models, which can then be applied to patients based on their unique characteristics. 
1.3. Tendon Composition and Structure 
Tendon has often been used as a model for structure-function studies because 
of its simple and highly ordered structure (Kastelic et al., 1978). Its specialised 
organisation and molecular composition result in a high strength structure, able to bear 
uni-directional forces (Kastelic et al., 1978). 
Tendon is a fibrous connective tissue, composed predominantly of type I 
collagen interspersed with tenocytes (tendon cells) and non-collagenous matrix, such 
as proteoglycans (Benjamin & Ralphs 1997). Tropocollagen molecules are grouped 
together to form fibrils, connected by intermolecular chemical crosslinks, resulting in 
high tensile strength (Avery & Bailey 2005, Birch et al., 1999). In turn, these fibrils, 
which are generally aligned along the long axis of the tendon (Kastelic et al., 1978), 
group together in order to form fibres, fascicles and finally the entire tendon, which is 
surrounded by a connective tissue sheath called the epitenon (Kastelic et al., 1978) 
(Figure 2). 
Tendon is composed of three main components: water, which makes up 
approximately 70% of the wet weight, extracellular matrix (ECM) and tenocytes 
(Elliott, 1965). The ECM consists predominantly of collagen type I molecules, 
constituting approximately 75 per cent of the dry tissue weight (Kjaer, 2004). In 
addition to type I collagen, which makes up approximately 95% of the total collagen 
content in tendon, a few other different types of collagen have also been identified, 
such as collagen types III, V, XII and XIV. The ECM also contains a small percentage 
of non-collagenous proteins, such as glycoproteins, proteoglycans (PGs) and a varying 
amount of elastin (Kannus, 2000). Approximately 10% of the tendon is cellular, and 
the major cell type is the tenocyte (Elliott, 1965). 
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1.3.1. Collagen Structure 
Collagen is a fibrous protein, and the most abundant protein in mammals. To 
date, at least 28 different types of collagen have been identified, although most 
connective tissues are composed predominantly of collagen types I, II or III (Burgeson, 
1988). The most abundant collagen in tendon and ligament is type I. The fibril forming 
type I collagen is responsible for the tendon’s high tensile strength. The second most 
abundant collagen in tendon is another fibrillar collagen – type III – which constitutes 
up to 10% of the total collagen, depending on tendon type and age (Birch et al., 1999). 
This collagen seems to play an important role in fibrillogenesis and the regulation of 
the type I collagen fibrils, and has been identified in immature and healing tendons 
(Banos et al., 2008). Collagen type V, is another fibrillar collagen in tendon, and is 
commonly found in the core of type I fibrils, where it is also important in the 
fibrillogenesis process (Riley 2004). The other types of collagen are characterised as 
Interfascicular Matrix 
Figure 2: Schematic of the tendon hierarchical structure. The organisation of tendon 
structure from collagen fibrils to the entire tendon is illustrated. The differences between each level 
of the hierarchy are demonstrated in the schematic and the diameter of each structure is indicated.  
Adapted from Thorpe et al., (2010a). 
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non-fibrillar collagens. Type IX, XII and XIV are examples of fibril-associated 
collagens with interrupted triple helices (Burgeson 1988, Banos et al., 2008), which 
play an important role by providing a molecular bridge between fibrillar collagens and 
the rest of the ECM and also maintaining the tensile integrity of the tendon.  
1.3.2. Collagen Synthesis 
Collagen synthesis is the responsibility of fibroblasts and other connective 
tissue cells. The collagen molecule is composed of three wound polypeptide α chains, 
which form a rope-like super helix. The three individual chains, known as pro-α 
chains, coil together to form a slow right-handed helix with a length of approximately 
300 nm (Kastelic et al., 1978), known as procollagen molecule.  
The procollagen molecule consists of a triple helical region with non-helical 
amino (N-) and carboxy (C-) terminal telopeptides at each end (Figure 3) (Canty & 
Kadler 2005). Each polypeptide chain that forms the triple helical procollagen 
molecule has a repeating Glycine (Gly)-X-Y triplet, where X and Y are normally 
proline and hydroxyproline, respectively (Canty & Kadler 2005). Glycine (Gly) is the 
smallest amino acid, and in this case the one that permits the procollagen molecule to 
form a helical structure, which is stablished by hydrogen bonds (Canty & Kadler 
2005). 
Several post-translational modifications occur to the polypeptide chains, 
including hydroxylation of proline and lysine residues. After the formation of the 
procollagen triple helix, the assembled polypeptide chains are transported to the Golgi 
apparatus, where the N- and C- propeptides are removed, resulting in collagen 
molecules, which are then able to assemble into fibrils (Canty & Kadler 2005). 
This process of assembling procollagen to form fibrils, is known as 
fibrillogenesis. Collagen type III, XII, XIV and Small Leucine Rich Proteoglycans 
(SLRPs) are thought to be involved in the regulation of fibrillogenesis, however there 
are other molecules which may help in this process as well (Banos et al., 2008). Fibrils 
in tendon are tightly packed and aligned along the long axis of the tissue. However, 
fibrils do not run perfectly straight and, in some areas, they present a crimped or kinked 
configuration (Franchi et al., 2010), which tends to disappear when they are under 
tension (Franchi et al., 2007). The crimp arrangement is dependent on the way the 
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tropocollagen was formed into fibrils, and  is thought to relate to the variations in crimp 
morphologies seen between species and with tendon type (Franchi et al., 2010). 
 
 
1.3.3. Collagen Cross-linking 
Fibrils are joined together by the formation of crosslinks between them, which 
help increase the tendon tensile strength. There are two different types of crosslinks 
formed in collagenous tissue: enzymatic and non-enzymatic adventitious crosslinks. 
The enzymatic crosslinks occur during the growth of immature tendons and are 
initiated by lysyl oxidase. On the other hand, non-enzymatic crosslinks are 
characterized by spontaneous reactions with sugars that happen to be present in the 
matrix. 
Figure 3: Schematic image showing the overview of the steps involved in the 
synthesis of collagen fibrils by fibroblasts. Adapted from Canty and Kadler, (2005) 
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1.3.4. Proteoglycans and Glycoproteins 
Proteoglycans (PGs) are composed of a varying number of glycosaminoglycan 
(GAG) chains, covalently attached to a protein core. The proteoglycan core protein 
binds to the collagen fibril at specific sites, and the GAG side-chains interact with side-
chains from other PGs, holding the fibrils at defined distances from each other (Scott, 
1995). Thus, it is thought that PGs may influence directly the mechanical properties of 
tendon, improving the resistance to tensile loading (Scott 1995, Screen et al., 2005). 
The most abundant proteoglycans found in tendon are the small leucine rich 
proteoglycans (SLRPs): decorin (the predominant PG in the proximal/tensional 
regions of the tendon and the one with the smallest core protein), biglycan, 
fibromodulin, lumican and also a small amount of aggrecan (Rees et al., 2000). The 
structure and function of proteoglycans found in tendons are described in Table 1. 
Glycosaminoglycans (GAGs) are long polysaccharide chains, composed of repeating 
disaccharide units. These hydrophilic chains are highly negatively charged, due to the 
sulphate or carboxyl group attached to the sugar residues. Also, as a result of their 
negative charge, they increase water absorption. In terms of glycoproteins, the most 
abundant in tendon tissue is cartilage oligomeric matrix protein (COMP), which is 
thought to play an important role in the fibrillogenesis and tendon development (Smith 
et al., 2002b). 
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Table 1: Resume of the properties of the most abundant proteoglycans within tendon. 
Adapted from (Yoon and Halper, 2005) 
Name Class Core Protein 
size (kDa) 
Structure and function in tendon 
Decorin SLRP 36 One GAG chain; Binds to fibrillar 
collagen; regulates collagen fibril 
structure and cell proliferation 
Biglycan SLRP 38 Binds to fibrillar collagen; predominant 
in cartilage 
Fibromodulin SLRP 42 Binds to type I collagen; helps formation 
of mature large collagen fibrils; 
modulation of tendons strength. 
Lumican SLRP 38 Binds to type I collagen; modulation of 
tendon strength. 
Aggregan Modular 220 Provides resilience; mainly present in the 
compressed regions 
 
Figure 4: Schematic image illustrating the different small-leucine rich 
proteoglycans (SLRPs) present in tendon. Modified from Yoon and Halper, 
(2005). 
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1.3.5. Elastin & Elastic Fibre Function 
Elastic fibres are major components of the ECM in many dynamically loaded 
tissues, particularly those requiring fatigue resistance (Braverman & Fonferko 1982, 
Pierce & Hocott 1960) and those undergoing large strains. They are composed of 
elastin and fibrillin microfibrils (Kielty et al., 2002), and are normally categorized in 
terms of the amount of elastin present in their structure. Mature elastic fibres contain 
a dense elastin core accounting for approximately 90% of the entire fibre, whereas 
elaunin fibres contain an intermediate amount of elastin. Elastic fibres which are 
composed entirely of microfibrils are called oxytalan fibres (Montes, 1996). The low 
modulus of elasticity and high resilience of elastin, allows elastic fibres to complement 
the collagen fibrillary tensile strength (Kielty et al., 2002). These particular properties 
are extremely important to the function of certain tissues such as blood vessels, lungs 
and skin as they undergo high deformations and efficient recoil. Elastin is an 
elastomeric protein, and one of the major structural proteins which provides 
extensibility and flexibility to the ECM. It is an important load-bearing protein in the 
bodies of vertebrates. Elastin is used specifically in tissues requiring high fatigue 
resistance or energy storage, as a result of its highly elastic mechanical behaviour and 
resilience (Greenwald 2007, Oxlund et al., 1988, Lee et al., 2001). 
Studies of elastin have generally focused on the cardiovascular system, where 
is thought elastin mechanical properties predominantly account for tissue stiffness at 
low strains. In an unloaded artery, both collagen and elastin appear undulated and 
wavy. As pressure increases and the artery reaches physiological loads between 50-
150 kPa, elastin is straightened and loaded, but less than 10% of the collagen fibres 
are straight and load bearing (Clark & Glagov 1985). As the pressure increases above 
physiological loads, the collagen fibres become straighter and load bearing also 
(Wolinsky & Glagov 1964, Carta et al., 2009) (Figure 5). Similarly, in the skin, while 
collagen is the main source for the mechanical strength and stiffness, elastin is thought 
to be responsible for the initial extensibility of the tissue (Oxlund et al., 1988). Elastin 
contributes to the compliance of a tissue by maintaining collagen in a crimped 
configuration, acting as a shock absorber when the force is applied (Oxlund et al., 
1988). 
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Studies of elastin in tendon are limited in number, and draw no firm 
conclusions. There remains debate concerning its abundance, or even presence, and no 
role for elastin in tendon has been identified (Shepherd & Screen 2013, Riley 2008).  
 
1.3.6. Elastin Biosynthesis and Biochemical Characterisation 
Elastin, was initially characterised as an amorphous polymer. However, some 
recent studies have suggested that elastin contributes to a vast range of biologic 
properties (Blanchevoye et al., 2013). Its presence in the extracellular matrix has 
important implications at the cellular and tissue level.  
The elastin gene is localized in chromosome 7 in humans (Fazio et al., 1991) 
and expressed by various cell types during pre- and neo-natal phases of development 
(Davidsons et al., 1982). Tropoelastin, the product of the elastin gene, is a protein of 
approximately 800 residues and its full sequence is already known for the human, cow, 
chick, rat, mouse and sheep species (Bressan et al., 1987, Indik et al., 1987, Mauch et 
al., 1994, Raju & Anwar 1987, Wydner et al., 1994). The elastin gene is normally 
Figure 5: Representative circumferential stress-stretch relationship for the mouse 
ascending aorta. At low pressure, the low stiffness behaviour of the aorta is dominated by 
elastin and at high pressure, dominated by collagen. The range of physiological blood pressures 
are indicated on the graph. Image from Carta et al., (2009). 
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composed of 34 exons (human) and 36 exons (bovine) and one intron (exon ratio of 
20:1), some of which code for lysine-containing segments (cross-linking domains), 
others for hydrophobic sequences (Indik et al., 1987, Fazio et al., 1991) (Figure 6). 
 
Tropoelastin is the soluble, monomeric form of elastin secreted by cells, which 
is present in solution in both globular and extended forms (Toonkool et al., 2006). Its 
hydrophobic domains are dominated by the following aliphatic residues: proline (P), 
alanine (A), valine (V), leucine (L), isoleucine (I) and glycine (G), which are very 
repetitive and usually described as di-, tri-,tetra-, hexa- and nona-peptides (Foster et 
al., 1973). The tropoelastin crosslinking domains are either alanine-rich (termed KA) 
or proline-rich (termed KP) regions, comprising either two or three lysyl residues 
(Foster et al., 1974, Keeley et al., 2002). Thus, the tropoelastin structure consists of 
alternating hydrophobic and cross-linking domains. 
  
Figure 6: Structure of human tropoelastin. (a) cDNA structure; (b) typical amino acid 
selected sequences Exons subjected to alternate splicing are marked with an arrow. Adapted from 
Vrhovski & Weiss (1998). 
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1.3.7. Elastogenesis 
The process responsible for the formation of functional elastin within the 
elastic fibre is known as elastogenesis. The deposition of elastic fibres is highly 
regulated during development and it is considered a very complex process. 
Elastogenesis starts inside the cell (Figure 7) when the tropoelastin molecule is 
synthesised. After that, tropoelastin binds to a receptor complex consisting of at least 
three proteins: a peripheral 67 kDa elastin-binding component in concert with 61 kDa 
and 55 kDa membrane-binding proteins. The 67 kDa domain is identical to β-
galactosidase and has at least two binding sites: one for tropoelastin and another for 
lectin. The elastin-binding protein (EBP) binds the tropoelastin and acts as a 
chaperone, preventing premature intracellular aggregation of tropoelastin molecules 
(Hinek & Rabinovitch 1994). When the complex (tropoelastin-chaperone) is excreted 
into the extracellular region, the companion chaperone loses its affinity for tropoelastin 
when it interacts with galactosugars. Consequently, the tropoelastin is released locally 
and the chaperone is recycled (Hinek, 1997) (Figure 7). 
 
Figure 7: Schematic image of elastin deposition. Image adapted from Hinek, (1997). 
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There are three known fibrillin isoforms, which have different spatial and 
temporal expression patterns – fibrillin-1, -2 and -3 (Corson et al., 2004, Zhang et al., 
1995). Fibrillin-1 (FBL-1) is the most abundant isoform in mature tissues, whilst 
fibrillin-2 (FBL-2) is usually expressed during early development stages (Ramirez & 
Pereira 1999). Both types of fibrillins are secreted as profibrilin dimers or trimers 
which then undergo N- and C- terminal processing to enable fibre assembly (Cain et 
al., 2006). In Figure 8(a) it is possible to see the assembly of fibrillin into microfibrils 
and the association of microfibrils with tropoelastin to form elastic fibres. Initially, the 
profibrillin secreted is processed and assembled into pericellular microfibrils and 
microfibril bundles Figure 8a (i); the elastin globules are aligned correctly and 
promptly modified by lysyl oxidase. Then, the elastin is incorporated in the microfibril 
scaffold by irreversible polymerization Figure 8(ii); finally, in the core of the mature 
elastic fibre, it is visible, rope-like structures of highly cross-linked elastin (Ronchetti 
et al., 1998). In Figure 8b, Exon 21, for instance, encodes a cross-linking domain in 
which pairs of lysine residues (K) are separated by two or three alanine (A) residues. 
On the other hand, exon 24 encodes hydrophobic domains characterised by repeating 
PGVGVA motifs (Figure 8b) (Keeley et al., 2002). Tropoelastin is subjected to 
extensive alternative splicing (Indik et al., 1987), and thus multiple tropoelastin 
isoforms are translated. Post-translational modifications of tropoelastin include the 
hydroxylation of some prolyl residues (Jacob & Hornebeck 1985). 
 
Figure 8: Schematic image of elastic fibre composition and assembly.  Profibrillins are 
assembled into microfibrils (ai) to form a microfibril scaffold for elastin deposition (aii) where 
elastin globules attach and crosslink, forming a rope-like structure (aiii). Tropoelastin structure 
consists of an alternating hydrophobic and crosslinking domains (b).Adapted from Sherratt, 
(2009). 
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1.3.8. Elastin Crosslinking 
Prior to elastic fibre formation, it is known that microfibrils act as a scaffold 
for the tropoelastin deposition. Indeed, after tropoelastin secretion into the 
extracellular space and subsequent assembly into microfibrils, the crosslinking occurs 
in the post-translational modification step. Crosslinking is initiated with the oxidative 
deamination of the ε-amino group of a κ residue to produce α-aminoadipic acid-δ-
semialdehyde (allysine) by the enzyme lysyl oxidase (LOX) or LOX-like proteins. 
Intra- and intermolecular cross-links are then generated by non-enzymatic 
condensation of two allysine residues via aldol condensation which produces allysine 
aldol (AA), or by reaction of an allysine residue with the ε-amino group of another 
lysine residue via Schiff base reaction, which produces dehydrolysinonorleucine (∆-
LNL). The reducible crosslink has been suggested to further condense to form the 
stable and non-reductible trifunctional cross-links merodesmosine and 
cyclopentenosine, the tetrafunctional cross-links desmosine (DES) and isodesmosine 
(IDES), as well as pentafunctional cross-links such as allodesmosine and pentasine 
(Akagawa & Suyama 2000, Vrhovski & Weiss 1998, Bedell-Hogan et al., 1993, Reiser 
et al., 1992) (Figure 9). 
 
Figure 9: Structure and formation pathways of elastin crosslinks. Adapted from Vrhovski 
& Weiss (1998). 
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1.3.9. Elastic Fibre Longevity and Degradation 
Usually, intracellular proteins have a short life-time. Intracellular enzymes, for 
instance, have a life-span measured in hours. However, many other ECM proteins can 
last several years. Some aspartic acid racemization studies suggested that collagen 
types I and II have life-times in human skin, articular cartilage and intervertebral disc 
of 15, 95 and 117 years, respectively (Sivan et al., 2008, Verzijl et al., 2000). However, 
elastic fibres and their molecular components usually last even longer. Elastin 
deposition starts in utero and reaches a maximum during early post-natal development 
(Berry et al., 1972). It is thought that fibrillin microfibrils are responsible for managing 
the elastogenic process, with FBN-2 expression preceding both tropoelastin and FBN-
1 synthesis in most mammalian tissues (Ramirez & Pereira 1999), as FBN-2 is required 
for the deposition of tropoelastin (Tsuruga et al., 2007). Tropoelastin expression is 
down-regulated in humans within a few months of birth (Ramirez & Pereira 1999), 
whereas FBN-1 and FBN-2 are continually expressed. This suggests that the elastic 
fibres formed during early development stages remain in the tissues for the life-time 
of the organism. In vivo, elastic fibres present a remarkable longevity, when compared 
to other ECM and intracellular proteins. However, like any material, it gradually 
accumulates damage (Sherratt, 2009). Some human skin studies indicated that elastin, 
undergoes age-related damage, as it functions without replacement (Ritz-Timme et al., 
2003).  
Given this lack of replacement and gradual accumulation of damage, elastin 
functional efficacy decays in ageing organisms. ECM proteins that exhibit low 
turnover, are prone to degradation by enzymatic, chemical and biophysical 
mechanisms. Metalloproteinases (MMPs) are zinc-dependent endopeptidases 
responsible for remodelling and homeostasis of the ECM and also cell signalling 
regulation. To date, eight MMPs are thought to be able to degrade elastic fibres in 
vitro: MMP-2, -7, -9, -10, -12 and -14 can all degrade insoluble elastin, giving rise to 
soluble fragments (Chakraborti et al., 2003), whilst fibrillin microfibrils are degraded 
by MMP-2, -3, -9, -12 and -13 (Tsuruga et al., 2007). In addition to MMP action, some 
studies have indicated that elastin is susceptible to reactive oxygen species (ROS) 
degradation, which can reduce the cross-linking, characteristic of aged elastic fibres 
(Umeda et al., 2001, Cantor et al., 2006). However, in contrast to this, the structural 
and functional changes of ECM proteins with age are commonly compromised by the 
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accumulation of pathological cross-links (Sherratt, 2009). Elastin cross-linking, which 
occur via the lysyl oxidase mediated deamination of lysine, leads to the formation of 
tetravalent desmosines and isodesmosines (Kielty et al., 2002). These cross-links, due 
to uncontrolled accumulation of glucose with ageing, experience several sequential 
modifications (formation of advanced glycan end products) which consequently cause 
an increase in tissue stiffness (Sims et al., 1996). Additionally, elastic fibre structure 
in ageing tissues may also be affected by calcification, fixation of lipids and 
mechanical fatigue (Robert et al., 2008). 
O’Rourke & Hashimoto (2007) suggested that mechanical fatigue is one of the 
crucial factors that cause elastic fibre failure. This study suggested that the 
microfibril/elastin interface within the elastic fibre structure was the most vulnerable 
region and, therefore the most affected. 
1.4. Tendon Mechanics 
Tendon is comprised of a well-ordered arrangement of load bearing collagen 
fibres, resulting in a material with highly anisotropic mechanical properties. These 
mechanical properties are crucial for function, ensuring tendons are stiff along their 
long axis and able to withstand large uniaxial loads. The aligned collagen fibres are 
surrounded by a proteoglycan rich matrix, resulting in a structure with good flexibility 
which is resistant to damage. Tendon is very often compared to a rope: while very 
strong under forces applied along the long axis, it cannot withstand longitudinal 
compression (Thorpe et al., 2015a). 
To investigate the mechanical properties of tendon in vitro, uniaxial tensile 
mechanical tests are commonly performed at a constant strain rate, where tendon 
samples are simply gripped and stretched to failure. The force and extension 
throughout the test are recorded and typical force-extension curves are plotted (Figure 
10). From these, considering the dimensions of the tendon, strain-stress curves are 
derived. In a typical strain-stress curve, four different regions can be identified: toe 
region, heel region, linear region and failure region (Figure 10). The toe region 
corresponds to the low stiffness behaviour of tendon and results from the straightening 
of collagen crimp and alignment of fibres. The heel region results from reordering of 
collagen molecules and some direct loading of different collagen parts. From this 
point, the application of further load will lead to the linear region, where collagen 
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fibres are directly loaded. It is still unclear what governs tendon extension in this 
region, but it is believe that it is a combination of extension and sliding of the collagen 
units. Although it has been hypothesised that proteoglycans play a role in managing 
this sliding behaviour and improving the resistance of tensile loading (Cheng & Screen 
2007, Screen et al., 2004, Khodabakhshi et al., 2013), this has not been proved yet. 
Recent studies comparing fascicles from the SDFT and CDET, have shown that the 
extension mechanisms of fascicles from functionally distinct tendons are different, 
with CDET fascicle extension enabled by fibre sliding, whilst in SDFT fascicles 
extension occurs mainly through rotation and collagen extension, suggesting a helical 
substructure within energy storing tendon fascicles (Thorpe et al., 2013b). 
 
 
Related to this, Thorpe et al., (2012) have shown that, under physiological 
loads, the leading extension mechanism in energy storing tendons is sliding at the 
fascicle level, which would also prevent excess collagen loading. The matrix between 
fascicles, the interfascicular matrix (IFM), has been shown to be load bearing and 
elastic in nature, allowing the fascicles to slide when loaded and slide back following 
unloading (Thorpe et al., 2012, Thorpe et al., 2015b). It was additionally demonstrated 
Figure 10: Schematic of a typical force-extension (inset-top left) and derived stress-
strain curves for tendon. Different regions of the curve and typical stress – strain values are 
shown. Image taken from Thorpe et al., (2015a). 
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that a loss of these specialisations with ageing leads to reduced tendon resistance and 
fatigue damage (Thorpe et al., 2013a, Thorpe et al., 2014). A significant decrease in 
the capacity of sliding between SDFT fascicles with ageing, suggests an increase in 
the IFM stiffness, which results in tendon fascicles being loaded earlier. This means 
that in aged SDFTs the fascicles may be damaged during normal loading situations 
more easily. Unfortunately, it has not been possible to find in the literature an 
explanation for the changes in IFM stiffness with ageing, and one of the main reasons 
is because very little is known about the composition of the IFM. 
It has been suggested that this loose connective tissue is comprised of type III 
collagen and PGs, and is synthesized and maintained by a small population of 
fibroblasts (Kannus 2000, Fallon et al., 2002). However, little is known about the 
structure and function of the IFM. Initially it was assumed that its function was just to 
bind the fascicles together. However some authors have suggested that IFM may have 
an important role in tendon function, contributing to tendon mechanical properties 
(Hirokawa & Hasezaki 2010). Our recent research has focused around understanding 
how energy storing tendons can behave more elastically and stretch further than 
positional tendons. 
Thorpe et al (2012) have reported that the differences in SDFT and CDET 
mechanical behaviour are not due to the mechanical properties of the constituent 
tendon fascicles, but due to the differences in the amount of sliding between them. 
Data indicated that this fascicle sliding capacity in ES tendons is greater compared to 
positional tendons, under physiological loads (Thorpe et al., 2012). These differences 
in tendon mechanical properties are likely regulated by differences in tendon structure 
and composition. Various studies have found that the mature SDFT has a higher GAG 
and water content than the CDET, also that the SDFT has higher levels of cellularity 
compared to the CDET (Batson et al., 2003, Birch et al., 2008a). Some authors have 
mentioned the importance of proteins, such as lubricin and elastin in the management 
of IFM mechanical properties. Lubricin, which is localised in the IFM (Funakoshi et 
al., 2010), may allow greater sliding between fascicles (Kohrs et al., 2011). On the 
other hand, elastin seems to be important not only in fascicle sliding but also in the 
fascicle recoil. Although the location and distribution of elastin within tendons are not 
known exactly, some canine ligament and bovine tendon studies have reported that 
elastin seems to be localised between fascicles and around tenocytes (Smith et al., 
2011, Grant et al., 2013). It was recently discovered that the matrix between fascicles 
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is load bearing and elastic in nature, allowing the fascicles to slide when loaded and 
slide back following unloading (Thorpe et al., 2012, Thorpe et al., 2015c). It was also 
suggested that a loss of these specialisations with ageing leads to reduced tendon 
resistance to fatigue damage (Thorpe et al., 2013a, Thorpe et al., 2014). Taking these 
results together, it was suggested that, in ES tendons, the IFM directly influences the 
mechanical properties of the whole tendon, whilst the IFM plays a less important role 
in the CDET (Thorpe et al., 2013c). This may also explain how the energy storing 
tendons are able to support much larger strains and greater extension than positional 
tendons (Thorpe et al., 2012, Thorpe et al., 2013a). 
Unravelling these mechanism has exciting implications for treating tendon 
injuries and targeting prevention approaches to stop age related loss of tendon 
elasticity. Recent data suggest that changes to the interfascicular matrix (IFM) with 
age are the primary cause for tendon overload damage (Thorpe et al., 2013a). 
However, very little is known about the IFM. Recent published data from our group 
demonstrate the presence of high levels of proteoglycans in the IFM, and also elastin 
bridging across the IFM, linking fascicles, mainly in the energy storing SDFT (Thorpe 
et al., 2016a). 
 
1.5. Elastic Fibre Localisation and Distribution in Tendon 
Initially, it was thought that elastin was present in only 10% of all tendons 
however, later studies showed that elastic fibres can also be found in many tendons of 
most animal species, such as in the Achilles tendons of young and old rabbits, and in 
other rat tendons (Kannus, 2000). More recently, Grant et al., (2013) published some 
work on elastin localisation and organisation in bovine flexor tendons. Their results 
indicated that elastic fibres are densely distributed around tenocytes and between 
fascicles and longitudinally oriented along the tendon (Grant et al., 2013). Some 
transverse sections of tendon clearly showed the interaction between elastic fibres and 
cells and also a mesh-like elastic fibre structure was found in the interfascicular region 
(Grant et al., 2013) (Figure 11). Also, studies of the cruciate ligaments clearly showed 
the presence of elastic fibres on the surface of the collagen bundles, and very often in 
the interfascicular region where they showed a looser organisation (Smith et al., 2011). 
Later, C. Thorpe et al., (2016a) investigated the localisation and organisation of elastin 
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in both the energy storing SDFT and positional CDET and reported that, in energy 
storing tendons, elastin was significantly more abundant in the interfascicular matrix, 
compared to the fascicular matrix. These results confirm previously published work 
and open the debate on whether elastin plays an important role in tendon or not, and if 
it is tendon type specific. 
 
 
Figure 11: Image showing organisation of the elastin fibres in bovine flexor tendon. (a) 
Longitudinal 3D reconstruction from a 20μm z-stack showing various fibres (red ab3090 – FBN-
1) localized around tenocytes (blue DAPI – cell nuclei). (b) Transverse sections showing a dense 
distribution of elastic fibres around cells and between fascicles. (c) High magnification transverse 
image highlighting the interaction of elastic fibres (red ab3090 – FBN-1) and cells (blue DAPI – 
cell nuclei). (d) 3D reconstruction of the mesh-like elastic fibre structure within the interfascicular 
matrix. Image taken from Grant et al., (2013). 
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1.6. Possible Role for Elastin in Tendon 
Elastic fibres, whose role in tendon in not yet well understood, seem to have a 
sparse distribution within tendon (Kannus, 2000), however, very few studies have 
really focussed on understanding overall elastin localisation, organisation or function 
in tendon (Caldini et al., 1990, Parry & Craig 1978, Screen et al., 2015, Grant et al., 
2013, Thorpe et al., 2016a). 
Elastin is a major component of tissues in vertebrates which require rapid 
extension and complete recovery, such as the nuchal ligament (Davidsons et al., 1982), 
aorta (Greenwald, 2002), lung (Pierce & Hocott, 1960) and skin (Oxlund et al., 1988). 
In tendon, on the other hand, elastin is a minor component, which does not mean that 
there is no role for elastin. In fact, previous studies suggested that elastin plays a very 
important role in sustaining the elasticity and tensile strength of these tissues (Ritz-
Timme et al., 2003). Elastic fibres seem to function to help collagen recover its wavy 
configuration after muscle contraction and tendon stretch (Kannus, 2000). 
More recently, it has been suggested that elastin is mainly localised to the 
interfascicular matrix and also around tenocytes (Grant et al., 2013). This close 
interaction between elastic fibres and cells sugests that elastic fibres play an important 
role in cell function. Indeed, the results from this study imply that the presence of 
elastic fibres around tenocytes may affect significantly the cell-level strains and 
consequently, their mechanobiological response to load. Additionally, it is thought that 
cells are well attached to fibres, being used as markers of how fibres are moving 
(Screen et al., 2005). During tendon deformation, groups of cells along one fibre move 
relative to those on adjacent fibres, so the elastic fibres may be present to help cells, 
and collagen fibres to return to their initial configuration. Additionally, the dense 
distribution of the elastic fibres between fascicles is likely to provide the IFM with 
elastic recoil capacity and stress protection, once it experiences large shearing forces 
during loading. Finally, in equine studies, elastin has been reported to be localised to 
the interfascicular matrix, mainly in energy storing tendons (Thorpe et al., 2016a). 
Previous work from the same group, indicated that the interfascicular matrix in energy 
storing tendons is specialised, as it has to extend more, be more elastic and compliant 
compared to other tendon types (Thorpe et al., 2013a). Hence, this suggests that elastin 
plays a role in overall tendon mechanics, allowing a greater interfascicular stretch and 
recoil that is required of an energy-storing tendon. 
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1.7. Project Aims and Objectives 
1.7.1. Global Hypothesis 
This thesis aims to test the global hypothesis that the IFM in energy storing 
tendons is specialised for function, and that elastin is the primary protein of importance 
for facilitating the high strain and rapid recoil behaviour of energy storing tendons. 
1.7.2. Aims and Objectives 
This hypothesis will be investigated through a series of hypotheses, and 
associated objectives, using in each case the equine superficial digital flexor tendon 
(SDFT) and common digital extensor tendon (CDET) as models of an energy storing 
and positional tendons, respectively.  
Hypothesis 1 
Elastin is more prevalent in energy storing tendons than positional tendons and 
is localised to the IFM in both tendon types. 
Objective 1.1. Develop methods to determine elastin content in whole energy storing 
and positional tendons, and in different regions of the tendon (fascicles and IFM). 
Objective 1.2. Develop methods to visualise elastin in tendon and its regional 
localisation. 
Objective 1.3. Develop approaches to semi-quantify elastin visualised in the different 
regions of the tendon; 
Hypothesis 2 
 Elastin becomes increasingly disorganised and fragmented with ageing, 
particularly in energy storing tendons. 
Objective 2.1. Develop methods to assess elastin fragmentation with ageing in both 
positional and energy storing tendons. 
Objective 2.2. Develop methods to quantify elastin organisation and fragmentation 
with ageing in both tendon types. 
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Hypothesis 3 
IFM mechanical properties are directly influenced by elastin content, 
particularly in energy storing tendons. 
Objective 3.1: Develop methods to remove elastin, and investigate mechanical 
properties of fascicles and IFM before and after elastin digestion. 
Hypothesis 4  
IFM fatigue resistance is directly correlated to elastin content.  
Objective 4.1. Develop methods to determine fatigue properties of fascicles and IFM, 
before and after elastin digestion.  
Hypothesis 5 
Elastin functions to transfer stress between fascicles providing an extensible 
interface with high recoil ability in the energy storing tendons. 
Objective 5.1. Develop methods to investigate the recoil ability of the IFM in energy 
storing tendons, before and after elastin digestion.  
Hypothesis 6  
Tendon mechanical properties are directly influenced by elastin content & 
elasticity of the IFM, particularly in energy storing tendons. 
Objective 6.1. Develop methods to remove elastin, and investigate mechanical 
properties of tendon longitudinal sections, before and after elastin  
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Chapter 2 - Sample Acquisition and Preparation 
2.1. Tendon Dissection 
In order to perform all of the technical development and experimental work 
described in the next two chapters, the forelimbs of euthanised horses, aged 3-7 years 
(young group) and 15-19 years (old group), were gathered from a commercial equine 
abattoir and prepared in the same manner, described once in this chapter. 
SDFTs and CDETs (Figure 12a1 and a2, respectively) were dissected free from 
the right and left limbs to the level of the metacarpophalangeal joint (Figure 12B). 
Tendons included in this study had no signs of previous injury at post-mortem 
examination. Tendons were secured to a dissecting board and all the connective tissue 
surrounding the tendon (sheath) was removed and stored in 1.5ml screw cap tubes for 
future analysis. Forceps were used to pull way the sheath from the surface of the 
tendon, which was then cut with a scalpel. Once all sheath was removed, tendons were 
divided into equal sized longitudinal sections, using a scalpel (Figure 12C). Each 
SDFT was divided into four longitudinal sections, while CDETs into two longitudinal 
sections (approximately 200 x 8mm each). Two of the longitudinal sections were 
assigned to immunohistochemical/biochemical analysis (Figure 12D) and the 
remaining to mechanical testing (Figure 12E). 
2.2. Samples for Mechanical Testing 
Longitudinal sections designated for mechanical testing were individually 
wrapped in tissue paper, previously impregnated with phosphate-buffered saline (PBS, 
Sigma, Poole, UK), and then in tin foil. These sections were then stored at -80ºC, with 
previous unpublished data from our group showing that tendon mechanical properties, 
specifically in similar size samples, are not affected by one freeze-thaw cycle. 
When required, the frozen tendon sections were removed from the freezer and 
allowed to thaw for about 30 minutes at room temperature prior to use. During this 
period, sections were kept hydrated by spaying several times with PBS. According to 
the type of test to be performed, these longitudinal sections were used whole, or further 
dissected into smaller samples: fascicles and/or IFM samples (Figure 12E). These 
smaller samples would be used not only in mechanical testing, but also in a variety of 
other tests, mainly in the validation step. 
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2.2.1. Fascicle Dissection 
Using a scalpel and size eleven blades, fascicles, proximally 40 mm in length 
and 0.2-0.4 mm in diameter, were dissected from the mid-metacarpal region of the 
tendon section, by cutting longitudinally through the tendon (Figure 12e1). During the 
dissection, fascicle hydration was maintained by storing the fascicles on a Petri dish 
covered with tissue paper dampened with PBS. 
 
2.2.2. IFM Samples Dissection 
Groups of two intact fascicles (bounded by the IFM), were dissected from the 
mid-metacarpal region of the tendon section. Using a custom-made dissection rig, IFM 
samples (approx. 40mm in length) were secured under a stereomicroscope fitted with 
an analyser and rotatable polarized lens (Leica), which enables a better visualization 
of the two individual collagen fascicles (Figure 12e2). After focusing the image, the 
opposing end of each fascicle was cut transversely with a scalpel, leaving 10mm of 
undamaged matrix in the middle (Figure 12e2). The areas of the cuts were identified 
with a pen mark for easier recognition during later mechanical testing. After removing 
the fascicle pairs from the dissection rig, samples were placed on a Petri dish covered 
with tissue paper dampened with PBS (Figure 12e3), similarly to the procedure adopted 
for the fascicles. The dissection process was completed quickly, to prevent samples 
from drying out. 
 
2.3. Samples for Immunohistochemical and Biochemical Analyses 
Sections assigned for immunohistochemical and biochemical analyses were 
dissected into small squared samples, approximately 5x5x5 mm in dimension (Figure 
12D). Only samples isolated from the mid-metacarpal region of the sections were used. 
Samples intended for immunohistochemical analysis (Figure 12d1) (minimum two 
samples per tendon type), were immediately embedded in optimal cutting temperature 
compound and snap frozen in hexane cooled on dry ice. From these, four longitudinal 
and four transverse cryosections, 5 and 10µm thick (2 slides each thickness), were then 
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cut from each sample and placed on poly-lysine slides, which were stored at -80ºC 
until required. Samples intended for biochemical analysis (Figure 12d2) (minimum 4 
samples per tendon type), were stored at -20 ºC in 1.5ml screw cap tubes for future 
analysis. During dissection, samples were kept hydrated by spraying several times with 
PBS. A list of materials used, with respective information regarding suppliers, 
catalogue and batch numbers, can be found in Appendix A.
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Figure 12: Schematic showing the main steps for tendon samples’ preparation. IFM dissection image (d2) adapted from Thorpe et al., (2015c). 
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Chapter 3 - Elastin Localisation and Organisation in 
Tendon 
3.1. Introduction 
The interfascicular matrix composition is still poorly defined. Previous studies 
have shown that the IFM has a distinct composition and greater cell density compared 
to fascicles (Thorpe et al., 2016c). Fascicles consist of highly aligned collagen fibres 
interspersed with sparsely distributed elongated cells, whilst the IFM is more 
disorganised in appearance, with a greater number of more rounded cells, more 
collagen type III and proteoglycans, but a lower collagen type I content (Thorpe et al., 
2016c, Kannus 2000, Fallon et al., 2002). Additionally, recent work suggests a greater 
rate of matrix turnover within the IFM, which may act to maintain healthy tendon 
structure (Thorpe et al., 2016c). 
Several recent studies have reported that the IFM is also rich in elastin (Grant 
et al., 2013, Thorpe et al., 2016a, Smith et al., 2011), where it may influence IFM and 
consequently whole tendon mechanics. Overall elastin content in tendon is low and it 
is sparsely distributed within fascicles (Kannus, 2000). However, its localisation to the 
IFM (Grant et al., 2013), suggests it may be particularly important for IFM function. 
However, there are no studies reporting relative elastin content and organisation 
between tendons regions, or changes with ageing in tendons with different functions. 
3.2. Aims and Hypotheses 
This chapter aims to quantify the total amount of elastin in different tendon 
types and age groups, and investigate elastin organisation and fragmentation in both 
fascicular matrix (FM) and IFM and how this changes with ageing. It hypothesises that 
elastin is more prevalent in energy storing than positional tendons, and is mainly 
localised to the IFM. It also hypothesises that elastin content decreases with ageing, 
especially in energy storing tendons, and lastly, that elastin becomes disorganised and 
fragmented with ageing, especially in energy storing tendons. 
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3.3. Quantitative Assessment of Elastin Content in Tendon 
3.3.1. Development of FM and IFM Microdissection Protocol  
In previous publications, researchers have reported the usage of manual 
microdissection as a successful method to provide very small amounts of tissue, 
dissected in situ, for biochemical analysis (Hunt & Finkelstein 2004, Thorpe et al., 
2016c). Based on this knowledge, a manual microdissection technique was developed 
to isolate small amounts of FM and IFM from tendon sections, in order to determine 
the amount of elastin and other important ECM components such as collagen, sGAG 
and DNA in each region of the tendon. Samples of tendon sheath and whole tendon 
(IFM+FM) were also investigated. For a better understanding, Figure 13 shows the 
overall tendon structure, highlighting the tissue dissected and used for this specific 
analysis. 
 
 
 
 
Tendon longitudinal sections, prepared as described in previous chapter, were 
used. Once defrosted, one end of the tendon section was secured to a dissecting board 
using a large spring clip. Thin longitudinal tendon sections were dissected from the 
middle of the tendon section (approximately 1-2mm thick), well away from the surface 
IFM 
 
FM 
 
Sheath 
 
Whole Tendon 
(FM+IFM) 
Figure 13: Schematic showing the overall tendon structure. The type of tendon tissue 
dissected is listed on the right hand side of the image: IFM, FM, Sheath and Whole Tendon. 
Adapted from Spiesz et al., (2015). 
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and any remaining sheath (Figure 14a), then a single thin section placed under a 
stereomicroscope (Leica) (Figure 14b). The section was positioned on top of a layer 
of rubber with a cork board underneath (Figure 14b) and secured to both layers by a 
metal pin, enabling better visualisation of the fascicles and interconnecting IFM 
(Figure 14c). 
Using microdissection tools, small amounts of FM and IFM were carefully 
dissected from the thin section and stored in 1.5ml screw cap tubes. After FM and IFM 
dissection, small transverse sections of this test piece (Figure 14c) were dissected from 
above the microdissection region. Sufficient tissue from each region was dissected to 
fill three tubes, each holding approximately 20mg (wet weight) of sample: one tube 
was assigned for general assays and two for an elastin assay.  
 
 
 
a 
b 
c 
Figure 14: Image showing the initial steps of microdissection. (a) Thin sections were 
dissected from the tendons, stored in a petri dish and kept hydrated with PBS; (b) the thin sections 
were positioned under a stereomicroscope (Leica) and secured with a metal pin; (c) it was then 
possible to visualise fascicular and interfascicular matrix for microdissection. 
Approx. 5mm 
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3.3.2. Sample Preparation for Biochemical Analyses 
After dissection, FM, IFM, Whole Tendon and Sheath samples were weighed 
using a high precision digital microgram scale with a resolution of 0.001 milligrams, 
and then freeze-dried for 24 hours. The lyophilised samples were reweighed, and water 
content calculated and expressed as a percentage of the wet weight. The samples were 
stored at -20°C until required for analysis. 
3.3.3. Papain Digestion 
In order to determine the amount of DNA, GAG and Collagen in each type of 
tendon tissue, papain (P3125, Sigma, UK), also known as papaya proteinase I, was 
used to digest the tissue (Thorpe et al., 2010b). Activated papain enzyme digestion 
solution (APEDS) was prepared with 4 units papain/ml papain buffer extract (100mM 
sodium phosphate buffer and 5mM Na2EDTA (in ultra-pure water), pH 6.5) and 10mM 
L-cysteine hydrochloride)). For every 10mg (dry weight) of tissue, 1ml of APEDS was 
added. Tube samples were secured in a rotator placed inside the oven and digested for 
18 hours at 60°C. 
3.3.4. Assessment of Tendon Matrix Composition - DNA 
After papain digestion, the DNA concentration of each sample was measured 
using a fluorometric assay adapted from that of Kim et al. (1988) using the 
bisbenzimidazole dye Hoechst 33258, which binds in the groove of the DNA double 
helix. 
Aliquots of papain digested tissue (100μl) were diluted to 500μl with papain 
buffer extract (PBE), and 100µl of diluted sample pipetted into the appropriate wells 
of a 96 well plate. 100μl of dye (1μg/ml Hoechst 33258 in 10 mM Tris-HCL, 1mM 
EDTA.Na2, 0.1 mM NaCl, pH 7.4) was added to each well. Fluorescence was measured 
using a fluorometer (FLUOstar OPTIMA); excitation wavelength: 360 nm, emission 
wavelength: 460 nm) in the presence and absence of dye to account for background 
tissue fluorescence. DNA concentration was calculated by comparison to a standard 
curve constructed using DNA standard stock (1mg/ml) which was diluted in PBE to 
concentrations from 0-20 μg/ml. The DNA concentration was expressed as μg/mg dry 
weight tendon tissue. 
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3.3.5. Assessment of Tendon Matrix Composition - GAGs 
Sulphated glycosaminoglycan (GAG) content was measured using the 
dimethylmethylene blue assay, which is able to quantify total sulphated 
glycosaminoglycans. The dimethylmethylene blue dye (DMMB) binds sulphated 
glycosaminoglycans (GAGs) and forms a complex that absorbs light at 525 nm 
(Farndale et al 1986). 
Aliquots of papain digested tissue (60 μl) were diluted to 180 μl with PBE, 
40µl of diluted samples pipetted into the appropriate wells of a 96 well plate, and 250μl 
of DMMB reagent (1L deionised water, 16mg DMMB, 5 ml ethanol, 5g HCO2Na, pH 
3.0) added to each well. Absorbance was measured using a spectrophotometer 
(SPECTROstar Nano) at 595 nm and the GAG concentration calculated by comparison 
to a standard curve constructed with a stock solution (1mg/ml) of bovine trachea 
chondroitin sulphate which was diluted in PBE to give concentrations from 0-60 
μg/ml. GAG concentration was expressed as μg/mg dry weight tendon tissue. 
3.3.6. Assessment of Tendon Matrix Composition - Collagen 
Collagen content was calculated by measuring the concentration of the amino 
acid hydroxyproline, which is assumed to make up 14% of collagen dry weight (Birch 
et al., 1998), and correspond to a hydroxyproline : collagen ratio of 1:7.69. 
Hydroxyproline content was calculated using a method adapted from Bergman and 
Loxley (1963) and Bannister and Burns (1970), where hydroxyproline is oxidised by 
chloramine T and coupled with dimethylbenzaldeyde (DMBA) which results in a 
coloured product which can be visualised using a spectrophotometer at 550 nm 
(Bergman & Loxley 1963, Bannister & Burns 1970, Birch et al. 1998)  
Aliquots of papain digested tissue (100μl) were hydrolysed overnight in HCl 
(37%) at 110°C, dried for 48 hours at 50°C and re-suspended in 200μl of ultra-pure 
water. Aliquots of the hydrolysed samples (100μl) were diluted to 10ml with PBE, and 
60μl of the diluted samples pipetted into the appropriate wells of a 96 well plate. 20 μl 
of assay buffer (1.5ml 1-propanol, 1 ml ultra-pure water and 5 ml citrate stock buffer 
(100ml ultra-pure water plus 5.04 g citric acid monohydrate, 11.98g sodium acetate 
trihydrate, 7.22g anhydrous sodium acetate, 3.4g sodium hydroxide and 1.26ml acetic 
acid (99.7%), pH 6.1)) and 40 μl of chloramine T reagent (141 mg Chloramine T, 
0.5ml ultra-pure water, 0.5ml 1-propanol and 4 ml citrate stock buffer) were added to 
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each well. Samples were left to stand for 20 min to allow hydroxyproline oxidation to 
complete. The colour reagent (6ml 1-propanol plus 3ml 70% perchloric acid and 4.5g 
4-(Dimethylamino) benzaldehyde) was finally added (80μl) and all reagents mixed 
until the solution became clear. The plate was then covered with SealPlate, wrapped 
in tinfoil and incubated at 60°C for 20 min. After a 25 minutes cooling period, the 
absorbance was measured on a spectrophotometer (SPECTROstar Nano) at 570 nm. 
Hydroxyproline concentration was calculated by comparison to a standard curve, 
prepared using a 50μg /ml hydroxyproline solution in PBE, from which standards from 
0-450 ng/well were prepared. Collagen content determined from hydroxyproline 
content, and expressed as a percentage of dry weight tendon tissue. 
3.3.7. Assessment of Tendon Matrix Composition –Elastin 
In order to determine the total amount of elastin in tendon, the FASTIN elastin 
assay was used. Previous studies have used this colorimetric assay mainly to determine 
the amount of elastin in urine, but only very few have examined tissue (Grant et al., 
2015, Nimeskern et al., 2016). Thus, a protocol was developed combining the 
manufacturer’s instructions and similar studies (Grant et al., 2015, Nimeskern et al., 
2016, Smith et al., 2014). There were a few steps that required optimisation: sample 
preparation, amount of tissue used for quantification and number of extractions 
performed. 
3.3.7.1. Fastin Elastin Assay Protocol 
To measure elastin content, the Fastin Elastin Assay (FASTIN Elastin Assay 
Kit, Biocolor, UK) was adopted. Before the assay could be performed, all test samples 
required the conversion of the native hydrophobic elastin into a water soluble derivate: 
α-elastin. The number of extractions needed to guarantee the complete solubilisation 
of the tendon elastin was not known. Previous studies in ligament indicated that, at 
least 6 extractions would be necessary to solubilise all elastin (Smith et al., 2014), 
whereas studies in rat tail fascicle indicated that 2 extractions would be sufficient to 
extract all tissue elastin (Grant et al., 2015). To be confident all elastin would be 
removed, six extractions were carried out in this initial experiment. A test sample 
without tissue was also included to serve as a sample blank. To complete one 
extraction, samples were heated to 100°C in 750µl of 0.25M oxalic acid. After each 
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one-hour extraction period, the tubes were allowed to cool for about 10 min and then 
centrifuged at 10000rpm for 10 min. The supernatant was pipetted off, into a 1.5ml 
Eppendorf, and tubes weighed before and after the liquid removal, to determine how 
much supernatant was pipetted off. To begin the next extraction, a further 750µl of 
0.25M oxalic acid was added to the residual tissue and the procedure repeated. 
The elastin in the extractions, was in the form of α-elastin, which has a 
molecular weight from 60-84 kDa, and, could therefore be directly assayed using the 
procedure described for soluble elastin (Fastin Elastin Assay Kit, Biocolour, UK). α-
elastin standards, with concentrations from 0-70 µg/ml, were prepared in duplicate 
using a 1mg/ml α-elastin standard solution (Biocolour, UK), and to all test samples, 
the sample blank and the standards, an equal volume of Elastin Precipitating Reagent 
was added (see Table 2 as an example for standards preparation). 
 
Table 2: Standards preparation protocols for the Tendon Elastin assay 
 
Tubes were briefly vortex to mix contents and left for 15 minutes to complete 
the precipitation of α-elastin. Then, tubes were centrifuge at 9500 rpm for 10 min and 
the liquid drained into a beaker. After removing the majority of the liquid by inverting 
the tubes, the remaining liquid was removed from each tube using thin strips of filter 
paper. 1 ml of Dye Reagent was added to each tube, briefly vortexed and placed on a 
mechanical shaker for 90 min to allow reaction between the α-elastin and the dye 
(Figure 15a). Once again, tubes were then centrifuge at 9500 rpm for 10 minutes, and 
all liquid removed from tubes to remove unbound dye (Figure 15b and c). The elastin-
dye complex could be observed as a reddish-brown deposit in the bottom and inside 
lower wall of the tubes (Figure 15d). Finally, 250µl of Dissociation Reagent was added 
to each tube, and tubes vortexed twice at 10 minutes intervals, to ensure that all bound 
dye had passed into solution. 200µl from each tube were transferred to the appropriate 
Standard ID Vol 0.25M Oxalic Acid 
Vol 1mg/ml α-elastin 
standard solution 
Vol Elastin 
Precipitating Reagent 
STD 0 100 µl 0 µl 100 µl 
STD1 0 µl 5 µl 5 µl 
STD2 0 µl 10 µl 10 µl 
STD3 0 µl 30 µl 30 µl 
STD4 0 µl 70 µl 70 µl 
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well of a 96 well flat bottom microwell plate, placed into a Spectrophotometer 
(SPECTROstar Nano) and absorbance was measured at 513 nm. Elastin concentration 
was calculated by comparison to a standard curve generated by the α-elastin standards, 
and expressed as a percentage of dry weight of tendon tissue. 
 
 
 
  
Figure 15: Pictures showing some of the Fastin Elastin Assay (Biocolor) protocol 
steps. After the addition of the dye reagent to all tubes (a); tubes were drained of unbound 
dye by inverting the tube (b); with any remaining liquid removed from each tube using thin 
strips of filter paper (c). The elastin-dye complex could be observed as a reddish-brown 
deposit in the bottom and inside lower wall of the tubes (d). 
a b 
c d 
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3.3.8. Statistical Analysis 
All statistical analyses in this chapter were carried out using the software 
Minitab 17 for Windows. Data were tested for normality using the Anderson – Darling 
test. If normally distributed, a two-way ANOVA (grouping information using the 
Tukey Method and 95% confidence) was used to evaluate differences between 
treatments and age groups. Treatment and horse age were used as factors for the 
ANOVA. The number of each individual donor was also included in the analysis of 
variance (nested with the horse age) to ensure each fascicle from the same tendon was 
not considered an independent biological repeat, but instead a “technical repeat”. Data 
that did not follow a normal distribution was first transformed using a Box Cox 
transformation, and if still not normally distributed, a nonparametric test: The Mann–
Whitney was used. The statistical test used for each parameter is indicated in the 
captions of the graphs. All the results were considered statistically significant for 
p<0.05.  
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3.3.9. Tendon Matrix Composition - Results and Discussion  
Preliminary data comparing the concentrations of each matrix component in 
each tendon region are summarised in Table 3. At a whole tendon level, results 
demonstrated significantly less GAG in the CDET than SDFT and also an increase in 
GAG with age in SDFT tendons. There were also significantly more cells in the SDFT 
than in the CDET, and water content was significantly higher in the young SDFT, but 
this increase was lost with ageing. 
These data generally confirm previous studies (Batson et al., 2003, Birch et al., 
1998), and it has been previously hypothesised that differences in tendon matrix 
composition affect the material and mechanical properties of the tissue. For example, 
a higher water content is hypothesised to be associated with a less stiff material (Birch 
2007), whilst glycosaminoglycans are thought to be responsible for organising 
collagen fibrils, particularly during development (Scott, 1995), and the increased 
GAGs in energy storing tendons might be a result of the need for more tightly 
organised collagen in these tendons. 
Whilst whole tendon data were readily compared to previous studies, 
compositional data from different regions of tendon was inconclusive and of concern, 
and regional specific data, relating to the fascicular matrix, interfascicular matrix and 
sheath, were not statistically analysed due to their incoherence (Table 3). Specifically, 
the content of GAG, DNA and collagen in the whole tendon was notably lower than 
the sum of these components across the constituent FM + IFM regions, whilst elastin 
content in old SDFT samples was higher in the IFM in isolation than across whole 
samples. Whilst this indication of high elastin levels in the IFM supports the 
hypothesis, the substantial variability in regional data, particularly from the IFM is of 
major concern. Variation was too large to suggest simple analytical variance, 
indicating a loss of sample during the preparation or technical issues around accurately 
weighing and analysing small quantities. 
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Table 3: SDFT and CDET tendon matrix components concentration from the equine forelimb. 
Tendons were separated into two groups based on age – Young (3-7 years old) and old horses 
(15-19 years old). Data from Old CDET are not displayed, as these experiments were not 
performed. Data are displayed as Mean ± SEM owing to poor confidence in the 
microdissection technique. Significant differences between groups are only provided for 
whole tendon samples, and are flagged with: *p<0.05; **p<0.01 and ***p<0.001 and between 
age groups with: 
a
 p<0.05; 
b
 p<0.01 and 
c
 p<0.001 (all normally distributed data – ANOVA) 
  
Young SDFT 
(Mean ± SEM) 
Young CDET 
(Mean ± SEM) 
Old SDFT 
(Mean ± SEM) 
Water 
Content 
(%) 
FM 69.96 ±  1.38 59.67 ± 1.21 56.40 ± 1.51 
IFM 78.49 ±  10.42 72.46 ± 2.53 71.07 ± 0.73 
Whole (IFM+FM) 73.62 ±  2.00*** 62.87 ± 0.55 66.78 ± 1.24a 
Sheath 83.38 ±  1.52 85.29 ± 0.87 84.51 ± 1.25 
GAG 
(µg/mg) 
FM 7.85 ±  0.23 3.58 ± 0.14 9.34 ± 0.41 
IFM 7.25 ±  0.48 3.69 ± 0.73 9.89 ± 1.19 
Whole (IFM+FM) 9.95 ± 0.76* 4.10 ± 0.10 11.28 ± 0.64 
Sheath 9.74 ± 0.23 13.78 ± 1.98 11.73 ± 0.68 
DNA 
(µg/mg) 
FM 1.80 ± 0.16 1.05 ± 0.13 1.97 ± 0.62 
IFM 1.94 ± 0.54 2.34 ± 0.89 3.49 ± 1.25 
Whole (IFM+FM) 3.11 ± 0.29* 1.67 ± 0.13 3.17 ± 0.73 
Sheath 9.74 ± 0.45 10.56 ± 0.46 10.35 ± 0.56 
Collagen 
(%) 
FM 73.62 ± 2.39 79.42 ± 2.06 68.93 ± 5.34 
IFM 65.08 ± 2.04 68.54 ± 2.03 55.05 ± 11.78 
Whole (IFM+FM) 81.60 ± 3.89 86.71 ± 1.09 93.66 ± 4.01 
Sheath 80.03 ± 1.52 73.58 ± 4.39 88.42 ± 6.67 
Elastin 
(%) 
FM 1.37 ± 0.07   2.10 ± 0.25 
IFM 2.05 ± 0.04   3.17 ± 0.18 
Whole (IFM+FM) 1.45 ± 0.11   1.55 ± 0.07 
Sheath       
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Results may indicate that there is an additional tendon region for which tissue 
is lost during preparation, leading to inconsistent comparisons of regional 
composition. Sheath tissue was included in the analysis to review this, however it did 
not help interpret the data, and with the previous samples dissected specifically from 
the core it seems highly unlikely. Further, nothing was removed during dissecting and 
all tissue was transferred to one of the regional analysis tubes (FM or IFM). It is 
therefore hypothesised that difficulties arise from the microdissection technique itself. 
The microdissection technique has proved time consuming and difficult to 
standardise, with low quantities of IFM available, which are difficult to dissect and 
weigh, particularly guaranteeing complete separation of fascicular matrix and IFM. 
Thus, it was decided that microdissection was not a viable technique for the 
quantitative analysis of elastin in tendon, and additional approaches were explored: 
1)  The Fastin elastin assay was further optimised to quantify the amount of 
elastin in the whole tendon tissue; 
2)  Other methods, such as multiphoton and immunohistochemistry, were 
used to semi-quantify the amount of elastin in different regions of the 
tendon. 
3.3.10. Development of Fastin Elastin Assay Protocol 
In the preliminary attempt at using the Fastin elastin assay (section: 3.3.7.1), 
six extractions were completed, which is timely and costly. Further, a large amount of 
elastin was collected from samples, with final quantities surpassing the amounts in the 
standard curve. Preliminary results showed that above 100µg/ml, the standard curve 
generated by the α-elastin standards was no longer linear. A series of preliminary 
experiments established that reducing by half the amount of tissue used (from 20mg 
to 10mg wet weight), only 2 extractions would be needed to extract all tissue elastin. 
Additionally, to facilitate tissue hydrolysis in 0.25M oxalic acid, and to help 
homogenise the tissue, whole tendon samples were powdered before the freeze drying 
step. The finalised Fastin elastin assay protocol for the whole tendon elastin 
quantification is described in Appendix B1. 
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3.3.11. Whole Tendon Elastin Quantification- Results  
Utilising the newly optimised protocol for the Fastin elastin assay (Appendix 
B1), tendon elastin content was determined. Results showed that elastin content in 
the whole tendon tissue was significantly greater in the energy storing SDFT 
(3.02% ± 0.60) than in the positional CDET (1.72% ± 0.18, p < 0.001) (Figure 16). 
With age, the amount of elastin decreased in the SDFT (2.17% ± 0.27, p < 0.01) 
whereas no age related changes were seen in the positional CDET (Figure 16). These 
results support the hypothesis that elastin is more prevalent in energy storing 
tendons and decreases in amount with ageing. 
The optimisation of the Fastin elastin assay protocol, based on preliminary 
results discussed in section 3.3.9, allowed a greater elastin extraction from the whole 
tendon samples using less tissue and less extractions. 
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Figure 16: Elastin content expressed as a percentage of dry weight of tendon tissue 
from 14 horses aged 3 to 7 years (defined as young group, n=7) and 15 to 19 years (old group, 
n=7). Significant differences between tendon types and age groups are identified by: ** p<0.01 
and *** p<0.001 (normally distributed data – ANOVA). Data are displayed as mean ± standard 
deviation. 
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3.4. Assessment of Elastin Localisation in Tendon 
Previous data indicating elastin localisation to the IFM (Grant et al., 2015, 
Thorpe et al., 2016a), suggest it may be particularly important for IFM function, 
although a quantitative assessment of elastin localisation has yet to be carried out. 
Further, there are no studies reporting elastin organisation or changes with ageing 
in tendons with different functions. Therefore, in this study, multiphoton 
microscopy and immunohistochemistry techniques were used to assess elastin 
localisation and organisation in both tendon types and age groups, hypothesising 
that elastin is mainly localised to the IFM in both tendon types. 
3.4.1. Sample Preparation for Multiphoton Microscopy 
For the validation of the elastin visualisation using multiphoton microscopy, 
different types of samples were used. The table below summarises all different 
tissues used and how they were prepared. 
Table 4: Summary of sample acquisition and preparation for multiphoton microscopy. 
 
Tissue Type Animal Preparation Mounting 
Medium 
Fascicles and 
IFM samples 
Equine SDFT and CDET Longitudinal 
sections were removed from 
freezer and allowed to thaw; 
fascicles and IFM samples were 
dissected as described previously 
(Thorpe et al., 2012)  
Mowiol or 
PBS 
Tendon 
Cryosections 
Equine Cryosections were removed from 
the freezer and allowed to thaw for 
one minute.  
Mowiol or 
PBS 
Aortic Tissue 
(Positive 
Control) 
Porcine Aorta tissue was collected from the 
abattoir and small thin pieces of the 
media layer manually dissected 
(5x5x0.5mm)  
PBS 
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Samples were mounted with either PBS or Mowiol as described in Table 4. 
Mowiol 4-88 (Polysciences, Inc., TA) is a commonly used mounting medium in 
immunofluorescence, as well as many other molecular biology techniques. It is a 
solution of polyvinyl alcohol and it hardens with time, having the same refractive 
index as immersion oil. Mowiol was prepared in the laboratory following the 
procedure described in Appendix B2. 
One drop of mounting medium was added to a poly-lysine slide. Individual 
samples were placed flat on top of each slide and approximately 15-20µl of extra 
medium was added to the sample. A coverslip was placed on top of the sample and 
slides incubated in the dark overnight to harden. Samples mounted in PBS, were 
sealed with nail polish, and kept in the fridge until required. 
3.4.2. Multiphoton Microscopy Protocol 
Samples were imaged using two-photon confocal microscopy to collect second 
harmonic generation (SHG) illumination. An inverted Leica laser scanning confocal 
TCS SP2 microscope with a tunable Ti:Sapphire femto-second multiphoton laser 
(Spectra-Physics), was used to obtain images. Samples were illuminated at 820 nm 
and the resulting signal was collected in the backward scattering direction (epi), after 
filtration through a SP700 dichroic. The photo-multiplier tube (PMT) was set to collect 
two-photon fluorescence at 500-650nm for elastin and 390-410nm for collagen. A x20 
and x63 (Oil-immersion) objective were used. Images were acquired with a frame 
average of 2 and a line average of 16 at intervals of 1 µm in the z-direction, each with 
a field of view equal to 238.1 x 238.1 µm containing 1024x1024 pixels. Collagen and 
elastin were assigned green and red, respectively. 
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3.4.3. Multiphoton Microscopy – Preliminary Results and Discussion 
 Green Channel 
Collagen 
Red Channel Elastin Merged Channels 
         
IFM 
Sample 
20x in 
Mowiol 
   
         
IFM 
Sample 
20x in 
PBS 
   
SDFT 
Cryo-
section 
20x in 
Mowiol 
   
SDFT 
Cryo- 
section 
20x in 
PBS 
   
       
Aorta 
63x in 
PBS 
   
Figure 17: Representative two-photon confocal images taken from a range of tendon 
and aorta samples. 
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Results from the multiphoton imaging were not satisfactory. Images from 
tendon samples showed substantial background, making it impossible to see elastin 
fibres (Figure 17). Also, there was no clear difference in image quality between 
samples mounted PBS or Mowiol, as all images showed substantial background 
(Figure 17).  
Samples of porcine aorta tissue were included in this study to validate the 
elastin imaging. In this case, using the same imaging protocol, images showed 
significantly less background and it was possible to distinguish elastin fibres from 
collagen fibres, most evident when both channels are merged, where it was possible to 
see that collagen and elastin co-localise (Figure 17). 
As an attempt to overcome the intense background fluorescence, IFM samples 
were mounted with Vectashield, following a similar procedure to the one used when 
mounted with Mowiol. Vectashield is a hard set antifade mounting medium, 
commonly used in fluorescence microscopy (Chen et al., 2011). Samples were imaged 
using the same multiphoton protocol described in section 3.4.2. Representative images 
are showed below (Figure 18).  
 
Images of IFM samples mounted with Vectashield showed no visible reduction 
of the background with no clear visualisation of elastin fibres. The high levels of 
background fluorescence are likely related to the extremely high collagen content in 
tendon, compounded by its dense, highly organised orientation. Multiphoton imaging 
is commonly preferred, as it allows elastin and collagen visualisation without having 
Figure 18: Representative two-photon confocal images showing a single IFM sample 
from a SDFT mounted with Vectashield. Collagen (a) elastin (b) and both channel’s (c) images 
have the same magnification. A 20x objective was used.  Scale bar 100µm.  
a b c 
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to use immunohistochemical techniques, which are timely and costly. However, 
autofluorescence in the large, dense tendons offers insufficient image clarity to 
continue its use. Thus, immunohistochemistry techniques were used as an alternative 
approach to determine elastin localisation in tendon.  
 
3.4.4. Elastin Immunostaining Development 
For elastin immunostaining validation, previously prepared longitudinal and 
transverse cryosections (Chapter 2), were allowed to thaw for 1 minute, before 
fixing with ice-cold methanol (−20 °C) for 20 minutes. Slides were rinsed 3 times 
in phosphate-buffered saline (PBS), treated with hyaluronidase (Sigma, H3884) 
(4800 units/ml in PBS containing protease inhibitor cocktail (complete mini, 
Roche)) to increase tissue permeability (Csóka et al., 1997), and incubated over 
night at room temperature. Cryosections that had not been treated with 
hyaluronidase were also included in this study. Cryosections were washed 3 times 
in PBS and incubated in blocking buffer (10% goat serum in PBS) for 1 hour at 
room temperature. They were then drained and incubated in the primary antibody. 
Two primary elastin antibodies were tested: ab9519 (Abcam Cambridge, UK) and 
E4013 (Sigma, UK). No previous equine studies with these antibodies were 
identified, but they were validated showing positive elastin staining in canine 
ligament tissue (Smith et al., 2011). Both antibodies were diluted in 5% goat serum 
in PBS (1:100 and 1:500 dilutions, respectively) and applied to different sections 
(approximately 100ul of antibody per section) before incubation overnight at 4 °C. 
After overnight incubation, sections were washed in PBS and incubated with Alexa 
Fluor 555 Goat anti-Mouse IgG Secondary Antibody diluted in 5% goat serum 
(1:500 dilution) for 1 h at room temperature (protected from light). Finally, sections 
were washed and mounted with ProLong Gold Antifade reagent with 4′, 6-
diamidino-2- phenylindole (DAPI), and allowed to cure overnight, at 4 °C in the 
dark, before being sealed with nail polish and imaged. Imaging was performed on a 
confocal microscope (Leica TCS SP2) using × 40 (oil) objective. Table 5 summarises 
the first set of test combinations for this validation.  
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Table 5: Summary of the first validation tests. Elastin staining was compared between 
two different antibodies and also with or without hyaluronidase treatment. 
Cryosections Used for 
validation 
Hyaluronidase 
Treatment 
Primary 
Antibody 
Secondary 
Antibody Comments 
Young SDFT 
(transverse section 
10µm thick) 
Yes 
Ab9519 
(1:100) 
Alexa Fluor 555 
Goat anti-Mouse 
IgG (1:500) 
Figure 19a 
Young SDFT 
(transverse section 
10µm thick) 
No 
Ab9519 
(1:100) 
Figure 19b 
Young SDFT 
(longitudinal section 
10µm thick) 
Yes 
Ab9519  
(1:100) 
Figure 19c 
Young SDFT 
(longitudinal section 
10µm thick) 
Yes 
E4013  
(1:500) 
Figure 19d 
 
 
Figure 19: Representative confocal images investigating elastin staining (red) and cell 
nuclei (blue) in young SDFT cryosections. The respective details of the different conditions 
tested are summarised in Table 5 (above). Images a and b contain 1024*508 pixels and c and 
d 1024*1024. Scale bar: 50µm.  
a b 
c d 
Transverse 
Longitudinal 
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Both antibodies worked in equine tendon samples, but confocal images from 
samples treated with hyaluronidase (Figure 19a) looked slightly clearer compared 
to images from non-treated samples (Figure 19b). Thus, hyaluronidase treatments 
were performed in all samples and the Ab9519 antibody (Abcam, Cambridge, UK) 
was chosen for further staining of elastin fibres in this study. 
Although both primary and secondary antibodies appear to work, it was 
necessary to test them for non-specific staining. Thus, negative controls were 
performed on longitudinal cryosections from young SDFTs and CDETs (10µm thick). 
Negative controls were performed by either omitting the primary antibody 
from the blocking buffer or by using an isotype control (mouse IgG1 (M5284; 1:100 
dilution)) instead of the primary antibody (Table 6, Figure 20c, d). These methods 
serve to test both primary and secondary antibodies for non-specific staining. Samples 
were stained as described in section 3.4.5 and imaged using confocal microscopy 
(Leica TCS SP2) and a × 40 (oil) objective. Representative images showing the 
outcome of these tests are also shown in Figure 20. 
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Table 6: Summary of the negative controls performed on both SDFT and CDET 
cryosections.  
Test Samples Treatments 
Primary 
Antibody 
Used 
Secondary 
Antibody Used 
Comments 
Negative 
Control by 
primary 
antibody 
omission 
Young CDET 
(longitudinal 
sections) 
Hyaluronidase 
(Sigma, H3884) 
Ab9519 
(1:100) 
Alexa Fluor 555 
Goat anti-Mouse 
IgG (1:500) 
Figure 20a 
Young CDET 
(longitudinal 
sections) 
Hyaluronidase 
(Sigma, H3884) 
No Primary 
Antibody 
Alexa Fluor 555 
Goat anti-Mouse 
IgG (1:500) 
Figure 20b 
Isotype 
Control 
Young SDFT 
(longitudinal 
sections) 
Hyaluronidase 
(Sigma, H3884) 
Mouse IgG1 
M5284 
(1:100) 
Alexa Fluor 555 
Goat anti-Mouse 
IgG (1:500) 
Figure 20c 
Young CDET 
(longitudinal 
sections) 
Hyaluronidase 
(Sigma, H3884) 
Mouse IgG1 
M5284 
(1:100) 
Alexa Fluor 555 
Goat anti-Mouse 
IgG (1:500) 
Figure 20d 
 
 
a b 
c d 
Figure 20: Representative images for cryosections, where staining shows elastin (red) 
and cell nuclei (blue). The respective details of the different conditions tested are summarised 
in Table 6 (above). No elastin staining was observed in any control images. Scale bar= 50μm. 
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While elastin staining was visible in Figure 20a, where the primary antibody 
was included, no staining was observed in Figure 20b, where the primary antibody was 
omitted form the blocking buffer. This suggests that neither the primary nor secondary 
antibodies show non-specific staining. Additionally, by replacing the primary antibody 
with the isotype control in both SDFT (Figure 20c) and CDET (Figure 20d) sections, 
no elastin staining was observed, which suggests that the primary antibody is not 
binding any non-specific antigens that could be present in the tissue. Taken together, 
data provide confidence that neither the primary nor the secondary antibodies show 
non-specific staining. The finalised elastin immunostaining protocol for young and old 
SDFT and CDET cryosections is described in Appendix B3. 
A positive control for elastin immunostaining was also investigated, with 
samples from the equine palmar common digital vein. Small samples of the equine 
palmar vein were harvested from the forelimbs of one young (6 years) and one old (18 
years) horses, within 24 hours of death. Two small samples, approximately 20mm in 
length and 4mm in diameter, were dissected from each limb and rinsed in PBS (Figure 
21a). These samples were cut in smaller pieces and immediately embedded in optimal 
cutting temperature compound (Figure 21b) and snap frozen in hexane cooled on dry 
ice. Four longitudinal and four transverse cryosections, 10μm thick, were cut from 
each sample and placed on poly-lysine slides, which were stored at -80 °C until 
required for immunostaining. 
 
10m
a b1 
b2 
Figure 21: Representative images showing part of the equine palmar common digital 
vein (a). Samples were cut in smaller pieces and placed in plastic cryomolds (b). Transverse 
(b1) and longitudinal (b2) cryosections, 10µm thick, were cut from each sample. 
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 Longitudinal and transverse cryosections of equine palmar common digital 
vein were used as positive controls. Poly-lysine slides were removed from the freezer 
and allow to thaw for 1minute. Cryosections were stained for elastin (Ab9519) and 
cell nuclei using the same protocol described before (section 3.4.4), however, instead 
of methanol, 4% paraformaldehyde was used to fix the sections. Sections were 
imaged using confocal microscopy (Leica TCS SP2) and a × 40 (oil) objective. To 
confirm the absence of non-specific staining, no primary antibody was included in the 
blocking buffer for one of the cryosections (Figure 22b). Representative images are 
shown below.  
 
 
  
b a 
Figure 22: Representative confocal images of the positive control performed on a 
transverse section of the equine palmar common digital vein showing the organisation of 
elastin (red) and cell nuclei (blue). Transverse cryosections that included the primary 
antibody (a) illustrates the elastin organisation and localisation. Similar cryosections where 
the primary antibody was omitted from the blocking buffer (b) showed no elastin staining. 
Scale bar: 50µm.  
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Confocal images of the equine palmar common digital vein immunostained for 
elastin and cell nuclei showed a typical elastin distribution and localisation as 
commonly seen in these tissues (Figure 22a) (Zócalo et al., 2013), providing further 
confidence that the elastin antibody used in this study (Ab9519) works for equine 
tissue.  
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3.4.5. Elastin Localisation in Tendon – Results and Discussion 
In order to investigate elastin organisation and localisation in young and old 
SDFTs and CDETs, cryosections from horses aged 3 to 7 years (defined as young 
group, n=3) and 15 to 17 years (old group, n=3) were prepared. Elastin and cell nuclei 
were stained, following protocols outlined in Appendix B3. For each section, at least 
2 regions were imaged in an area where both fascicular and interfascicular regions 
could be visualised. Images were captured at a resolution of 1024 × 1024 pixels. 
Immunostaining images showed that elastin is mainly localised to the IFM in 
both tendon types. Barely any elastin fibres were seen in the fascicular matrix. Images 
suggested that there is more elastin in the SDFT IFM (Figure 23a) compared to the 
CDET IFM (Figure 23b). With ageing, no changes in elastin staining were seen in the 
CDET (Figure 23d), whereas elastin staining appeared to decrease in the SDFT (Figure 
23c).  
 
b 
d 
a 
SDFT CDET 
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Figure 23: Representative confocal images showing elastin (red) organisation in 
young and old SDFT and CDET. Longitudinal sections from young SDFT (a), young 
CDET (b), old SDFT (c) and old CDET (d) were immunostained for elastin (red). Cell 
nuclei were also stained (blue). Scale bar: 50μm. 
56 
 
A closer look at these images also shown that elastin seems to be localised 
around circular/oval structures that resemble blood vessels, particularly in the IFM of 
the energy storing SDFT. This raised some concerns whether the elastin seen in the 
IFM was mainly associated with blood vessels present in the tissue. Previous studies 
have shown that tendon blood vessels tend to be present between fascicles, providing 
the source of tendon vascularization. Thus, it was decided to investigate this further.  
Additional cryosections from young and old SDFTs and CDETs (n=2) were 
immunostained simultaneously for both elastin (ab9519, Abcam Cambridge, UK) and 
the endothelial cell marker CD31 (rabbit polyclonal, ab28364, Abcam Cambridge, 
UK; 1:25 dilution). Alexa Fluor 555 Goat anti-Mouse IgG and Alexa Fluor 488 Goat 
anti-Rabbit IgG were used as secondary antibodies for elastin and CD31, respectively. 
Longitudinal and transverse cryosections of the equine palmar common digital vein 
from young and old horses (n=2) were also used to serve as positive controls. Sections 
were stained for elastin, CD31 and DAPI. Sections were immunostained following the 
protocol described in section 3.4.4., except 4% paraformaldehyde was used to fix the 
sections instead of methanol, as preliminary results indicated a better image quality for 
endothelial cell markers when fixed in PFA. 
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The equine palmar common digital vein positive control confirmed that the 
CD31 stained worked in equine tissue (Figure 24). Images taken of transverse sections 
of the equine vein clearly showed typical elastin organisation in blood vessels with 
endothelial cells in small vessels embedded in the media and adventitia of the vein 
(Figure 24). 
 
 
 
 
 
 
 
 
Figure 24: Representative image of the CD31 positive control performed on a 
transverse section of the equine palmar common digital vein showing the organisation of 
elastin (red) and CD31 (green). Scale bar= 200μm. Endothelial cells in small vessels 
embedded in the media and adventitia of the vein are clearly seen. 
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CD31 staining was also seen in all tendon samples. However, staining 
consistently detected only very low levels of CD31, which were always localised 
exclusively to the IFM region (Figure 25), indicating that the majority of elastin within 
tendon is not associated with the presence of blood vessels. 
 
 
Taken together, results from the immunostaining suggested that there is more 
elastin in the IFM of energy storing tendons then in the positional tendons correlating 
positively with previous quantitative analysis that elastin is more prevalent in energy 
storing tendons (section 3.3.11). Still to be determined is the amount of elastin in each 
region of the tendon. Since microdissection was not a viable technique for the regional 
quantitative analysis of elastin in tendon, a semi-quantitative approach was developed 
to determine the amount of elastin in each tendon structure (FM and IFM from the 
immunohistochemistry) and investigate how it varies with ageing. 
  
a b 
c d 
Figure 25: Representative images of a single longitudinal section of the SDFT showing 
elastin (red) (a) and CD31 (green) (b) staining as isolated channels. The combined elastin and 
CD31 staining can be seen in image c. Sections were also stained with DAPI (blue) and this 
channel of information is additionally shown in (d). Scale bar= 50μm. 
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3.5. Semi-quantification of Regional Elastin in Tendon 
3.5.1. Elastin Semi-Quantification Methodology 
Semi-quantitative analysis of the elastin immunostained confocal images was 
performed using ImageJ software. The first step was to establish an unbiased method 
to identify both fascicular matrix (FM) and interfascicular matrix (IFM) areas, based 
on their appearance under bright-field microscopy and UV fluorescence. Cell 
morphology and density, alongside collagen organisation and density were adopted as 
determining factors to distinguish the two regions (Figure 26). Whilst in the FM, cells 
are elongated, aligned with the collagen fibres and sparsely distributed, in the IFM, 
cells are round, high in number and randomly distributed. 
The IFM region was manually drawn only using the bright field images merged 
with the blue channel (cell nuclei), so that the elastin fibres localisation would not 
influence the delimitation of the IFM area. Once the region of interest (ROI) was 
delimited, both blue and red (elastin) channels were merged and the amount of elastin 
in each region determined in a semi-quantitative manner by calculating the percentage 
area stained positive for elastin. 
Although images were taken on different days, the same thresholding was 
applied to all images, prior to analysis, so that the staining intensity would be as 
consistent as possible. As an additional measure, the ratio of IFM : FM area was also 
determined for each image, enabling a comparison of the area occupied by IFM 
between tendon types and determination of how it changes with age.  
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Figure 26: Representative image of a longitudinal section of the SDFT showing tendon 
structure and cell morphology used to identify the IFM, which is enclosed by white dashed 
lines. Note the greater cell density, and more rounded morphology of cells, in the IFM 
compared to those in the FM. Scale bar= 50μm. 
IFM 
FM 
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3.5.2. Elastin Semi-Quantification in Tendon – Results and Discussion 
Results revealed that most of the elastin (>90%) was localised to the IFM in 
both SDFTs and CDETs (Figure 23, Figure 27). The IFM in the SDFTs showed greater 
immunostaining for elastin (area fraction: 15.5% ± 4.2) compared to the IFM in the 
CDETs (7.6% ± 3.7, p<0.001) (Figure 27a). Likewise, the fascicular matrix in the 
SDFTs showed a larger percentage of elastin staining (0.24% ± 0.12) than the CDET 
FM (0.03% ± 0.02, p<0.001) (Figure 27b), although values were an order of magnitude 
less than measured in the IFM. 
 
Figure 27: Percentage area of IFM (a) and FM (b) showing positive immunostaining 
for elastin in young and old SDFTs and CDETs. Note the differences in scale between the IFM 
(a) and FM (b) regions. The ratio of IFM : FM area was also calculated for all samples, and is 
compared across tendon types and age groups (c). Significant differences between tendon types 
and age groups are identified by: * p<0.05, ** p<0.01 and *** p<0.001 (all normally distributed 
data – ANOVA). Data are displayed as mean ± standard deviation. 
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There was a decrease in the amount of elastin staining with age in the SDFT 
IFM (9.6% ± 2.4, p<0.001), whilst no age-related changes were seen in the CDET IFM 
(Figure 27a). In the fascicular matrix, there was a minor increase (p=0.038) with 
ageing in the percentage of elastin in the positional CDET and no age-related changes 
in the SDFT (Figure 27b). 
Concerning the amount of IFM in each tendon type, there was a significantly 
greater IFM : FM area ratio in the energy storing SDFT (0.36 ± 0.10) compared to the 
positional CDET (0.14 ± 0.05, p<0.001), and this ratio increased with age in both 
tendon types (p<0.01) (Figure 27c). 
These results support the hypothesis that elastin is localised to the IFM in both 
tendons types, with a higher prevalence in the IFM of energy storing tendons compare 
to positional tendons. Semi-quantitative analysis focusing on percentage area stained 
positive for elastin does not take into account overlapping fibres and so, an intensity 
measurement may assist in more fully characterising elastin prevalence. However, 
these results correlate well with the elastin localisation data, previously shown in this 
thesis (section 3.3.5). These results have now been published, reporting for the first 
time, on elastin localisation and semi quantification in different tendon types and how 
it changes with age (Godinho et al., 2017).  
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3.6. Assessment of Elastin Organisation in Tendon 
3.6.1. Image Scoring Methodology 
Semi-quantitative methods to assess elastin organisation in the immunostained 
images were also explored. Image scoring is one of the most traditional methods to 
assess organisation of different structures from microscopy images. Hence, this 
technique was first used to investigate elastin organisation in tendon. Confocal images 
were scored semi-quantitatively for elastin organisation by four independent scorers, 
blinded to tendon type and age. The observers were asked to score overall elastin 
organisation, and elastin fibre alignment parallel and perpendicular to the IFM. For 
each image, overall elastin organisation within the IFM was scored on a scale from 1 
to 5, where 1 denoted highly disorganised elastin fibres and 5 denoted highly organised 
elastin fibres. A representative image of a longitudinal section from a young SDFT 
was chosen and presented to all independent scorers. Scorers were provided context, 
in that a highly organised elastin structure (5) would mean they could identify one or 
more clear directions with which nearly all fibres were aligned, whilst highly 
disorganised elastin fibres (1) would equate to no clear directionality to any fibres. 
Looking more specifically at the orientation of elastin in the IFM, overall 
direction of elastin alignment (parallel or perpendicular to the IFM) was also scored 
on a scale from 1-5, where 1 was used to denote parallel to the IFM and the tendon 
long axis and 5 to denote high alignment in that direction. 
This type of assessment is limited, as it is affected by the subjective 
interpretation of the observers. Considering that observers will occasionally agree or 
disagree simply by chance, it is crucial to measure the agreement between them. The 
kappa statistic (or kappa coefficient) is the most commonly used statistic for this 
purpose (Viera & Garrett, 2005). A kappa of 1 indicates perfect agreement, whereas a 
kappa of 0 indicates agreement correspondent to chance. Thus, inter observer 
agreement was assessed by using an online software tool 
(http://dfreelon.org/utils/recalfront/recal3/) which determines the average pairwise 
Cohen’s Kappa statistic (Viera & Garrett, 2005).  
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3.6.2. Image Scoring – Results & Discussion 
Scorers reported that in both young and old tendons, SDFT elastin fibres 
showed significantly greater alignment perpendicular to the IFM (Figure 28c), whilst 
a significantly greater proportion of CDET elastin fibres were aligned parallel to the 
IFM (Figure 28b). Additionally, there was a significant reduction in the overall elastin 
organisation with ageing in SDFTs, which was not evident in CDETs (Figure 28a). 
Data shown in Figure 28 report a mean ± standard deviation of sample 
variability, adopting a mean of each observers score for each individual sample. 
Observer variability was further investigated with the analysis of the Cohen’s Kappa. 
The average pairwise Cohen’s Kappa for the overall elastin organisation, fibre 
alignment parallel to the IFM and perpendicular to the IFM were: 0.45, 0.48 and 0.39 
respectively, where 0.21–0.40 is considered fair agreement, 0.41–0.60 moderate 
agreement, 0.61–0.80 substantial and 0.81–1 almost perfect agreement between 
assessors (Viera & Garrett, 2005).  
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Figure 28: Image scoring for overall elastin organisation (a), alignment of elastin 
parallel with the IFM (b) and alignment of elastin perpendicular to the IFM (c). Overall elastin 
organisation within the IFM was scored on a scale from 1 to 5, where 1 denoted highly 
disorganised elastin and 5 denoted highly organised elastin. A scale of 1-5 was also used for 
elastin alignment parallel or perpendicular to the IFM, where 1 denotes poor alignment in the 
direction of interest and 5 denotes high alignment in that direction. Significant differences 
between tendon types and age groups are identified by: *p<0.05, **p<0.01 and ***p<0.001 
(all normally distributed data – ANOVA). Data are displayed as mean ± standard deviation of 
sample variability, adopting a mean each observer score for each individual sample. 
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3.6.3. Fast Fourier Transform - Method Development 
These data provide a first report of elastin organisation in tendon and how it is 
affected by ageing. However, as previously mentioned, blind scoring is very dependent 
on the user, and although the inter observer agreement was reasonable, there is still a 
high subjectivity implicit. Thus, using a more objective technique to investigate elastin 
organisation would improve the robustness of the analysis. 
The confocal images of elastin organisation were also analysed using a Fast 
Fourier Transform (FFT), which allows the extraction of quantitative data regarding 
elastin fibre orientation and alignment (Liu, 1991). First, the orientation of the tendon 
long axis was defined from the ordered structure of fascicular matrix. Four lines were 
drawn connecting the rows of tenocytes within the tendon fascicle, and from these, the 
average fascicle orientation was established, and adopted as the tendon long axis 
(Figure 29a). The directionality plugin was run in Fiji/ImageJ (Schindelin et al., 2013) 
which, having performed a FFT on the original image, determines the preferred 
orientation of structures present in the input image relative to the defined long axis. 
The plugin assumes any line of 2 or more pixels in length to be a fibre. This plugin 
computes a frequency distribution histogram, from the transformed image, indicating 
the number of structures in a given direction (Figure 29b). Briefly, it divides the image 
into small squares and computes their Fourier power spectra. Later, these spectra are 
analysed in polar coordinates and the power is measured for each angle (Liu, 1991). 
Data were reported in bins of 2 degrees over an angular range of 180 degrees (-90 to 
+90 degrees), with zero degrees denoting alignment with the tendon long axis. The 
circular standard deviation was calculated for each image, using CircStat (MATLAB) 
which returns the circular standard deviation of a vector of circular data. The mean 
and standard deviation of the circular standard deviation were determined for each 
tendon type and age group. To facilitate data visualisation, values were grouped 
together to generate 9 bins (20 degrees each). 
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c 
b a 
20 µm 
Figure 29: Pictorial representation of the methods used to determine the distribution 
of elastin fibre alignment within histological sections. The orientation of the tendon long axis 
was first established. Four lines were drawn connecting rows of tenocytes within the tendon 
fascicle and, from these, an average orientation was calculated and adopted as the tendon 
long axis (a). The orientation of elastin fibres within the IFM (seen more clearly in the inset) 
was then determined relative to the tendon long axis. The image J Directionality plugin was 
then run, to give frequency distribution histograms, indicating the number of fibres in any 
given direction, initially relative to the image x axis, reporting the data in bins of 2 degrees 
over an angular range of 180 degrees (-90 to +90 degrees, where 0 is aligned with the x axis) 
(b). Taking the calculation of tendon long axis, described in part a, fibre angles were 
corrected, such that 0 degrees would correspond to the direction of the tendon long axis, and 
the frequency distribution redrawn (c). 
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3.6.4. Elastin Organisation in Tendon – Results & Discussion 
Analyses of the frequency distribution of elastin fibre orientation in each image 
showed no significant differences in the circular standard deviation between tendon 
types in young samples, and no age related changes in CDETs (Table 7 and Figure 30a 
and b). On the other hand, old SDFTs have a higher circular standard deviation 
compared to young SDFTs (Table 7, Figure 30a), indicating that elastin fibres in 
energy storing tendons become more disorganised with age. Also, old SDFTs showed 
a higher circular standard deviation compared to old CDETs (Table 7), suggesting that 
the age related loss of elastin organisation is specific to the SDFT. 
 
Table 7: Circular standard deviation values, denoting the variability in elastin 
organisation in young and old SDFTs and CDETs. A larger number denotes more randomly 
distributed fibres. Significant differences between age groups are flagged with: *p<0.05, 
whilst significant differences between tendon types are denoted by: ª p<0.001 (normally 
distributed data – ANOVA). Data are displayed as Mean ± Standard Deviation. 
 
 
 
 
 
 
Circular Standard 
Deviation 
Young Old 
SDFT 42.81 ± 2.86* 46.10 ± 3.38 
CDET 40.37 ± 4.02 37.32 ± 5.52ª 
69 
 
 
These results support the initial hypothesis that elastin becomes disorganised 
with ageing, mainly in energy storing tendon.  
Previous studies have suggested that, with ageing, elastin undergoes damage 
which accumulates over time (Robert et al., 2008) and report an increase in elastin 
fragmentation with ageing, mainly in cardiovascular tissue (Sherratt, 2009, 
Greenwald, 2007). Taken together, the loss in elastin organisation in energy storing 
tendons, might be related to elastin fragmentation.  
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Figure 30: Frequency distribution of elastin fibre alignment, comparing young and old 
SDFT samples (a) (n=3), and young and old CDET samples (b) (n=3), with data combined 
from 48 images from three tendons from each group. Angles (θ) are given relative to the long 
axis of the tendon (denoted as 0 degrees). Data are displayed as mean ± standard deviation.  
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3.7. Assessment of Elastin Fragmentation in Tendon 
3.7.1. Desmosine Quantification – Method Development 
To explore elastin fragmentation with ageing in both tendon types, the presence 
of desmosine, a crosslink unique to mature elastin, was investigated as a marker of 
elastin fragmentation (Luisetti et al., 2008, Sherratt 2009, Lee et al., 2001, Heinz et al., 
2011). 
Tendon samples were separated into soluble and insoluble fractions using 
guanidine hydrochloride extraction and the amount of desmosine in each fraction was 
determined. Whilst the desmosine in the insoluble fraction represents the functional 
elastin crosslinked within the tendon matrix, the desmosine in the soluble fraction 
represents the crosslinked mature elastin which has been partially degraded. 
3.7.1.1. Protein Extraction  
Approximately 70mg wet weight of tendon, from 6 young and 6 old SDFT and 
CDET explants, previously prepared as described in Chapter 2, was used for 
desmosine analysis. Preliminary results showed that this amount of tissue was enough 
to perform the whole experiment. Tissue was powdered and freeze dried overnight, 
resulting in approximately 20mg of lyophilised powdered tissue.  
Soluble proteins were extracted by incubating overnight with agitation at 4°C 
in guanidine hydrochloride (GuHCl; 600μl of 4M guanidine hydrochloride, 50mM 
sodium acetate, pH 6.8 plus protease inhibitor cocktail) (Birch et al., 2008). The 
remaining pellet was centrifuged (15000g for 15 minutes) and the supernatant 
collected, after which the pellet was re-suspended in GuHCl and the extraction process 
repeated. A solution of 50 mM sodium acetate in 95% ethanol was added to the 
supernatant, at a ratio of 900 μl per 100 μl of supernatant. The soluble fraction was 
precipitated overnight at -20 °C, and the supernatant was removed following 
centrifugation (16000 g for 25 min). The pellet was washed three times (to remove all 
guanidine) with 95% ethanol in water, air dried and re-dissolved in 600 μl of 50 mM 
sodium acetate. The insoluble fraction was washed six times with water and freeze 
dried for 24h. Samples were weighed to determine how much soluble protein was 
extracted. Samples were then assayed for desmosine content as described below. 
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3.7.1.2. Desmosine Quantification 
A solid–phase competition Enzyme-linked Immunosorbent assay (ELISA) 
(B.I.T.S.® Desmosine ELISA Kit (Mologic Ltd, UK) was adopted to quantify levels 
of the crosslink desmosine as a marker of elastin degradation (Luisetti et al., 2008). 
This kit has been optimised in terms of assay range, specificity and interference to 
measure desmosine excreted into human urine as a free form, when elastin is degraded 
(Watanabe et al., 1989, Gunja-Smith 1985). Although desmosine in humans is 
identical to desmosine in different animal species, using this kit to measure desmosine 
in tendon tissue still represents a big challenge and requires validation of the its 
performance.  
First, total elastin content was measured in a small amount of both the soluble 
and insoluble fractions of each sample, using the FASTIN elastin assay, as developed 
previously (finalised protocol in Appendix B1). Approximately 300µl of the re-
dissolved soluble fraction (in 50mM sodium acetate) was measured and directly 
assayed. No dilutions or extractions were required. Regarding the insoluble fraction, 
approximately 2x2mg dry weight tissue was weighed and extracted twice in 0.25M 
oxalic acid. The resultant supernatant was assayed and the amount of elastin 
determined.  
Then, the remaining soluble and insoluble fractions of each sample were 
hydrolysed with 6M HCl (5mg/ml) for 48h at 110°C. Once cooled, samples were 
neutralised by adding an equivalent amount of 6M NaOH to every sample. pH paper 
was used to confirm that samples had a pH of approximately 7, as it had been 
established that if samples were too basic or acidic, the ELISA would not work. It 
should be noted that, as part of the validation process, direct removal of the HCl was 
attempted through lyophilisation, however poor mixing of proteins prevented use of 
this approach and necessitated the use of NaOH as neutralising agent  
Soluble and insoluble fractions were diluted prior to assay: 1:3 and 1:10, 
respectively to bring them within the range of the standard curve.  Previous tests were 
performed to determine the range of standards and the sample dilution factors. The 
ELISA protocol was performed according to the manufacturer’s instructions (Mologic 
LTD, UK). Both standards and test samples were assayed in duplicate. Desmosine 
content was determined by comparison to a standard curve and expressed as ng 
desmosine per mg of elastin content. 
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3.7.2. Desmosine Quantification – Results and Discussion 
Results showed that in the insoluble fraction, the amount of desmosine was 
significantly greater in the CDET (5720.8 ng DES/mg elastin ± 1516.8) compared to 
the SDFT (1776.1 ng DES/mg elastin ± 888.6, p<0.01) (Figure 31a). However, no 
tendon type differences were seen in the soluble fraction (Figure 31b). Similarly, in 
the old group, the amount of desmosine was significantly greater in the CDET (6758.5 
ng DES/mg elastin ± 1875.4) compared to SDFT (2871.8 ng DES/mg elastin ± 1418.9, 
p<0.01) (Figure 31a) with no tendon type differences identified in the soluble fraction 
(Figure 31b). No age-related differences in desmosine content were seen, either in the 
soluble or insoluble fractions. 
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Figure 31: Desmosine content expressed as ng desmosine per mg of elastin in both 
insoluble (a) and soluble (b) fractions of SDFTs and CDETs from horses separated into 2 groups 
based on age (n=6/age group). Note the differences in scale in the y axis between a and b. 
Significant differences between tendon types and age groups are identified by: ** p<0.01 (all 
normally distributed data – ANOVA). Data are displayed as mean ± standard deviation. 
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3.8. Discussion 
The majority of these results have been published in Scientific Reports 
(Godinho et al., 2017). This is the first study to quantify elastin content in two 
functionally distinct tendons, additionally reporting changes with ageing. The 
organisation and distribution of elastin fibres were also investigated, using several 
techniques to characterise their alignment, organisation and fragmentation in both 
young and old SDFTs and CDETs. The results broadly support the hypotheses, 
showing a greater amount of elastin in the energy storing SDFT, mainly localised to 
the IFM. With ageing, there was a decrease in elastin content and organisation in the 
energy storing SDFT, although no fragmentation was identified.  
Most of the elastin (>90%) was localised to the IFM in both tendon types, with 
greater elastin staining observed in the SDFT IFM compared to the CDET IFM. These 
findings support previous studies that have shown the IFM is comparatively rich in 
elastin, both in tendon (Grant et al., 2013) and ligament (Smith et al., 2011). Further, 
the data confirm recently published work suggesting a greater abundance of elastic 
fibres in the IFM of the energy storing SDFT, relative to the CDET IFM (Thorpe et 
al., 2016a). Previous studies have shown that the IFM in the SDFT is more extensible 
and less viscoelastic compared to CDET IFM (Thorpe et al., 2012, Thorpe et al., 
2015b). Therefore, these data suggest that the presence of elastin may provide the IFM 
with its elastic recoil ability, necessary for the efficient energy storing and return that 
is required in energy storing tendons (Thorpe et al., 2015b). 
It is important to highlight that this study is focused on equine tendon, and 
specifically on elastin as a component of the IFM. It is possible that energy storing 
tendons from other species utilise different mechanisms to facilitate extension, or that 
IFM components other than elastin confer the specialised mechanical properties of the 
IFM. However, the role of the SDFT, as an extreme energy storing tendon (Alexander, 
1991), makes it a useful tendon to investigate, as we would expect specialisations to 
be more pronounced. Also, as we are investigating structural differences associated 
with fatigue resistance, an initial focus on elastin seems appropriate. 
It should be noted that some of the elastin seen in the IFM may be associated 
with blood vessels. Indeed, the positive staining for endothelial markers observed in 
all samples of both tendon types, confirms the presence of blood vessels in both the 
SDFT and CDET, and localisation of vessels to the IFM, agrees with previous data 
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identifying this region as the source of tendon vascularisation (Tempfer & Traweger 
2015, Fenwick et al., 2002).The extent of CD31 staining is perhaps surprising, with 
every region of IFM in all samples staining positive, indicating that vascularisation of 
the IFM is extensive in all tendon types, not just the more highly loaded energy storing 
tendons. However, despite the prevalence of CD31 staining, a qualitative analysis of 
the IFM highlighted that the majority of elastin was not localised exclusively to the 
region of CD31 staining and vessels, suggesting a role for elastin as an integral 
component of the tendon matrix also. Applying a fast Fourier transform to the confocal 
images, yielded quantitative data about elastin alignment and orientation, and allowed 
comparison with a more traditional histological image scoring approach (Liu 1991, 
Berens 2009). In the young group, there were no significant differences in elastin 
organisation between tendon types, with both frequency distributions identifying a 
predominant fibre orientation parallel to the IFM. This seems at odds with the 
additional image analysis performed by the independent scorers, who reported that 
there were a greater number of elastin fibres aligned perpendicular to the IFM in the 
young SDFT than in the CDET. However, a closer comparison of the quantitative 
frequency distribution data does suggest that a greater proportion of fibres are fully 
aligned with the IFM in the CDET than the SDFT and fibres orientation is more evenly 
distributed in the SDFT. As fibres denoted “perpendicular” to the IFM by the scorers 
are unlikely to be at a precise angle of 90 degrees, it is likely the range of 
“perpendicular” fibres are seen across the bins at either end of the frequency 
distribution data, where greater values are seen for the SDFT compared to CDET. The 
presence of perpendicularly aligned elastin fibres in the SDFT IFM, suggests that, 
elastin orientation in the IFM may indeed play a crucial role in allowing fascicles to 
slide. We hypothesise that elastin fibres oriented in this perpendicular manner may 
serve as a “bridge” between adjacent fascicles, which would assist in returning 
fascicles to their initial location once external forces have been removed. 
With ageing, circular standard deviation increased in the SDFT, resulting in a 
significant difference in elastin organisation between old SDFTs and CDETs. This 
suggests that elastin fibres in the IFM of CDETs tend to remain more closely aligned 
with the tendon long axis than those in the IFM of the SDFTs, which become more 
dispersed with age. 
These data correlate well with image scoring, which indicated a significant 
decrease in the overall organisation of elastin in old SDFTs compared to young SDFTs. 
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Taken together, the results indicate that elastin becomes more disorganised with ageing 
in the energy storing SDFT. It was notable that, a significant increase in the IFM : FM 
area ratio in both tendon types was observed with ageing, suggesting that the IFM may 
be losing its structural integrity, possibly associated with changes in elastin 
organisation and decreased elastin content (Godinho et al., 2017). In contrast, previous 
studies have reported a significant reduction in SDFT IFM thickness with ageing, 
mainly in the distal region of the tendon (Ali et al., 2018). This might be explained by 
the different sectioning orientation these samples might undergo prior to further 
analysis. Often during sectioning, IFM region is damaged and the IFM tissue gets 
ripped apart, which may cause a misleading increase in thickness. 
In this study, immunofluorescent methods were used to assess semi-
quantitatively the amount of elastin in different tendon compartments. Attempts were 
made to establish the absolute amounts of elastin within the IFM and FM in both 
tendon types using a microdissection technique. However, this technique has proved 
time consuming and difficult to standardise. Laser capture microdissection was 
considered as an alternative approach to collect specific matrix regions. However, 
while the use of this technique allows isolation of different regions of tendon tissue 
with negligible contamination, it only allows the collection of very small amounts of 
tissue, such that biochemical assays would not be possible. Fortunately, biochemical 
assays are not the only available techniques that allow absolute quantification of the 
proteins in the laser captured tissue. Mass spectrometry is a well-established technique 
which also allows to determine the abundance of proteins in a sample. However, 
previous studies were unable to detect elastin in laser captured samples of FM and 
IFM, likely a technical issue because elastin is extremely insoluble and highly 
crosslinked, and therefore particularly difficult to identify using mass spectrometry 
(Thorpe et al., 2016c, Dakin et al., 2014). Future studies should focus on improving 
the methodology by implementing a few additional steps to the mass spectrometry 
analysis which have been suggested to help on the elastin detection (Heinz et al., 
2013). 
As elastin is highly hydrophobic and crosslinked, it is also highly resistant to 
proteolytic degradation. However, under repetitive loading, it undergoes damage 
which accumulates over time (Robert, Robert and Fu, 2008). With ageing, elastin is 
also degraded through chemical mechanisms which affect its function (Robert, Robert 
and Fu, 2008). Studies have shown an increase in elastin fragmentation with ageing, 
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which links to changes in tissue elasticity in cardiovascular tissues and increased 
human mortality (Sherratt 2009, Greenwald 2007).  
Indeed, previous studies have demonstrated that the IFM stiffens with age and 
becomes less fatigue resistant in energy storing tendons (Thorpe et al., 2013a, Thorpe 
et al., 2017). Elastin is a highly extensible, elastic and fatigue resistant protein, hence 
the overall reduction in IFM elastin seems likely associated with reduced IFM 
extensibility (Godinho et al., 2017). Further, the associated reduction in IFM fatigue 
resistance in ageing tendons has previously been linked to reduced IFM recoil after 
loading (Thorpe et al., 2013a, Thorpe et al., 2017, Thorpe et al., 2015c, Thorpe et al., 
2016b), and current data indicates that this may stem for the loss of elastin organisation 
and reduction in elastin “bridges” between fascicles (Godinho et al., 2017) . 
Taking these findings together, it was hypothesised that the reduction in elastin 
content and increasing elastin disorganisation seen with ageing may be due to elastin 
fragmentation (Godinho et al., 2017). Thus, in the current study, desmosine, an unique 
crosslink in mature elastin, was used as a marker of elastin fragmentation (Luisetti et 
al., 2008, Sherratt 2009, Lee et al., 2001, Heinz et al., 2011). The number of desmosine 
crosslinks was measured in the insoluble fraction (functional elastin crosslinked within 
the tendon matrix), and also in the soluble fraction (crosslinked mature elastin which 
has been partially degraded and therefore can be solubilised (Luisetti et al., 2008)). 
Data showed a 2-fold greater amount of desmosine per unit elastin content in the 
insoluble fraction of CDETs compared to SDFTs, however, no tendon type differences 
were seen in the soluble fraction. 
These results were unexpected and do not support the hypothesis. This might 
be due to the fact that the method used cannot detect fragmentation if the fragments 
remain insoluble. Alternatively, this might indicate that CDETs are more densely 
crosslinked compared to SDFTs. Previous studies have shown that the cross-linked 
regions of elastin are more rigid than regions free of crosslinks, meaning more 
crosslinking would reduce the overall compliance of the surrounding structure (Anwar, 
1990). This may explain why CDET IFM is less extensible than SDFT IFM. Similarly, 
in the old group, the CDET has a greater number of desmosine crosslinks in the 
insoluble fraction compared to SDFT. In the soluble fraction, once again, no 
significant changes were identified. However, it is important to highlight the greater 
variation in the SDFT data, mainly in the soluble fraction, compared to CDET. This 
could be due to variations in exercise history between horses, which may lead to 
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different levels of mechanical degradation within the tendon and different degrees of 
crosslink fragmentation. Unfortunately, it was not possible to collect an exercise 
history for the horses used in this study. It is also noteworthy that previous studies have 
demonstrated large variations in the mechanical properties of the IFM in the SDFT, 
particularly in the stiffness, failure properties (Thorpe et al., 2015c), and fatigue 
resistance (Thorpe et al., 2017, Thorpe et al., 2016b). These individual variations may 
result in the large variations in SDFT failure properties reported previously (Thorpe et 
al., 2013a, Batson et al., 2003) and also aid in explaining why some individuals are 
more at risk of tendon injury than others. 
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Chapter 4 -   The Effect of Elastin Depletion on the 
Mechanical Properties of Tendon 
4.1. Introduction 
Previously published work has focused on understanding how energy storing 
tendons can behave more elastically and stretch further than positional tendons. Two 
key energy storing tendon specialisations have been discovered; individual fascicles 
are helically wound like springs for elasticity (Thorpe et al., 2013b), and the matrix 
between fascicles is load bearing and elastic in nature, allowing fascicles to slide when 
loaded and slide back when load is removed (Thorpe et al., 2012). It has also been 
demonstrated that a loss of these specialisations with ageing leads to reduced fatigue 
tendon resistance (Thorpe et al., 2013a, Thorpe et al., 2014). Unravelling these 
mechanisms has exciting implications for treating tendon injuries, not only providing 
the functional understanding from which to develop treatments, but also for targeting 
preventive approaches to stop age-related loss of tendon elasticity. 
Published data suggested that changes to the interfascicular matrix (IFM) with 
ageing are a primary cause of tendon overload damage (Thorpe et al., 2013a). 
However, very little is known about the IFM and its overall contribution to tendon 
mechanics. Recent studies have shown high levels of proteoglycans in the IFM, and 
also elastin bridging across the IFM, linking fascicles (Thorpe et al., 2016a, Thorpe et 
al., 2016b). 
In chapter 3, it was shown that overall elastin content in tendon is low, but 
mainly localised to the IFM of energy storing tendons (Kannus 2000, Grant et al., 
2013, Godinho et al., 2017) suggesting that it may be of particular importance for IFM 
function, mainly in energy storing tendons. This chapter investigates the functional 
consequences of elastin in tendon in further detail, focusing on the energy storing 
SDFT. 
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4.2. Aims and Hypotheses 
The interaction of structural molecules in the extracellular matrix (ECM) of 
tendon influences its mechanical properties and response to load. Understanding how 
individual molecules contribute to the overall mechanics of the tissue is very important 
to better understand and treat tendon injuries, which affect severely both humans and 
animals. However, defining the mechanical role of a minor component of the ECM 
such as elastin, where it makes up less than 5% of the tendon dry weight, is 
challenging. Common approaches are either the use of genetic knockout models, or 
direct enzymatic treatment, combined with mechanical testing (Grant et al., 2015, 
Beenakker et al., 2012). 
It is hypothesised that IFM failure and fatigue properties will be detrimentally 
affected by a reduction in elastin content, whilst fascicle mechanical properties will 
not be affected. It was further hypothesised that SDFT IFM ability to recoil will be 
affected by elastin digestion. Lastly, it was hypothesised that tendon fatigue resistance 
is directly correlated to elastin content and elasticity of the IFM. These hypotheses 
were tested by performing elastase treatments to remove elastin from tendon sections, 
fascicles and IFM samples followed by analysis of the samples’ failure and fatigue 
properties. A custom designed uniaxial rig was also used to investigate IFM recoil 
ability after cyclic loading.  
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4.3. Sample Preparation for Validation of Elastin Removal  
Prior to any mechanical characterisation, it was necessary to optimise methods 
for removing elastin from tendon fascicles and IFM samples. 
Fascicles and IFM samples are of similar size and considered together for 
validation purposes. To simplify the validation process and to ensure penetration of 
the enzyme throughout the tissue, groups of at least 2 fascicles, joined by the IFM, 
were prepared for validation, such that if the removal of elastin was successful across 
fascicles and IFM in these larger samples, no difficulties will be anticipated for single 
fascicles. 
A SDFT quarter sections (n=1; 7 years old; Chapter 2) was removed from the 
freezer and allowed to thaw for 30min at room temperature, while being kept hydrated 
by spraying several times with PBS. Using a scalpel and size eleven blades, roughly 
20-25 groups of 2 intact fascicles (bounded together by the IFM), were dissected, and 
stored in a petri dish with a layer of tissue impregnated with PBS and placed in the 
fridge until required. Samples served as their own controls by comparing analysis with 
and without treatment. 
 4.4. Elastase Treatment Validation – Method Development 
To validate the elastase treatment, dose response experiments (enzyme 
concentration) were performed to determine the amount of elastase needed to digest 
the elastin in a pre-set incubation period of 16H. A 16H incubation period was set as 
a similar time period to other studies, and one which was compatible with the time 
available to do each experiment. Pairs of fascicles were divided into 3 groups: fresh, 
control and elastase. Samples in the “fresh” group remained stored in the petri dish in 
the fridge and were used within 16hours; samples in the “control” group were 
incubated in the buffer solution without elastase while samples in the “elastase” group 
were incubated in the buffer solution with elastase, both for 16 hours at room 
temperature. The purpose of having a “control” group in the validation is to help 
differentiate the influence of the incubation of the IFM samples from the action of the 
elastase in the specimens. 
While some studies have shown that 1U/ml and 36 hours of incubation were 
enough to digest approximately 50% of elastin from rat tail fascicles (Grant et al., 
2015), others showed that 3U/ml and 12 hours would be enough to digest similar 
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percentages of elastin from rat caudal and lumbar motion segments (Barbir et al., 2010) 
and human lumbar spines samples (Smith et al., 2008). Considering that both samples 
tested in these studies are of similar size to tendon IFM samples, it was decided to first 
test IFM samples treated under one of the following conditions: control (0 U/ml), 2 
U/ml, 4U/ml or 6U/ml elastase (approx. 4 IFM samples/condition). IFM samples were 
incubated in the control buffer (5ml 1x PBS plus 0.1mg/ml soybean trypsin inhibitor 
(SBTI)) with the specified amount of elastase (trypsin-free porcine pancreatic elastase, 
EPC134, Elastin Products Co., Owensville, MO). Elastase concentration (U/ml) was 
determined based on manufacturer-stated activity of >9 U/mg of protein on the 
substrate Suc-Ala-Ala-Ala-pNA, and that 1U will hydrolyse 1 μmol of 
substrate/minute at pH 8.3 and 25°C. Soybean trypsin inhibitor was added to the 
control buffer as it has been suggested that it helps block proteolytic action against 
collagen, in case the elastase is contaminated with trypsin (Oxlund et al., 1988, 
Henninger et al., 2013). Previous studies have established that 0.1mg/ml SBTI is 
enough for disabling any trypsin activity in the elastase solution (Grant et al., 2015). 
4.4.1. Immunostaining - Methodology for Measuring Elastin Depletion 
Confocal microscopy was used to investigate changes to the tissue composition 
with the elastase treatment. After incubation, one sample of each group: fresh, control, 
elastase (2U/ml, 4U/ml and 6U/ml) was rinsed twice in PBS, to facilitate removal of 
digested elastin fragments trapped in the tissue macrostructure, and immunostained for 
elastin and cell nuclei. Samples were fixed in 4% PFA for 30 min at room temperature, 
and then washed 3x in PBS. Samples were incubated in 10% Goat Serum for 1H at 
room temperature and then incubated overnight in the elastin antibody (Ab9519; 1:100 
dilution in 5% Goat Serum) at 4°C. They were then washed 3x in PBS and incubated 
in the secondary antibody (555 Goat anti Mouse IgG H+L, 1:500 in 5% Goat Serum) 
for 1H at room temperature (protected from light). After incubation, samples were 
washed 3x in PBS and incubated, for 5min, in DAPI staining (1:1000 in 5% goat 
serum). Preliminary results showed better cell nuclei staining if DAPI staining was 
carried out first, instead of combined Prolong Gold with DAPI staining step, as it 
seems to penetrate the tissue better. Tissue samples were finally washed twice in PBS, 
placed on poly-lysine slides and mounted with prolong Diamond antifade, and 
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coverslipped. Samples were stored in the fridge overnight to cure and imaged within 
24 hours. 
Samples were analysed under a laser scanning confocal microscope Zeiss 
ELYRA (Carl Zeiss AG, Oberkochen, Germany). A 63x oil objective was used for all 
imaging. Confocal z series were taken with a format of 225 x 225μm and a pixel size 
of 0.11 x 0.11μm and a z-step size of 0.25μm.  
4.4.2. Immunostaining - Preliminary Results & Discussion 
Samples from each treatment were imaged and while elastin was visible in both 
fresh and control samples, no elastin was seen in any of the samples incubated in the 
elastase solutions (2, 4 nor 6 U/ml). Thus, it was decided to prepare further samples 
and incubate them in solutions with a lower elastase concentration: 0U/ml 0.2U/ml 
and 2U/ml, while keeping the same incubation period (16H) and temperature (room 
temperature).  
A longitudinal section of another young SDFT tendon (6 years old), previously 
prepared was used.  IFM samples were dissected and incubated for 16H in one of the 
solutions as previously described: 0U/ml 0.2U/ml and 2U/ml. A few samples were 
kept aside for the fresh group and stored in a petri dish at 4°C until required. After 
incubation, samples were washed in 2x in PBS and divided into 2 groups – samples 
for biochemical analysis and samples for immunohistochemical analysis. Fresh 
samples were also equally divided. Samples for biochemical analysis were stored in 
cryotubes at -20°C until required, whereas samples for immunohistochemistry analysis 
were prepared as explained previously (4.4.1). 
Immunohistochemistry images showed elastin fibres in the IFM region of both 
fresh (Figure 32a) and control (Figure 32b) samples. Very few elastin fibres where 
seen in the samples treated with 0.2U/ml elastase (Figure 32c), and no elastin fibres 
were seen in the 2U/ml elastase treated samples (Figure 32d). 
These data confirmed the preliminary result that all elastin was removed with 
an elastase concentration equal or above 2U/ml. Thus, in order to further validate the 
elastin depletion and to investigate potential non-specific degradation of other 
structural ECM molecules, biochemical analyses were performed. 
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Figure 32: Representative confocal images showing IFM fresh samples (a) and after 
incubation in control buffer (b), 0.2U/ml elastase solution (c) and 2U/ml elastase solution (d) 
stained for elastin (ab9519 – red) and cell nuclei (DAPI-blue). The IFM region was imaged 
using a 63x oil objective lens. Scale bar: 20μm. Visible elastin fibres are noted with white 
arrows. 
b 
d c 
a 
84 
 
4.4.3. Biochemical Analysis – Methodology for Elastin Measuring Depletion 
The Fastin elastin assay (Fastin Elastin Assay Kit, Biocolor, UK), 
hydroxyproline assay (Birch et al., 1998) and DMMB assay (Farndale et al., 1986) 
were used to quantify the amount of elastin, collagen type I and sulphated GAG in 
fresh, control, 0.2U/ml and 2U/ml elastase treatment groups. In each group, at least 4 
samples were included (to ensure enough tissue to perform all three biochemical 
assays). All samples were powdered using a Micro dismembrator and then freeze 
dried. From each treatment group, approximately 2x3mg (dry weight) of the resulting 
tissue was measured, and stored in 2 different tubes for the Fastin Elastin assay. The 
remaining tissue (10-20mg dry weight) was solubilised in papain (section 3.3.3) in 
preparation for the hydroxyproline and DMMB assays. All assays were carried out 
following protocols described in section 3.3.2. 
4.4.4. Statistical Analysis 
All statistical analysis in this chapter were carried out using the software 
Minitab 17 for Windows. Data were tested for normality using the Anderson – Darling 
test. If normally distributed, a two-way ANOVA (grouping information using the 
Tukey Method and 95% confidence) was used to evaluate differences between 
treatments and age groups. Treatment and horse age were used as factors for the 
ANOVA. The number of each individual donor was also included in the analysis of 
variance (nested with the horse age) to ensure each fascicle from the same tendon was 
not considered an independent biological repeat, but instead a “technical repeat”. Data 
that did not follow a normal distribution was first transformed using a Box Cox 
transformation, and if still not normally distributed, a nonparametric test: The Mann–
Whitney was used. Details about the test used for statistical analysis in each instance 
is included in the captions of the graphs. All the results were considered statistically 
significant for p<0.05. Data in bar graphs are displayed as mean ± standard deviation. 
Box plots graphs show all data points (small circles). The bottom and top of the boxes 
represent the first and third quartiles, while the line inside the box represents the 
median. The ends of the whiskers correspond to the lowest/highest data point of the 
distribution.  
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4.4.5. Biochemical Analysis – Results  
Results from the Fastin elastin assay showed a significant reduction of tissue 
elastin content when incubated in either 0.2U/ml or 2U/ml elastase (approximately 
59% and 71% elastin reduction, respectively) compared to fresh samples (Figure 33). 
No significant differences were seen between fresh and control samples, suggesting 
that the elastin content of IFM samples was not affected by incubation itself, but only 
when elastase was present in the solution. Although the more concentrated enzyme 
treatment reduced the elastin content by approximately 11%, this difference was not 
statistically significant, suggesting that the 10 fold increase in elastase concentration 
does not proportionally result in a reduction of elastin (Figure 33).  
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Figure 33: Elastin content, expressed as a percentage dry weight of tendon tissue, 
with the percentage of elastin reduction shown with the green arrows and associated numbers. 
Samples from 1 horse aged 6 years were used. Significant differences between treatments are 
identified by: *** p<0.001 (normally distributed data – ANOVA). Data are displayed as mean 
± standard deviation. 
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Results from the DMMB assay showed no significant changes in GAG content 
between fresh and control samples. However, a significant GAG reduction was seen 
when samples were incubated in 0.2U/ml and 2U/ml elastase (approximately 74% and 
80% GAG reduction, respectively) compared to fresh samples (Figure 34). These 
results suggest that GAG content is not affected by the incubation itself, but is affected 
by the presence of elastase. There were no significant differences in GAG content 
between samples incubated in 0.2U/ml and 2U/ml (Figure 34). 
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Figure 34: GAG content, expressed as µg/mg dry weight of tendon tissue, with the 
percentage of GAG reduction shown with the green arrows and associated numbers. Samples 
from 1 horse aged 6 years were used. Significant differences between treatments are identified 
by: *** p<0.001 (normally distributed data – ANOVA). Data are displayed as mean ± standard 
deviation. 
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Results from the hydroxyproline assay showed no significant changes in 
collagen content between any treatments (Figure 35), but a trend towards increased 
collagen content, particularly after elastase treatment. 
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Figure 35: Collagen content, expressed as a percentage dry weight of tendon tissue, 
with the percentage of collagen increase shown with the green arrows and associated 
numbers. Samples from 1 horse aged 6 years were used. No significant differences (normally 
distributed data – ANOVA). Data are displayed as mean ± standard deviation. 
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4.4.6. Elastase Treatment Validation – Discussion 
Results from the biochemical analysis showed an elastin reduction of over 70% 
when samples were incubated in a 2U/ml elastase solution. These results support 
previous studies, that have reported similar elastin reduction, when comparable 
treatments were performed (Grant et al., 2015, Smith et al., 2008). 
Immunohistochemistry data showed no elastin fibres when samples were subject to 
the same treatment (2U/ml elastase). The low amount of elastin measured by the Fastin 
elastin assay might be a result of elastin fragments trapped in the tissue, which were 
either too small to visualise with immunohistochemistry or digested in such a manner 
that the elastin antibody no longer recognised them. 
Elastase treatment also resulted in a significant decrease in GAG content, 
particularly in a 2U/ml elastase solution (>80%). Previous studies have similarly 
reported significant reduction of GAG content (32-92%) in other tissues exposed to 
elastase treatments, likely occurring as GAG is less tightly bound within the ECM, and 
thus easily released by any disruption (Smith et al., 2008, Jacobs et al., 2012, Grant et 
al., 2015). Whilst the loss of GAG is of concern, several previous studies have 
investigated the effect of GAG digestion on tissue mechanics, as it has been suggested 
GAGs may have an important function as facilitators of load transfer between fibrils, 
and failed to show real changes in mechanics when GAGs are enzymatically removed 
from the tissues (Legerlotz et al., 2013, Lujan et al., 2009). 
In contrast to GAGs, collagen content was not reduced by treatments, but there 
was a trend towards increased collagen content in samples exposed to elastase. These 
data are unsurprising when it is noted that data are presented as percentage of dry 
content, and elastin and GAG content were both drastically reduced. 
There were no significant differences in elastin, GAG or collagen content in 
samples treated with 0.2U/ml and 2U/ml, suggesting a logarithmic effect and thus 
diminishing returns from increasing the enzyme concentration. Nonetheless, digestion 
of elastin was consistently elevated at 2U/ml relative to 0.2U/ml. The validation was 
performed in young samples, which have shown a higher amount of elastin (Chapter 
3). As no differences in elastin crosslinking between young and old SDFT samples 
were identified in previous tests, elastin in young and old samples was expected to be 
digested similarly. 
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Taking these results together, it was decided to use 2U/ml elastase solution to 
remove elastin from the IFM and fascicle samples, and subsequently, assess changes 
in their mechanical properties. 
 
4.5. Failure Properties of SDFT Fascicles and IFM Exposed to 
Elastase 
4.5.1. Sample Preparation 
SDFTs from 5 young (3 to 7 years – young group) and 5 old (15 to 19 years - 
old group) horses were used. Approximately 45 fascicles and 45 IFM samples were 
dissected from longitudinal tendon sections previously prepared, as described in 
Chapter 2. Fascicles and IFM samples were equally separated into 3 groups: Fresh, 
Control and Elastase (15 fascicles and 15 IFM samples/treatment/tendon used). After 
dissection, samples in the fresh group were tested within 16 hours and the remaining 
samples were incubated for 16 hours at room temperature in control buffer or control 
buffer + elastase. 
4.5.2. Incubation Protocol 
Fascicles and IFM samples in the Control group were placed in a petri dish and 
covered with 5 ml of 1x PBS plus 0.1mg/ml SBTI solution. Samples in the elastase 
group were also placed in a petri dish and 5 ml 2U/ml elastase (trypsin-free porcine 
pancreatic elastase, EPC134, Elastin Products Co., Owensville, MO) in 1x PBS plus 
0.1mg/ml SBTI solution was added. Samples were incubated for 16H, at room 
temperature, with moderate agitation. 
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4.5.3. Fascicles and IFM Failure Properties – Protocol for Testing 
After incubation, samples were removed from the solutions, rinsed twice in 
PBS and transferred to a new petri dish with tissue paper dampened with PBS. After 
incubation, fascicle diameter was measured using a non-contact laser micrometer 
(Thorpe et al., 2013a) (Figure 36). Assuming that fascicles have a circular shape, the 
smallest Cross Section Area (CSA) of fascicles was calculated using the formula below 
[1].  
𝑪𝑺𝑨 = 𝝅𝒓𝟐                    [1] 
 
 
Figure 36: Images showing the procedure for measuring the diameter of fascicles using 
a non-contact laser micrometer (a). Fascicles are placed in a metal holder (b), which has a 
10mm gap. The metal holder is manually moved so that the 10mm gap is exposed to the laser 
beam. The metal holder is moved so the length of the fascicle in the 10mm gap travels though 
the laser beam and the diameter of the fascicle continually recorded along the testing region 
(b). The smallest number was taken (c) and used as the final diameter of the fascicle, for 
calculating CSA. 
a b 
c 
Metal Holder 
Laser 
10mm Gap 
Fascicle 
Metal Holder 
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The failure properties of fresh, control and elastase treated fascicles and IFM 
samples were investigated. For mechanically testing these samples, an electrodynamic 
testing machine (Instron ElectroPuls 1000) with a 250N load cell, was used (Figure 
37a).  Samples were gripped using pneumatic grips (gripping pressure of 4Bar) with a 
layer of rubber (0.3mm thick) and sandpaper (0.1mm thick) over each grip surface. 
The distance between the grips was set to 20mm. The test method was set using the 
Instron software for dynamic and fatigue testing (WaveMatrix™). 
Fascicles were secured in the grips (Figure 37b) and pre-loaded to 0.1N, which 
represents a load of approximately 2% of fascicle typical failure load, to remove the 
slack. After the pre-load, the value of grip to grip distance was recorded as the correct 
value of gauge length. Then, fascicles were preconditioned with 10 loading cycles 
between 0 and 3% strain (approx. 25% of failure strain) using a sine wave at frequency 
of 1Hz. Immediately after preconditioning, fascicles were pulled to failure, at room 
temperature, at a strain rate of 5% per second. Samples was kept hydrated by spraying 
with PBS. For each test, the location of sample failure was also recorded (e.g. broke 
in the middle or in the grips; slipped in one or in both grips) and any fascicles that 
broke close to the grips or slipped were excluded from further analysis. 
IFM samples were pre-loaded to the smallest positive load value that could be 
detected (approximately 0.02N; to remove slack). Once the intact end of each opposing 
fascicle was gripped (Figure 37c), the interfascicular matrix was pre-conditioned with 
10 loading cycles between 0 and 0.5mm of extension (approx. 25% of failure 
extension) using a sine wave at frequency of 1Hz. Then, samples were pulled apart to 
failure at a speed of 1mm/s at room temperature (Figure 37d). Samples were kept 
hydrated by spraying with PBS. For each test, the location of sample failure was also 
recorded. In cases where fascicles broke rather than pulling apart, samples were left 
out of further analysis.  
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Figure 37: Images showing an electrodynamic testing machine - Instron ElectroPuls 
1000 - with a 250N load cell (a). Fascicles (b) and an IFM samples (c) were secured in the 
pneumatic grips, prior to testing. Samples were pulled to failure at room temperature. Image 
showing an IFM sample where the opposing fascicles were totally pulled apart at the end of 
the test is also included (d). 
d 
a b 
Fascicle 
c 
IFM 
Sample 
Load 
Cell 
Pneumatic 
Grip 
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4.5.4. Calculation of Fascicle and IFM Failure Properties 
Force and displacement data for both fascicles and IFM failure tests were 
continuously recorded at 100 Hz during both preconditioning and pull to failure. Due 
to some unexpected noise from the machine, force data was smoothed, prior to any 
calculations, using a 9-point moving average filter (Legerlotz et al., 2010). 
Displacement at which the initial pre-load was reached was taken as the start point for 
the test to failure in both fascicles and IFM samples.  
MATLAB was used to determine all mechanical test outputs from the data 
directly. Failure load was determined as the maximum load samples sustained prior to 
failure, and failure extension as the extension at the point of failure load. A continuous 
stiffness was calculated across every 9 data points of each force-extension curve. From 
these data, a maximum stiffness value was determined. 
For each fascicle sample, engineering stress and strain were calculated using 
the CSA (calculated from the previously measured individual fascicle diameter) and 
effective gauge length, respectively. A continuous modulus was calculated across 
every 9 data points of each stress strain curve and smoothed using a 5-point moving 
average filter. From these data, a maximum modulus value was determined. 
For all samples, hysteresis was also calculated as the percentage difference in 
the area under the loading and unloading curves comparing behaviour in the first and 
tenth preconditioning cycles. 
After analysis, any fascicle or IFM sample in which failure properties or 
maximum modulus were more than 2.5 times above or below the standard deviation 
of the mean, were excluded. 
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4.5.5. Fascicle Failure Properties – Results 
Fascicle failure and viscoelastic properties are shown in Figure 38- Figure 40. 
There were no significant differences between treatments in any of the failure nor 
viscoelastic properties. No significant differences with ageing were identified in any 
of the calculated parameters either. These results correlate well with previous studies, 
where no major ageing changes were identified in SDFT fascicles (Thorpe et al., 
2015c), and also support the initial hypothesis that elastin, which comprises less than 
1% of the total area occupied by the fascicular matrix, does not have an effect on the 
mechanical properties of fascicles when removed. It is important to note that 
engineering stress calculations were adopted, such that CSA was considered 
unchanged throughout the failure tests, as it is extremely hard to determine changes in 
CSA during these tests. Whilst a calculation of true stress would account for this, and 
larger stress would be expected during the latter stages of the test, the difficulties in 
accurately calculating values precludes its use. Further, the measurement of stress is 
commonly confounded in biological tissues, owing to the fibre composition and 
hydrated nature of the tissue. The large diameter changes seen during tests stem 
primarily from water movement and not changes to fibre volume, making a stress 
calculation potentially flawed. For these reasons, almost all tests utilise an engineering 
stress calculations, hence this parameter is important for comparing across studies. 
However, assuming that SDFT fascicles have a Poisson’s ratio of approximately 1.3, 
it was calculated that during the latter stages of the fascicle failure tests, CSA would 
decrease approximately 26% (Thorpe, C., et al., 2013b). 
 
Figure 38: Failure Load (a) and Failure Extension (b) young and old SDFT fascicles 
subject to different treatments: Fresh, Control and Elastase (n=5/age group; total samples 
tested: 15/treatment/tendon). No significant differences were identified (all normally 
distributed data – ANOVA). 
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Figure 39: Stress (a), Strain (b) and maximum modulus (c) of young and old SDFT fascicles 
subject to different treatments: Fresh, Control and Elastase (n=5/age group; total samples tested: 
15/treatment/tendon). No significant differences were identified (all normally distributed data – 
ANOVA). 
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Figure 40: Hysteresis Cycle 1 (a) and Hysteresis Cycle 10 (b) of young and old SDFT fascicles 
subject to different treatments: Fresh, Control and Elastase (n=5/age group; total samples tested: 
15/treatment/tendon). No significant differences were identified (all normally distributed data – 
ANOVA). 
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4.5.6. IFM Failure Properties – Results 
IFM failure and viscoelastic properties are shown in Figure 41 and Figure 42, 
respectively. 
Fresh IFM samples showed similar mechanical properties to previously 
published data, with a failure force of around 1.5N, two thirds that of fascicles (Thorpe 
et al., 2015c, Thorpe et al., 2013a). No significant differences between fresh and 
control samples were found in any of the parameters calculated, which indicates that 
any treatment related differences are due to the elastase treatment and not due to the 
incubation. 
By contrast, the overall mechanical properties of IFM samples exposed to 
elastase were significantly affected. Results showed a significant reduction in the IFM 
failure load (Figure 41a) and maximum stiffness (Figure 41c) when elastin is removed, 
both in the young and old groups. Data also showed an overall increase in hysteresis 
in cycle 1 (Figure 42a) in young and old samples, and cycle 10 (Figure 42b) in young 
samples, between fresh/control and elastase treated samples. 
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Figure 41: Failure Load (a), Failure Extension (b) and Maximum Stiffness (c) of young 
and old SDFT IFM samples subject to different treatments: Fresh, Control and Elastase (n=5/age 
group; total samples tested: 15/treatment/tendon). Significant differences are flagged with: 
*p<0.05; **p<0.01 and ***p<0.001 (all normally distributed data – ANOVA). 
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Figure 42: Hysteresis Cycle 1 (a), Hysteresis Cycle 10 (b) of young and old SDFT IFM 
samples subject to different treatments: Fresh, Control and Elastase (n=5/age group; total 
samples tested: 15/treatment/tendon). Significant differences are flagged with: *p<0.05; 
**p<0.01 and ***p<0.001 (Hysteresis Cycle 1 - normally distributed data – ANOVA; 
Hysteresis Cycle 10 – non-normally distributed data– Man-Whitney test). 
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4.6. Fatigue Properties of SDFT Fascicles and IFM Exposed to 
Elastase 
4.6.1. Sample Preparation 
SDFTs from 5 young (3 to 7 years) and 5 old (15 to 19 years) horses were used. 
Approximately 45 fascicles and 45 IFM samples were dissected from longitudinal 
tendon sections previously prepared, as described in Chapter 2. Tendons used for 
fatigue testing were matched with those used for failure tests (shown in section 4.5), 
taking different longitudinal sections from the same tendon. Fascicles and IFM 
samples were equally separated into three groups: Fresh, Control and Elastase (15 
fascicles and 15 IFM samples/treatment/tendon used). After dissection, samples in the 
fresh group were tested within 16H and the remaining samples were incubated for 16H 
at room temperature in control buffer or control buffer and elastase. 
4.6.2. Incubation Protocol 
Fascicle and IFM samples in the Control group were placed in a petri dish and 
covered with 5 ml 1x PBS plus 0.1mg/ml SBTI solution. Samples in the elastase group 
were also placed in a petri dish, and 5 ml 2U/ml elastase (trypsin-free porcine 
pancreatic elastase, EPC134, Elastin Products Co., Owensville, MO) in 1x PBS plus 
0.1mg/ml SBTI solution was added. Samples were incubated for 16H, at room 
temperature, with moderate agitation. 
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4.6.3. Fascicles and IFM Fatigue Properties – Protocol for Testing 
After incubation, samples were removed from the solutions, rinsed twice in 
PBS and transferred to a new petri dish with tissue paper dampened with PBS. After 
incubation, fascicle diameter was measured and CSA calculated as previously 
described (Section: 4.5.3; Figure 36). 
The fatigue properties of fresh, control and elastase treated fascicles and IFM 
samples were investigated. For mechanically testing these samples, a mechanical 
testing machine (Electroforce 5500, TA instruments, Delaware, USA) (Figure 43a) 
with a 22N load cell, was used (Figure 43a). This machine functions inside a cell 
culture incubator (37 °C, 20% O2, 5% CO2). 
Each sample was secured in a custom designed chamber (Figure 43b). Samples 
were first secured in the top grip and then the bottom grip, with a grip to grip distance 
of 10mm. Once samples were secured, chambers were filled with PBS to prevent 
samples from drying out, and attached to the machine (Figure 43c). The test method 
was set using the Bose software WinTest®7 Controls. 
Fascicles were preloaded to 0.1N to remove any slack in the samples. As failure 
strain is more consistent between cycles than failure stress (Thorpe et al., 2012), one 
loading cycle of 1 mm displacement was applied, which corresponds to approximately 
10% strain, and 50% of the predicted failure strain (Thorpe et al., 2012). The peak load 
during the cycle was recorded, and used as the target load for the creep tests. 
IFM samples were pre-loaded to 0.02N to also remove any slack, and in the 
same manner, the load for creep tests was determined from a single loading cycle to 
1mm displacement, equivalent to approximately 50% of the predicted failure extension 
(Thorpe et al., 2012). 
In both fascicle and IFM tests, the identified load was applied cyclically to the 
samples at a frequency of 1 Hz until sample failure, with force and maximum and 
minimum displacement data, continuously recorded at 100 Hz throughout the tests. 
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4.6.4. Calculation of Fascicle and IFM Fatigue Properties  
For each test, the number of cycles to failure was recorded and creep curves to 
failure were drawn using the maximum and minimum displacement data. The creep 
rate (mm/cycle) of the first 10 loading cycles, as well as the secondary creep rate of 
both maximum and minimum displacements (mm/cycle) were calculated (Figure 44). 
Data from fascicle and IFM samples were compared between treatments and age 
groups. Samples that did not fail or where curves showed a clearly atypical shape 
(examples shown in Figure 45), were rejected from the data set. 
a c 
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Bottom Grip 
Top 
Grip 
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Figure 43: Images of the fatigue testing set up. The mechanical testing machine 
(Electroforce 5500) sits inside the incubator (a). Samples are secured in the metal chamber (b) 
where the load cell and other connectors attach (c). 
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Figure 44: Representative creep curve of a young SDFT fascicle. Minimum and 
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Figure 45: Representative curves that have been excluded from the data set. These 
curves were very different from the majority and showed a clear atypical behaviour. In some 
instances, friction in the grips or immediate overload of samples was evident (a); in other 
instances, the sample was not loaded, reporting no data at all (b). 
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4.6.5. Fascicle Fatigue Properties – Preliminary Results and Discussion 
The fatigue properties of fascicles are shown in Figure 46. Due to time 
constraints, only fascicles from two young and one old SDFTs were tested. Data 
showed considerable variability but no significant differences between treatments in 
any of the fatigue parameters calculated (Figure 46). With ageing, fascicles in the fresh 
group showed a significant increase in creep between cycles 1 and 10 (Figure 46b), 
which indicates, as seen in trends in other creep parameters, that old SDFT fascicles 
are more prone to creep than young fascicles. However, no differences in cycles to 
failure were seen. These results support the hypothesis that fascicle fatigue properties 
are not elastin content dependent. 
 
 
  
Figure 46: Cycles to failure (a), creep between cycles 1 and 10 (b), secondary creep 
rate of minimum (c) and maximum (d) displacement of young and old SDFT fascicles subject 
to different treatments: Fresh, Control and Elastase (n=2 (young group), n=1 (old group); total 
samples tested: 15/treatment/tendon). Significant differences are flagged with: **p<0.01 (all 
normally distributed data – ANOVA). 
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4.6.6. IFM Fatigue Properties – Results 
SDFT IFM fatigue properties are shown in Figure 47. Representative creep 
curves for young and old SDFT IFM samples are also shown in Figure 48. 
Data shows a significant reduction in the number of cycles to failure in elastase 
treated samples compared to both fresh and control groups (Figure 47a, Figure 48a). 
Results also show a significant increase in creep between cycles 1 and 10 (Figure 47b, 
Figure 48a) and also an increase in the secondary creep rate for minimum and 
maximum displacement, compared to both fresh and control groups (Figure 47c and 
d, respectively). 
With ageing, there was a trend towards the decrease in the number of cycles to 
failure in both fresh and control groups, as reported previously. However, after elastase 
treatment, samples showed the same significant decrease in the number of cycles to 
failure, and increase in all creep parameters (Figure 47, Figure 48b).  
No changes were seen between fresh and control groups in any of the 
parameters calculated, which supports the hypothesis that changes between treatments 
are caused by the presence of elastase and not by the incubation itself. Overall, these 
results support the hypothesis that, while fascicle fatigue properties are not affected by 
elastin depletion, IFM fatigue properties are directly influenced by elastin content.  
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Figure 47: Cycles to failure (a), creep between cycles 1 and 10 (b), secondary creep rate of 
minimum (c) and maximum (d) displacement of young and old SDFT IFM samples subject to 
different treatments: Fresh, Control and Elastase (n=5/age group; total samples tested: 
15/treatment/tendon). Significant differences are flagged with: **p<0.01 and ***p<0.001 (Cycles to 
Failure: normally distributed – ANOVA, all remaining IFM fatigue data not normally distributed – 
Mann-Whitney test). 
ElastaseControlFresh
12000
10000
8000
6000
4000
2000
0
C
y
c
le
s 
to
 F
a
il
u
re
Young
Old
*** 
ElastaseControlFresh
16
14
12
10
8
6
4
2
0C
re
e
p
 B
e
tw
e
e
n
 C
y
c
le
s 
1
 a
n
d
 1
0
 (
m
m
)
Young
Old** 
* 
ElastaseControlFresh
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
S
e
c
o
n
d
a
ry
 C
re
e
p
 R
a
te
 o
f 
M
a
x
. 
D
is
p
. 
(m
m
/C
y
c
le
)
Young
Old
*** 
ElastaseControlFresh
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
S
e
c
o
n
d
a
ry
 C
re
e
p
 R
a
te
 o
f 
M
in
. 
D
is
p
l.
 (
m
m
/C
y
c
le
)
Young
Old
*** 
** 
a b 
c d 
105 
 
 
 
 
  
0.0
1.0
2.0
3.0
4.0
0 100 200 300 400 500 600 700 800
D
is
p
la
ce
m
en
t 
(m
m
)
Cycle Number
Fresh vs Control vs Elastase Young SDFT IFM - Typical Creep Curves 
Fresh Max. Disp. (mm) Fresh Min. Disp. (mm)
Control Max. Disp. (mm) Control Min. Disp. (mm)
Elastase Max. Disp. (mm) Elastase Min. Disp. (mm)
a 
0.0
1.0
2.0
3.0
4.0
0 100 200 300 400 500 600 700 800
D
is
p
la
ce
m
en
t 
(m
m
)
Cycle Number
Fresh vs Control vs Elastase Old SDFT IFM - Typical Creep Curves
Fresh Max. Disp. (mm) Fresh Min. Disp. (mm)
Control Max. Disp. (mm) Control Min. Disp. (mm)
Elastase Max. Disp. (mm) Elastase Min. Disp. (mm)
b 
Figure 48: Typical creep curves of young SDFT IFM (a) and old SDFT IFM (b). 
Maximum and minimum displacement for each treatment Fresh, Control and Elastase are 
represented. 
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4.7. Recovery Properties of SDFT IFM Exposed to Elastase 
4.7.1. Sample Preparation 
SDFTs from 5 young (3 to 7 years) and 5 old (15 to 19 years) horses were used. 
Approximately 16 IFM samples were dissected from longitudinal tendon sections 
previously prepared, as described in Chapter 2. All samples used in recovery tests were 
matched with the ones used in the failure and fatigue testing (shown in section 4.5 and 
4.6, respectively). IFM samples were separated into three groups: Fresh, Control and 
Elastase (6 IFM samples/treatment/tendon used). After dissection, samples in the fresh 
group were tested within 16H and the remaining samples were incubated for 16H at 
room temperature in control buffer or control buffer and elastase, following the 
procedure outlined in section 4.6.2. 
 
4.7.2. IFM Recovery Properties - Protocol for testing 
Previously prepared and treated samples were divided in three testing groups 
as described in the schematic below.  
 
18x IFM 
Samples/tendon
6x Fresh
2 x 0.5mm Displacement (~25% Failure Extension)
2 x 1mm Displacement (~50% Failure Extension)
2 x 1.5mm Displacement (~75% Failure Extension)
6x Control
2 x 0.5mm Displacement (~25% Failure Extension)
2 x 1mm Displacement (~50% Failure Extension)
2 x 1.5mm Displacement (~75% Failure Extension)
6x Elastase
2 x 0.5mm Displacement (~25% Failure Extension)
2 x 1mm Displacement (~50% Failure Extension)
2 x 1.5mm Displacement (~75% Failure Extension)
Dissection Treatment Testing
Figure 49: Schematic showing how samples were divided for the IFM recovery testing. 
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A custom designed tensile straining rig (Figure 50) with a 10N load cell was 
used to investigate the ability of IFM samples to recover initial dimensions after cyclic 
loading. The rig was developed and validated by Screen’s group and previously used 
to measure the microstructural response of tendon fascicles when subjected to different 
strains (Cheng & Screen 2007). 
Stainless steel grips were secured at a 15mm grip to grip length, using a metal 
spacer (Figure 50a), and the sample secured in the grips, such that a single intact 
fascicle was held at each end, with the IFM testing region in the middle (Figure 
50b).Once samples were secured in the grips, grips were turned upside down and four 
vertical lines (equally spaced) were manually drawn across the 10mm IFM testing 
region using a permanent marker pen, so that they would be visible when observed 
from above (Figure 50c). Grips were then secured into the rig and the sample immersed 
in PBS (Figure 50d). 
 
a 
b 
c 
d 
e 
Figure 50: Images showing the preparation of samples for IFM recovery testing. Grips 
were secured using a 15mm spacer (a) and the sample secured in the grips (b). Four lines were 
drawn transversely across the 10mm testing region of the samples (c), then grips were 
transferred to the rig (d). A camera is positioned so that the test could be recorded from above 
(e). 
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A Canon EOS 700D camera with a Sigma 105mm F2.8 EX DG MACRO OS 
lens was secured in a tripod and placed over the sample to allow visualisation of sample 
movement. Controlled by linear actuators, the grips were slowly moved apart, applying 
0.05mm increments of displacement, whilst visually monitoring the sample until it 
lifted slightly off the base of the rig (Screen et al., 2004). This provided a consistent 
start point for tests and removed any slack. 
Samples were subjected to 10 loading cycles at 0.5Hz between 0mm and 
0.5mm, 1mm or 1.5mm, which corresponds to approximately, 25, 50 or 75% of IFM 
predicted failure extension, respectively, followed by a ten second hold period to allow 
for any IFM recovery. Video footage was recorded throughout the test. At the end of 
the test, samples were pulled to failure at a rate of 1mm/s, to ensure there were no 
intact fascicles in the test region. Samples that did not fail properly or that had intact 
fascicles in the testing region were excluded from the data set. 
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4.7.3. IFM Recovery Properties - Data analysis 
The video of each test was split into frames, from which four specific time 
points during the test were selected and further analysed (Figure 51): 
A - Initial point (after pre load and before cyclic loading to serve as a 
reference); 
B - Maximum displacement (taken as the peak of the last loading cycle); 
C - After loading (recovery immediately after load is removed); 
D – Holding period (recovery ten seconds after load is removed). 
 
 
A cutting board was placed under the rig, where 1 square equals 10 mm, 
(Figure 50c) to provide a scale for images. 
A MATLAB code was then written and validated by a member of Screen’s 
research group, to analyse the angular deviation of lines, comparing images taken at 
different moments of the testing. The code was able to automatically identify each line 
(also called marker), trace its orientation and then detect its angle relative to the 
vertical. The code was divided into two sections: one to “find the marker” (Appendix 
C1.1) and another to “analyse the image” (Appendix C1.2). 
Figure 51: Representative displacement over time graph of an IFM sample being 
cyclically loaded between 0 and 25% of its predicted failure extension. For this case, thirty-
nine frames in total were extracted from the video and from those, four were extracted at the 
specified moments for further analysis (identified with the red circles and corresponding 
images); A: initial point, B: maximum displacement, C: after loading and D: holding period. 
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To briefly describe the process, Fiji (ImageJ) was used to draw a region of 
interest (ROI) around the lines, using ROI manager function, allowing the relevant 
image region to be cropped (Figure 52). The same ROI was then applied to the other 
selected images of that sample. 
 
Original images (Figure 53a) were smoothed in MATLAB using a Gaussian 
filter and then thresholded, using the same parameters for all images (sensitivity 0.1; 
marker margin 10, chosen from empirical data) (Figure 53b). Each marker was divided 
into multiple horizontal rectangles, and for each one, the centre of mass was found 
(position in x axis) (Figure 53c) and the interpolated line drawn (Figure 53d). Then, 
the interpolated lines generated from the first image (initial point – called “Ref=A”) 
were compared with those in the second image (maximum displacement – called 
“set1=B”, Figure 53e), third image (after loading – called “set2=C”, Figure 53f) and 
finally fourth image (holding period – called “set3=D”, Figure 53g). The displacement 
of each line, and angle relative to that in the reference image (initial point - “ref “), 
were calculated. Efforts were made to adjust images for some motion of the entire rig. 
However, it was not possible to do this robustly. As involuntary motion will only affect 
absolute measurement of displacement, it was decided to report only angle deviation 
of lines in further analysis, as this variable is not affected by vertical or horizontal 
motion. 
Figure 52: Print screen of the method used to crop the images for MATLAB analysis. 
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b 
c 
d 
A B C D 
a 
A B 
A C 
A D 
e 
f 
g 
Figure 53: Images showing the step-by-step procedure for data analysis using 
MATLAB. Original images (a) were smoothed and thresholded (b). Each marker was 
divided into multiple horizontal rectangles, and for each one, the centre of mass was found 
(c) and the interpolated line drawn (d). Then, the interpolated lines generated from the first 
image (Ref=A) were compared with those in the second image (e) (set1=B), third image (f) 
(set2=C) and finally fourth image (g) (set3=D). 
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Once the angle deviation between “A & B”, “A & C” and “A & D” for every 
line on a single image was calculated, data from the four lines was averaged, and used 
as the overall angle deviation of the sample at maximum displacement (“B”), after 
loading (“C”) and holding period (“D”). From this, other variables were calculated 
such as: percentage recovery after loading (at “C”) and the total percentage recovery 
after holding period (10s of extra recovery - at “D”). 
 
 
Deviation of lines was evident when analysing all videos, however in many 
instances, particularly with smaller applied displacements, the angles were very small. 
Validation of possible error in the MATLAB code showed that shifting the 
interpolated lines by 1 pixel, would affect the calculated angle by approximately 0.2 
degrees. Thus, from the data set, any values lower than 0.2 degrees were excluded 
from the data set. Most of these cases happened in samples that had been cyclically 
loaded up to 25% or 50% of the predicted sample failure extension. For these cases, 
the angle deviation was very small and data was extremely variable (Figure 54). 
Hence, further detailed analysis focusses on samples only loaded up to 75% of their 
predicted failure extension. 
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Figure 54: Angle deviation at maximum displacement for young SDFT IFM samples 
(n=5; total samples tested: 2/treatment/testing condition/tendon). Data are displayed as mean 
± standard deviation. 
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4.7.4. IFM Recovery Properties - Results 
IFM recovery properties are shown in Figure 55 - Figure 57. Data showed a 
significant increase in the angle deviation in the elastase group compared to both fresh 
and control groups (Figure 55). The percentage recovery after loading was also 
significantly lower in the elastase group compared to either of the other groups, both 
immediately after loading (Figure 56) and total recovery including the holding period 
(Figure 57). In aged samples, similar overall trends were evident, but it was notable 
that immediate recovery after loading was significantly better in the aged then young 
elastase treatment group (Figure 56). Total recovery showed no age related changes, 
however results showed no significant differences between fresh and control groups 
in any of the calculated parameters, suggesting that the changes in the IFM recovery 
properties between groups are specific to the elastase treatment and not the incubation. 
These results support the hypothesis that elastin functions to transfer stress between 
fascicles providing an extensible interface with high recoil ability in the IFM of energy 
storing tendons. 
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Figure 55: Angle deviation (degrees) calculated at the point application of 75% of the 
failure extension (“B: Maximum displacement - taken as the peak of the last loading cycle”) 
for young and old SDFT IFM samples subject to different treatments: Fresh, Control and 
Elastase. Samples were stretched up to 75% of their predicted failure extension. Significant 
differences are flagged with: *p<0.05 (data non-normally distributed – Mann-Whitney test). 
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Figure 56: Recovery after loading to 75% of the failure extension (“C: After loading 
- recovery immediately after load is removed”) for young and old SDFT IFM samples subject 
to different treatments: Fresh, Control and Elastase. Samples were stretched up to 75% of 
their predicted failure extension. Significant differences are flagged with: *p<0.05 and 
**p<0.01 (data non-normally distributed – Mann-Whitney test). 
Figure 57: Total Recovery to 75% of the failure extension (“D: Holding period - 
recovery ten seconds after load is removed”) for young and old SDFT IFM samples subject 
to different treatments: Fresh, Control and Elastase. Samples were stretched up to 75% of 
their predicted failure extension. Significant differences are flagged with: *p<0.05 (data non-
normally distributed – Mann-Whitney test). 
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4.8. Failure Properties of SDFT Quarter Sections 
4.8.1. Sample Preparation for Validation of Elastin Removal 
SDFT quarter sections, previously prepared (Chapter 2), were used to first 
validate the ability to remove elastin with elastase from these much larger sections of 
tendon. Four sections from a young (n=1; 7 years old) and four from an old (n=1; 17 
years old) SDFT were removed from the freezer and allowed to thaw for 30 minutes 
at room temperature. During this period, tissue was kept hydrated by spraying several 
times with PBS. Samples served as their own controls by comparing analysis with and 
without treatment.  
4.8.2. Elastase Treatment Validation Protocol 
To validate the elastase treatment, dose response experiments (enzyme 
concentration) were performed to determine the amount of elastase needed to digest 
the elastin in a pre-set incubation period of 24H. One young and one old sections were 
allocated to a fresh group, with the remaining six samples utilised for elastase 
treatment. Fresh samples were immediately dissected, to remove small squared 
samples (5x5x5mm), from the mid-metacarpal region of the section, which were then 
stored in cryotubes. Samples in the “elastase” group were incubated in the buffer 
solution (1x PBS plus 0.1mg/ml SBTI solution) with elastase (trypsin-free porcine 
pancreatic elastase, EPC134m Elastin Products Co., Owensville, MO), for 24 hours at 
room temperature, in either 1 U/ml, 5U/ml or 10U/ml elastase (1 young and 1 old 
section/condition), with mild agitation. 
SDFT quarter sections are roughly 10 times the volume of IFM samples, which 
means that a much greater volume of solution would be needed. As elastase is such an 
expensive enzyme, a special container was designed and manufactured, especially to 
fit these samples and use the least amount of solution possible (Figure 58). 
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It was calculated that for each cavity, 20ml of solution would be needed, and 
appropriate concentrations of elastase in buffer were prepared accordingly. 
Longitudinal sections (Figure 59a) were incubated in the control buffer with elastase. 
Taking into account the design of the container, only the middle region of the section 
(the region of interest) was immersed in the solution (Figure 59b). To prevent samples 
from drying out, the ends of the sections were wrapped in tissue (dampened in PBS) 
(Figure 59b) and the whole container in foil (Figure 59c). More foil was then added 
on top of the container, to prevent evaporation of the solution. 
After treatment, samples were rinsed three times in PBS, and small squared 
samples (5x5x5mm) dissected from the middle region of the section and stored at -
20°C in cryotubes, as described for fresh samples. 
 
 
 
 
 
 
Figure 58: Plastic container designed for the incubation of longitudinal quarter tendon 
sections. Scale bar: 30mm. 
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4.8.3. Biochemical Analysis 
A Fastin Elastin assay (Fastin Elastin Assay Kit, Biocolour, UK), 
hydroxyproline assay (Birch et al., 1998) and a DMMB assay (Farndale et al., 1986) 
were used to quantify the amount of elastin, collagen type I and sulphated GAG, 
respectively. When needed, samples were removed from the freezer, and organised in 
groups according to the treatment (fresh, 1U/ml, 5U/ml and 10U/ml). In each group, 
at least 4 small squared samples were included in the analysis, to make up enough 
tissue to perform all three biochemical assays. All samples were powdered using a 
Micro dismembrator and then freeze dried. From each group, approximately 2x3mg 
(dry weight) was measured and stored in 2 different tubes for the Fastin Elastin assay. 
The remaining tissue (10-20mg dry weight) was solubilised in papain (as described in 
Section 3.3.3) in preparation for the hydroxyproline and DMMB assays. Samples were 
assayed following protocols described in section 3.3. Statistical analysis was only 
conducted for elastin content, due to the limited number of samples in the 
hydroxyproline and DMMB assays. 
 
Fresh 
Section 
Sections for 
Elastase 
Treatment 
a b c 
Figure 59: Images showing SDFT quarter sections (a) being submerged for elastase 
treatment incubation (b). The ends of each section were wrapped in tissue and covered in foil 
(c) to avoid sample dehydration. Scale bar: 30mm. 
118 
 
4.8.4. Elastase Treatment Validation – Results and Discussion 
Results from the Fastin elastin assay are shown in Figure 60. No significant 
differences were seen between treatments or age groups. Although there was a trend 
towards elastin reduction in both young and old groups with elastase treatments, that 
reduction was not significant and only reached about 30% in the young samples and 
44% in the old samples, compared to fresh SDFT samples (Figure 60). 
Results from the DMMB assay (Figure 61) and hydroxyproline assay (Figure 
62) were not statistically analysed due to the fact that only one sample was measured. 
However, similar to previous observations, elastase treatments seem to induce some 
GAG release from the tendon tissue (Figure 61) but not collagen. Collagen content 
increased in the elastase treated samples, compared to fresh samples in both young and 
old samples (Figure 62). 
Although these results supported the previous elastase treatment validation in 
smaller SDFT samples, the percentage of elastin digested from the tissue was lower. 
This can be explained by the fact that these samples are much longer and thicker than 
IFM samples and so, much harder for the enzyme to penetrate the tissue. Indeed, 
digestion efficacy matched other published studies, highlighting the difficulties in 
removing the protein. Previous studies have attempted to quantify the mechanical 
effects of the partial digestion, but results analysis can be challenging. 
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4.9.5. Failure Properties of Fresh SDFT Quarter sections 
4.9.5.1. Sample Preparation 
4.9.5.2. Protocol for testing 
4.9.5.3. Results 
4.9.5. Fatigue Properties of Fresh SDFT Quarter Sections 
4.9.5.1. Sample preparation 
4.9.5.2. Protocol for testing 
4.9.5.3. Results and Discussion 
 
 
Figure 60: Elastin content, expressed as a percentage of dry weight tendon tissue, and 
the percentage of elastin reduction. Samples from one young horse (7 years) and one old horse 
(17 years) were used. No significant differences were found (all data normally distributed – 
ANOVA). Data are displayed as mean ± standard deviation. 
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Figure 61: GAG content, expressed as µg/mg of dry weight tendon tissue, and the 
percentage of GAG reduction. Sample from one young horse (7 years) and one old horse (17 
years) were used. 
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4.8.5. Failure Properties of SDFT Quarter Sections 
Protocols for mechanically testing large tendon sections were next established, 
and the mechanical properties of fresh quarter tendon sections first investigated. 
4.8.5.1. Sample Preparation 
SDFTs from 5 young (3 to 7 years – young group) and 5 old (15 to 19 years - 
old group) horses were used. A single longitudinal tendon section from each tendon 
(as described in Chapter 2) was removed from the freezer and allowed to thaw for 30 
minutes. Sections were kept hydrated by spraying several times with PBS. Once 
defrosted, the CSA of each section was measured, simple and non-destructive method 
using alginate paste (Goodship & Birch, 2005). This paste was used to create a cast 
around the tendon cross section, then after removal, transverse sections were cut along 
the cast, and digital images were taken (Figure 63). Using image analysis software 
(ImageJ) the CSA was determined by measuring the area that had been occupied by 
the tendon section. 
Figure 62: Collagen content, expressed as percentage dry weight tendon tissue, and the 
percentage of collagen reduction. Sample from one young horse (7 years) and one old horse 
(17 years) were used. 
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4.8.5.2. Protocol for Testing 
Gripping large tendon specimens is difficult, as failure forces are large. Also, 
tendon is highly hydrated, hence the forces required to prevent slippage are very large. 
In order to mechanically test large tendon sections, it was first necessary to optimise a 
gripping method to securely grip samples during testing, whilst minimizing both 
slippage and sample damage. Multiple attempts were made to use classic wedge-
shaped compressions grips, and increase the coefficient of friction at the grip surface 
with sandpaper or cardboard to balance gripping force and friction to secure the 
samples without slippage or excess damage. After a series of failures, cryogrips 
(Figure 64a) were custom made for these samples, freezing the ends, to enable tighter 
compression gripping without damage (Riemersa & Schamhardt, 1982). 
The failure properties of fresh longitudinal SDFT quarter sections were 
investigated. For mechanically testing these samples, a hydraulic testing machine 
(Instron 8801) with a 50KN load cell, was used (Figure 64b). Cryogrips were installed 
in the testing machine, with a grip to grip distance of approximately 100mm and cooled 
down using CO2 provided by cylinders connected to the grips. Once the grip surfaces 
were frozen, tendon samples were quickly placed between them (Figure 64c) and grips 
Figure 63: Transverse cut of the alginate cast formed around the tendon section. The 
scale (created with a ruler) is used to calculate the cross sectional area corresponding to the 
tendon section. 
Sample CSA 
Alginate Cast 
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lightly tightened. Grips were kept frozen by controlling the CO2 flow and the samples 
hydrated by spraying several times with PBS. After a few minutes, the ends of the 
samples within the grip surfaces started freezing, and a freezing line started forming. 
The grips were then manually fully tightened and the freezing line identified using a 
marker pen. This way, it was possible to identify any slippage that may have occurred. 
The distance between the grips (initially set to 100mm) was adjusted as needed during 
the tightening of the grips, so that the samples were not in tension. 
Once fully secured, samples were pre-loaded to 25N, which represents 
approximately 1% of the predicted failure load. The grip to grip distance, was recorded 
after the application of pre-load to give the correct value of gauge length. Sections 
were then preconditioned with 10 loading cycles between 0 and 5% strain (approx. 
25% of expected failure strain) using a sine wave at a frequency of 1Hz, before pulling 
to failure at room temperature at a strain rate of 5% per second. Force and extension 
data were continuously recorded at 100Hz during preconditioning and the pull to 
failure. 
 
 
a 
b 
c 
Figure 64: Images of the cryogrips designed and used for the failure tests of SDFT 
quarter sections (a). Cryogrips were installed in a hydraulic testing machine (b) (Instron 
8801). Sample’s ends were frozen in the grips and pulled to failure (c). 
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4.8.5.3. Failure Properties Calculations 
Displacement at which the initial pre-load was reached was taken as the start 
point for the test to failure. 
Failure load was determined as the maximum load sustained by the sample, 
and failure extension as the extension at this point. For each sample, engineering stress 
and strain were calculated using the CSA (determined as described in section 4.8.5.1) 
and effective gauge length, respectively. A continuous modulus was calculated across 
every 10 data points of each stress strain curve and smoothed using a 9-point moving 
average filter. From these data, a maximum modulus value was determined. 
Percentage hysteresis in the first and tenth cycles was also calculated, as the 
percentage difference in the area between the loading and unloading curves for each 
cycle. 
 
4.8.6. Failure Properties of SDFT Quarter Sections - Results 
Results showed no significant differences in any of the failure variables (Figure 
65) nor viscoelastic properties (Figure 66) of young and old SDFT sections. These 
results correlate well with previous studies, where no ageing changes were identified 
in whole SDFTs subjected to quasi-static testing (Thorpe et al., 2013a). Of additional 
importance, the parameters reported for quarter sections tests matched those 
determined in whole tendon tests (Thorpe et al., 2013a). 
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Figure 65: Stress (a), Strain (b) and maximum modulus (c) of young and old SDFT 
quarter sections. No significant differences were identified (all normally distributed data – 
ANOVA). Data is displayed as mean ± standard deviation. 
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Figure 66: Hysteresis Cycle 1 (a) and Hysteresis Cycle 10 (b) of young and old SDFT 
quarter sections. No significant differences were identified (all normally distributed data – 
ANOVA). Data is displayed as mean ± standard deviation. 
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4.9. Discussion 
This is the first study to investigate how elastin depletion affects the 
mechanical properties of fascicles and IFM samples from energy storing tendons. It is 
also the first study to investigate how elastase treatments differentially affect different 
aged tendon samples. Furthermore, methods were optimised to investigate the effects 
of elastase treatment on quarter tendon samples, providing the opportunity to 
characterise multi-scale tissue response. Time constraints prevented completion of 
these studies prior to submission but these are ongoing. 
The failure, fatigue and recovery properties of fascicles and IFM samples from 
young and old energy storing SDFTs were investigated. The results generally support 
the hypothesis, showing a significant decrease in IFM mechanical properties with 
elastase treatments, whereas fascicle mechanical properties remain unchanged. With 
ageing, these changes in the elastase group were maintained, with all elastase treated 
IFM samples consistently showing a significantly lower ability to withstand load and 
resist fatigue loading, as well as a lower ability to recover after loading. 
Enzyme efficacy and specificity should be questioned when carrying out 
targeted digestion assays such as this. Further, it is important to investigate possible 
effects of the buffer solution, particularly swelling, or consider if the enzyme may 
cause structural disruption in the tissue, and subsequently affect mechanical properties. 
IFM is mainly composed of collagen type III, proteoglycans and elastin. 
Elastase treatment validation reported a significant reduction of elastin (>70%) but 
also of GAGs (>80%). These data lead to concern as to whether the reported loss of 
mechanical properties stems from changes in collagen or GAG content. Previous 
studies have reported that GAGs interact with collagens, supporting its fibril network, 
but also with elastin, where they are believed to associate with microfibrils and 
contribute to their integration into the ECM (Kielty, Sherratt and Shuttleworth, 2002). 
It is possible that changes in GAG content affected IFM mechanics, however, previous 
studies have failed to prove that tendon mechanical properties are affected by GAG 
digestion (Legerlotz et al., 2013, Lujan et al., 2009). Furthermore, a preliminary trial 
of GAG digestion in IFM samples showed no effects of 90% GAG removal on IFM 
mechanical behaviour. Structural imaging of the current samples, demonstrate no clear 
disruption to the tissue and collagen content was not altered. Taken together, data 
suggest that any changes in tissue mechanics originate from loss of elastin and not 
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GAG. Further, the inclusion of a control group, maintained in the incubation media 
provides confidence that swelling, or water modification effects are accounted for. 
Data demonstrates no changes to fascicle failure or fatigue properties post-
elastase treatment. With fascicles comprising in excess of 90% collagen, these findings 
are perhaps not surprising. By contrast, after elastase treatment, IFM failure load and 
stiffness were both significantly reduced compared to both fresh and control groups. 
There are few relevant studies with which to compare these findings, but they do 
correlate well with previous studies in tendon that reported a significant reduction in 
whole tendon stiffness after elastase digestion (Millesi et al., 1995). With ageing, 
although not significant, there was a trend towards maximum stiffness increasing in 
both fresh and control samples. These results support previous findings where IFM 
samples were observed to become stiffer with ageing in SDFTs (Thorpe et al., 2015c) 
and it was interesting to note that elastase treatment masked any ageing changes. 
Interestingly, no changes were observed in the failure extension of young or 
old SDFT IFM samples after elastase treatment. Although changes with ageing were 
not expected (Thorpe et al., 2015c), the fact that failure extension did not change with 
elastase treatment was surprising and requires further discussion. This might be 
explained by the preconditioning step. Samples were preconditioned with 10 loading 
cycles prior to pull to failure, and extension was normalised after the preconditioning, 
as per other studies (Thorpe et al., 2015c). Such an approach means that any extension 
that occurred during the preconditioning cycles was not included in final values. With 
other datasets demonstrating poor recoverability of IFM in elastase treated samples, it 
seems likely that the elastase treated IFM samples extended notably during those initial 
cycles, perhaps more so than any other samples, as the IFM was less able to sustain 
applied load. 
Elastase treatments also influenced the viscoelastic properties of IFM samples 
specifically. Data showed a significant increase in hysteresis in both cycle 1 and 10 in 
elastase treated IFM samples, and a severe reduction in fatigue resistance such that 
most elastase treated samples failed immediately. Similar to previous studies, no 
changes in the IFM hysteresis were observed between age groups (Thorpe et al., 
2015c), and it was also notable that fascicle fatigue properties were not affected by the 
elastase treatment.  
It is important to note that all IFM samples, regardless of what treatment they 
were subject to, were fatigue loaded from zero to the peak load found by applying one 
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cycle between 0 and 50% of IFM predicted failure extension. This protocol was based 
on previously published data (Thorpe et al., 2015c), but might have caused some 
samples to be over-loaded and others under-loaded. However, large numbers of 
samples were tested to help account for this, and the fact that no differences were 
observed between fresh and control groups, whilst elastase treated samples were so 
significantly different (p=0), gives confidence in treatment effects. Indeed, it was also 
notable that elastase treated samples showed a significant increase in creep between 
cycles 1 and 10 and in both minimum and maximum displacement creep curves, all 
indicated reduced fatigue resistance. Taken together, both failure and fatigue data 
suggest that IFM samples become less able to withstand load and more viscoelastic 
with reduced fatigue resistant when subject to elastase treatments. 
In order to directly explore how the IFM loads and recovers when subject to 
elastase treatments, further experiments combining imaging and mechanics were 
designed and performed. An experimental protocol stretching IFM samples under a 
camera was conceived, and Digital Image Correlation (DIC) developed in order to 
investigate sample response to loading and recovery. With these experiments it was 
possible to compare IFM sliding and recoil when samples were stretched up to 75% of 
the IFM predicted failure extension, between fresh, control and elastase treated 
samples in both young and old samples. It would have been very useful if force and 
displacement data had been recorded throughout the test, such that hysteresis could 
have been calculated and compared to previous data. However, the load cell attached 
to the rig was not working. This provided an additional concern, that it was not possible 
to guarantee that all samples were preloaded with exactly the same amount of load 
prior to testing. However, a previously published protocol which looked for lifting of 
samples from the base of the rig to define the start point was adapted, which has shown 
good repeatability (Thorpe et al., 2013b). Finally, it should be noted that the 
displacement applied to all samples was based on average values from previous 
publications. Thus, similar to the scenario described for fatigue tests, some samples 
may have been over loaded, and others under loaded. However, the consistency in 
response, once again, provides confidence in the data. 
Data showed a significant increase in the angle deviation in the elastase group 
compared to both fresh and control groups, suggesting that elastase treated IFM 
samples stretched more than fresh and control samples, when subject to similar 
displacements. This additional IFM extensibility in elastase treated IFM samples 
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appears contradictory to earlier studies of IFM mechanical properties, but is more 
intuitive as a sample response. As IFM extension was not normalised in these tests, 
but is a report of all extension from the first loading cycle, it adds further evidence in 
support of the previous hypothesis that, after elastase treatment, the IFM responds 
immediately to applied load with irrecoverable extension and shear. Further 
corroborating this behaviour, results also showed a significant decrease in the 
percentage recovery of IFM sliding after load is removed in the elastase group 
compared to all other treatment groups. Indeed, while recovery in fresh and control 
samples was close to 70%, elastase treated samples showed a much lower percentage 
recovery (30%, approximately). After an unloaded hold period, fresh and control 
samples showed little further recovery, as most of the recovery was observed 
immediately after load was removed. On the other hand, it was interesting to note that 
elastase treated samples did show a continual gradual recovery with time, from 
approximately 30% to 55%, as a result of the holding period. However, the total ability 
to recover for these samples was still significantly lower compared to the control 
group. Taken together, data implies that elastase treatment results in increase IFM 
sliding and reduced ability for the IFM to withstand or recoil after loading, all 
contributing to reduce fatigue resistance. These findings are of crucial importance to 
structure-function studies, allowing a new level of insight into the hierarchical 
mechanics of tendon.  
Unfortunately, complete elastin removal is not achieved in SDFT quarter 
sections. However, the reported >30% removal of elastin is in line with that 
demonstrated in other published papers, where the ability to interpret such a graded 
loss is argued. Here, protocols are prepared to investigate the response of these 
samples, and it will be interesting to investigate how elastase treatments affect the 
whole SDFT and the contribution from fascicles and IFM. 
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Chapter 5 - Overall Discussion and Future Work 
5.1. Main Findings 
This body of research has shown that most of the elastin (>90%) in equine 
tendon is localised to the IFM, but has also demonstrated differences in elastin 
associated with functionally distinct tendons. Overall tendon elastin content was 
greater in the SDFT compared to the CDET, and with ageing, there was a decrease in 
elastin content and organisation in the energy storing SDFT, whilst no changes were 
seen in the CDET (Godinho et al., 2017). These results support previous studies in 
other species, that have shown that the IFM is comparatively rich in elastin (Grant et 
al., 2013, Smith et al., 2011), and have also suggested that enrichment is particularly 
evident in energy storing tendons (Thorpe et al., 2016a). 
In this study, immunohistochemistry followed by confocal microscopy was 
used to establish regional elastin organisation and structure in tendon. However, the 
amount of processing these samples have to undergo prior to imaging should be 
considered. Tissue had to be snap frozen, sectioned, fixed and stained, and whilst 
arguably less destructive than the dehydration stages of wax embedding, it may cause 
damage to the structure of the tissue. During sectioning, for instance, it is very common 
that regions of the IFM, tear apart. Various other techniques have been suggested for 
elastin visualisation. 
5.2. Alternative Techniques for Elastin Visualisation 
Early studies used transmission electron microscopy (TEM), and scanning 
electron microscopy (SEM) to investigate the ultrastructure of elastic fibres in tendon 
(Parry and Craig, 1978), however these techniques also have limitations. Both 
approaches require complete tissue dehydration, and SEM is limited to surface 
imaging, while TEM requires ultra-sectioning of tendon tissue (Pang et al., 2016). 
Furthermore, although the substructures of elastin can be well visualised with these 
techniques, the magnification range is too high to clearly visualise elastic fibres, which 
are the functional unit of the elastin structure. Hence imaging of fibre organisation is 
not easily achievable. Other techniques that require minimal tissue processing and 
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enable good elastin visualisation were also considered. Multiphoton high resolution 
imaging is a very promising technique as it allows elastic fibres detection within intact 
tissue specimens, without any need for preparation processes that may damage the 
tissue and compromise the visualisation of certain structures. By changing the laser 
excitation wavelengths, elastic fibres can be differentiated from collagenous structures 
and other matrix elements without having to use any staining (Press, 2005). In the 
current thesis, multiphoton microscopy was investigated, however, images from 
tendon samples showed substantial background fluorescence, making it impossible to 
see elastin fibres.  
5.3. Elastin Organisation in Tendon 
Despite the limitations, clear images of elastin fibres were acquired using 
immunohistochemistry. Automated image analysis of these samples suggested 
predominant fibre orientation parallel to the IFM. However, when blind scorers were 
asked to identify elastin organisation, they reported that there were a greater number 
of elastin fibres aligned perpendicular to the IFM in the young SDFT than in the 
CDET. The presence of perpendicularly aligned elastin fibres, particularly in the SDFT 
IFM, suggests that, elastin orientation may specifically facilitate mechanical function. 
Elastin fibres oriented in this perpendicular manner may serve as a “bridge” between 
adjacent fascicles, which would assist in returning fascicles to their initial location 
once external forces have been removed. However, the question remains: how exactly 
does elastin bridge the IFM? The schematic in Figure 67 illustrates a hypothesis of 
how elastin might function to connect fascicles, and how it is affected by ageing. In 
the unloaded condition, elastic fibres are shown to bridge fascicles, in a coiled 
conformation (Figure 67a). When external forces are applied, the elastin network can 
unfold and stretch as the fascicles slide (Figure 67b1), providing initial low stiffness 
fascicle sliding with a clear increase in stiffness as the collagen and elastin bridging 
the IFM are directly loaded. Once load is removed, elastin fibres recoil and help 
fascicles return to their original position (Figure 67b2). However, with ageing, IFM 
elastin content reduces and organisation is lost, accompanied by decreased protein 
turnover in the IFM, meaning that regions of damage may not be repaired as 
effectively. Together, these changes likely reduce capacity for low stiffness fascicle 
sliding (Figure 67c1). Therefore the fascicles themselves will be stretched more 
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readily, and so, both IFM and fascicles become more likely to be damaged, which is 
likely to contribute to the age-related increase in tendon injury (Figure 67c2).  
 
 
To investigate this hypothesis in further detail, a custom designed tensile 
straining rig (Figure 50) was used to investigate the recoverability of IFM samples 
after cyclic loading, imaging local tissue mechanics during loading and recovery. This 
system was previously used by Screen’s group to measure the microstructure response 
of tendon fascicles when subject to different strains (Cheng & Screen 2007), and 
allows fresh samples to be loaded while in situ on the stage of a confocal microscope. 
Preliminary studies clearly showed sliding and recoil in the IFM, with a series of 
elastase treatment experiments specifically implicating elastin in this response. If 
Figure 67: Schematic of the IFM in tendon mainly composed of collagen type III 
proteoglycans and elastin (green fibres) (a). When two adjacent fascicles are pulled in different 
directions (b1), the IFM stretches and the elastin fibres unfold adopting a more elongated 
configuration. Once the load is removed (b2), fascicles slide back, and elastin folds again, 
returning to its original configuration. With ageing (c1), elastin content is reduced and 
remaining elastin shows signs of fragmentation. Together, these changes reduce capacity to 
control fascicle sliding and recoil, which leads to fascicle overload and damage (c2). Adapted 
from schematic by C Thorpe. 
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multiphoton imaging difficulties could be overcome, future studies could potentially 
use this technique to directly visualise elastin organisation and strain response in the 
IFM samples to more fully probe the hypothesised model in Figure 67. Staining could 
be used to identify other IFM proteins or cells also, to create a more detailed 
description of how the different matrix components respond to loading and unloading, 
and also investigate how elastin influences that response. Ideally, samples of different 
ages and from functionally distinct tendons would allow a clear structure-function 
investigation. 
5.4. Importance of Elastin Models 
As a compliment to experimental work, several studies have been focussing on 
developing models of protein behaviour, and elastin being such an important ECM 
protein is no exception (Tarakanova & Buehler, 2013). Initially, computational models 
of elastin-like polymers were developed to study the source of elastin elasticity and 
provide fundamental understanding of the molecular mechanisms behind the 
biological function of elastin (Hoeve & Flory 1958, Venkatachalam et al., 1981). More 
recent approaches have aimed to model elastin interactions using an atomistic 
modelling approach, in which molecular dynamics can be used to predict protein 
response to loading (Rousseau et al., 2004). Being able to use computational modelling 
to investigate elastin functionality at a molecular level has contributed massively to 
the development of demanding biomaterials, and here, it may help establish how 
elastin controls collagen sliding and how elastin conformational changes with age or 
disease may impact IFM function. 
Most of the elastin in the body is produced in the early stages of development 
of life. This means that any damage or injury to the elastin rich tissues is very difficult 
to repair (Swee et al., 1995). As a consequence, various diseases including emphysema 
and cutis laxa are related to mutations within or malfunction of elastic fibres (Vrhovski 
and Weiss, 1998). Tissue replacements using elastin-based biomaterials are in high 
demand. In addition to physiological compatibility, elastin-based peptides show 
excellent material properties that can be used to create smarter biomedical 
applications. Some examples are elastin hydrogels, developed as matrices for 
controlled drug delivery, or elastin-based synthetic fibres to be used as prototypes for 
tissue engineering and artificial cardiovascular tissue (Swee et al., 1995). The most 
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important aspect of elastin, in terms of biomedical applications, is its ability to undergo 
a lifetime of extensions, to strains several times its resting length, and to reversibly 
return to its original length. As such, most computational models have focussed on 
investigating the source of this elasticity. However, how elastin interacts with the 
surrounding components, such as other proteins or even cells, is not yet known. Tissue 
extensibility often arises from reordering of tissue fibres (collagen or elastin) as well 
as directly from stretching of resident fibres, so investigating matrix interactions is as 
important as the properties of the elastin itself. 
Previous studies in tendon have suggested that elastin also regulates the 
interactions between cells and extracellular matrix (Pang et al., 2016, Grant et al., 
2013). Data have shown elastic fibres localised around tenocytes, forming a sparse 
meshwork style configuration. This close interaction between elastic fibres and cells 
in the tendon pericellular matrix, is likely to have a substantial effect on the forces 
experienced by cells, and therefore, their mechanobiological response to load. Tendon 
cells have previously been reported to attach to collagen fibres, and thus slide on one 
fibre relative to another during deformation (Screen et al., 2004). Elastin may also 
serve to protect cells during this mechanical loading and sliding, by helping them glide 
relative to adjacent fibres, and to return to their original configuration following 
unloading. Elastin has also been suggested to play a crucial role in cell attachment, 
working as an intermediate link between cells and collagen (Grant et al., 2013). 
Previous studies have demonstrated that elastin functionalised substrates are useful 
tools to investigate cellular adhesion and proliferation (Vassalli et al., 2013, Ito et al., 
1998). Indeed, studies with elastin coated substrates showed excellent fibroblast 
proliferation and adhesion, compared to un-functionalised substrates, where cells 
remained round-shaped (Barenghi et al., 2014). These results support previous work 
showing that tropoelastin, a precursor of elastin, promotes fibroblast adhesion, 
proliferation, and spreading (Rnjak et al., 2009). 
Another useful approach to investigate the influence of specific proteins on 
tissue function is to adopt either direct enzymatic treatments, or use genetic knockout 
models, and carry out testing with these. Integrating these approaches with the novel 
local mechanics assessments described in this thesis, could provide exciting insight 
into the specific effects of different treatments.  
Genetic knockout models have been used mainly to investigate the role of 
minor tissue components, such as specific proteoglycans and glycoproteins (Robinson 
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et al., 2005, Waller et al., 2013), as elastin knockout models can only be partial. It has 
been shown that when levels of elastin in a knockout drop below 30%, animal viability 
is compromised, owing to its crucial role in the lungs and circulatory system (Hirano 
et al., 2007, Wagenseil et al., 2005). As an attempt to overcome this problem, some 
studies are using site-specific recombination to generate conditional gene knockouts 
and thus, targeting specific cell types, tissues or even specific time points (Pappas et 
al., 2018).  
Whilst a highly successful approach in many tissues, its successful 
implementation necessitates clear cell markers in the tissue of interest to target the 
treatment, and to date, such markers have not been identified for tendon. Furthermore, 
knockout studies all adopt mouse models, and mouse tendons are so small they do not 
have a clear IFM structure, which provides a further substantial limitation. Recent 
advances such as Clustered Regularly Interspaced Short Palindromic Repeats 
(CRISPR), offer opportunity here, in which knockout approaches can be translated 
into other larger animals (Ma et al., 2014). The rat has been identified as an ideal model 
system, with the appropriate IFM structure present. However, the absence of clear cell 
markers for tendon, means this approach remains challenging. 
5.5. Advantages and Disadvantages of Elastase Treatments  
In this thesis, it has been shown that elastin depletion has a significant effect 
on overall tendon mechanics, but specifically through an influence on IFM mechanics, 
where elastin is predominantly localised. Failure and fatigue tests showed a significant 
reduction in the ability of the IFM to withstand load, as well as a significant reduction 
in the IFM fatigue resistance when elastin is partially removed. Additionally, direct 
assessment of IFM recovery properties, showed that elastase treatment strongly 
impaired the ability of IFM samples to recoil. These results are very promising as they 
support the hypothesis that elastin is a key contributor to all aspects of the tendon 
mechanical behaviour. However, enzymatic treatments can be challenging, as they can 
have a non-specific effect on other ECM components and can also compromise the 
structure of the tissue. Despite typical limitations of the enzymatic treatments, results 
were promising. In the validation process, changes in tendon structure and composition 
were investigated and results showed very few non-specific changes with elastase 
treatments. Also, the addition of a control group supported the hypothesis that changes 
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in the mechanical properties are caused by enzyme treatments and not by the swelling. 
Taking these observations together, this thesis suggests that combining elastase 
treatments with the detailed structure-function microscopy studies, described earlier in 
this work, would provide unprecedented insights into how elastin governs fascicle 
sliding and interacts with other proteins and cells to enable energy storing tendons to 
stretch further than positional tendons. 
5.6. Elastin Contribution to Overall Tendon Mechanics 
Over the years, most studies of elastin have focused on the cardiovascular 
system, where elastin is a major structural component. In these tissues, such as arteries 
and smaller blood vessels, elastin is thought to provide tissue stiffness at low strains. 
As the tissue is first strained, elastin is straightened and loaded, while only 10% of the 
collagen is straightened and loaded (Clark and Glagov, 1985). Only when pressure 
increases above physiological loads, do the collagen fibres become straight and load 
bearing also (Clark & Glagov 1985, Carta et al., 2009). Similarly, in the skin, while 
collagen is the main source for the mechanical strength, elastin is thought to be 
responsible for the initial extensibility of the tissue (Oxlund et al., 1988). Differences 
in how elastin contributes to the overall tissue mechanics, may be reflected in how 
elastin is organised in the tissue. Indeed, while in the cardiovascular tissue elastin is 
arranged in an interconnecting fenestrated network, called a lamellar unit (Wagenseil 
& Mecham, 2013), in skin, elastin forms a branching network between bundles of 
collagen (Oxlund et al., 1988). In tendon, elastin seems well organised, with specific 
localisation to the IFM and very often located around cells (Godinho et al., 2017, Grant 
et al., 2013), which might explain why changes to the mechanics with elastin depletion 
were only significant in the IFM and not in the fascicles.  
Taken together, given the unique ability of elastin to undergo large 
deformations, and considering the findings presented in this work, it is believed that 
elastin provides tendon with elastic recoil and resilience. In this study, it was 
demonstrated that, despite the low amounts of elastin in tendon, elastin plays a role in 
its mechanical properties, which is consistent with previous studies of soft tissues, such 
as tendon (Grant et al., 2015) and ligament (Henninger et al., 2013). For rat tail tendon 
fascicles and human supraspinatus tendon, elastin depletion affected the mechanical 
properties of the tissue, including a significant decrease in the stress values (Grant et 
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al. 2015, Fang & Lake, 2016). Ligament was also shown to have smaller stresses after 
elastin digestion under tensile and shear loading (Henninger et al., 2013).  As previous 
mentioned, energy storing tendon deformation is governed by sliding of fascicles, and 
the concentrated distribution of elastic fibres in the interfascicular space is likely to 
provide this region with elastic recoil, by “bridging the fascicles” and transferring 
stress. Unfortunately, it is still unclear how elastin and collagen interact to enable its 
function. It is known that type VI collagen, although only 0.33% (wet weight) of 
tendon (Carvalho et al., 2006), is a major constituent of the pericellular matrix (Ritty 
et al., 2003). Interestingly, FBN-1 (an important constituent of elastic fibres) has been 
shown to bind to type VI collagen (Midwood and Schwarzbauer, 2002). Therefore, 
elastic fibres may form an intermediate link between the cell and type VI collagen, 
which binds to collagen fibrils. 
5.7. Future work 
As a final body of further work, it would be interesting to probe IFM 
composition and function and the role of elastin in tendons from other species. Recent 
studies are providing increasing evidence of variation in hierarchical structure and 
composition between tendons from different species and with different functions 
(Thorpe et al., 2015a, Thorpe et al., 2016a). However, horse tendons have been shown 
to have a similar epidemiology and aetiology to human tendon injury (Ely et al., 2009), 
and recent still unpublished work from QMUL group indicated similar arrangements 
of elastin in human and equine energy storing tendons. Indeed, as the equine SDFT is 
an extreme example of an energy storing tendon, it arguably provides one of the best 
models for studying key structure-function relationships. This kind of work to further 
understand human tendon injury is very important as such injuries are still a big clinical 
problem.  
Future work could also focus on further probing elastin contribution to specific 
tendon structure-function, by looking in more detail at elastin organisation and 
interaction with other proteins, such as collagen and PGs, using scanning electron 
microscopy or multiphoton microscopy. Whilst some investigations of such 
relationships have been carried out in cardiovascular tissues, relationships remain 
unexplored in tendon (Midwood and Schwarzbauer, 2002).    
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Making use of the already validated methods for elastin depletion, it would 
also be interesting to investigate how mechanical and fatigue properties of whole 
tendons change when elastin is removed from those samples. The same elastin 
depletion methods could be further used to determine the impact of elastin on whole 
tendon local strain patterns, or investigate changes in the transverse mechanics perhaps 
more specifically targeting mechanics of the elastin-rich IFM region. 
Elastin ageing process remain under explored, and it would be of benefit here 
to establish the impact of elastin ageing on overall tendon mechanics. 
Understanding how minor components of tissues, such as elastin in tendon, 
contribute to the overall tendon function, will help identify key structure and function 
relationships in different tendons. This way, new approaches can be proposed to target 
specific matrix components or cells to support healthy function, or even avoid or treat 
tendinopathies. With a better knowledge of elastin’s role in tendon, new approaches 
for modulation of exercise could be developed to maintain a heathy IFM. Perhaps a 
lubricant could be used to prevent elastin overload and damage. Similarly, synthetic 
biology could create an elastin analogue to replace the dysfunctional one, or even new 
approaches to manipulate elastin turnover and ageing could be adopted. 
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Appendixes 
Appendix A – List of Materials used and Respective Details 
 
Table 8 – List of some of the materials used for both immunohistochemical and biochemical 
analysis with details regarding the supplier, catalogue and batch numbers. 
Product Supplier 
Catalogue 
Number 
Batch 
Number 
Immunohistochemical Analysis 
Isotype Control Mouse IgG1 Sigma  M5284 - 1mg 066M4750V 
Alexa Fluor 488 Goat Anti rabbit Life Technologies A11008 1678787 
Alexa Fluor 555 Goat Anti-Mouse IgG Life Technologies A21424 1691772 
Hyaluronidase from Bovine  Sigma H3884-100mg SLBL6343V 
OCT Thermo Scientific LAMB/OCT 3803431 
ProLong Gold antifade reagent with DAPI Life Technologies P36931 1506916 
Mowiol 4-88 Sigma 81381-50g BCBL8261V 
Biochemical Analysis 
Elastase 
Elastin Products 
Company 
EC134 1335 
Soybean Trypsin Inhibitor 
Roche Diagnostics 
GmbH 
10109886001 19752620 
Complete Mini Protease Inhibitor Cocktail 
Roche Diagnostics 
GmbH 
11836153001 10948000 
DESMOSINE ELISA Kit B.I.T.S. BDEXV1 MJ311016 
Papain from papaya latex Sigma P3125-100mg SLB6471V 
Guanidine Hydrochloride Sigma G3272-100g SLBJ2599V 
L-Cysteine Hydrochloride Sigma C7477-25g 1436197 
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Appendix B - Protocols 
B1. Fastin Elastin Assay – Finalised Protocol 
Tendon elastin was quantified using the FASTINTM Elastin Assay (Biocolor, 
UK). Before the assay could be performed, the native hydrophobic elastin in the 
powdered, lyophilised samples (~3 mg dry weight) required conversion into the 
water soluble derivate α-elastin. The conversion was achieved by heating the 
samples to 100 °C for 2 one hour periods with 750 µl of 0.25 M oxalic acid to 
guarantee complete solubilisation of the tissue elastin. Preliminary tests were 
performed to determine that two extractions were sufficient to solubilise all elastin. 
After each test sample extraction, the tubes were allowed to cool down for about 10 
min and then centrifuged at 10000rpm for 10 min. The supernatant was then pipetted 
off to a 1.5ml Eppendorf. Tubes were weighted before and after the liquid removal. 
As explained before, to the residual tissue in the tubes was added a further 750µl of 
0.25M oxalic acid and another extraction was performed. 
After the extractions, the tissue elastin was in the form of α-elastin, which has 
a molecular weight range of 60-84 KDa. Thus, the extract (supernatant) could be 
directly assayed using the procedure described for soluble elastin (Fastin Elastin Assay 
Kit, Biocolour, UK). α-elastin standards, with concentrations from 0-90 µg/ml, were 
prepared in duplicate using a 1mg/ml α-elastin standard solution (Biocolor, UK). To 
each tube, including test samples, sample blank and standards, was added an equal 
volume of Elastin Precipitating Reagent.  
Tubes were briefly vortex to mix contents and left for 15 minutes to complete 
the precipitation of –αelastin. Then, tubes were centrifuge at 9500 rpm for 10 min and 
the liquid was drained into a beaker. After removing the majority of the liquid by 
inverting the tubes, the remaining liquid was removed from each tube using thin strips 
of filter paper. Then, to each tube 1.00 ml of Dye Reagent was added and tubes were 
briefly vortex and placed on a mechanical shaker for 90 min to allow reaction between 
the –αelastin and the dye. Once again, tubes were then centrifuge at 9500 rpm for 10 
min. All tubes were drained from unbound dye by inverting the tube and the remaining 
liquid was removed as previously described, by using thin strips of filter paper. The 
elastin-dye complex could be observed as a reddish-brown deposit in the bottom and 
inside lower wall of the tubes. Finally, to each tube was then added 250µl of 
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Dissociation Reagent. Tubes were vortexed twice every 10 min to ensure that all bound 
dye has passed into solution. The tube’s content was transferred (200µl) to a 96 well 
flat bottom microwell plate, placed into a Spectrophotometer (SPECTROstar Nano) 
and absorbance was measured at 513 nm. Elastin concentration was calculated by 
comparison to a standard curve, generated by the α-elastin standards and it was 
expressed as a percentage of dry weight tendon tissue. 
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B2. Preparation of Mowiol Mounting Medium 
For the preparation of the Mowiol mounting medium, a 50ml plastic 
centrifuge tube was used. 6g of glycerol and 2.4g of Mowiol 4-88 were mixed 
together, using a stirrer. While stirring, 6ml of distilled water was added and the 
solution was left stirring for 2hours at room temperature. 12ml 0.2M Tris (pH 8.5) 
was added to the mixture and incubated in a hot water bath (50-60°C) for 10 
minutes. The solution was centrifuged for 15min at 5000g to remove any 
undissolved solid parts, transferred to 1ml aliquots, and stored in the freezer until 
required. When required, tubes were removed from the freezer and allowed to thaw 
at room temperature. 
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B3. Elastin Immunostaining – Finalised Protocol 
For elastin immunostaining, previously prepared longitudinal and transverse 
cryosections (Chapter 2), were allowed to thaw for 1 minute, before fixing with ice-
cold methanol (−20 °C) for 20 minutes. Slides were rinsed 3 times in phosphate-
buffered saline (PBS), treated with hyaluronidase (Sigma, H3884) (4800 units/ml in 
PBS containing protease inhibitor cocktail (complete mini, Roche)) to increase tissue 
permeability (Csóka et al. 1997), and incubated over night at room temperature. 
Cryosections were washed 3 times in PBS and incubated in blocking buffer (10% goat 
serum in PBS) for 1 hour at room temperature. They were then drained and incubated 
in the primary antibody. Elastin primary antibody ab9519 (Abcam Cambridge, UK) 
was diluted in 5% goat serum in PBS (1:100) and applied to different sections 
(approximately 100ul of antibody per section) before incubation overnight at 4 °C. 
After overnight incubation, sections were washed in PBS and incubated with Alexa 
Fluor 555 Goat anti-Mouse IgG Secondary Antibody diluted in 5% goat serum (1:500 
dilution) for 1 h at room temperature (protected from light). Finally, sections were 
washed and mounted with ProLong Gold Antifade reagent with 4′,6-diamidino-2- 
phenylindole (DAPI), and allowed to cure overnight, at 4 °C in the dark, before being 
sealed with nail polish and imaged. Imaging was performed on a confocal microscope 
(Leica TCS SP2) using × 40 (oil) objective. 
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Appendix C – MATLAB Code 
C1 – IFM recoil ability – Angle Deviation Calculation 
C1.1 MATLAB code “Find_Marker” 
Credit to Dr. Wing Keung Cheung (Screen’s Group) 
function [crop_A, Label, s] = find_marker(Image) 
A = imread(Image); 
 crop_A = rgb2gray(A); 
 crop_A = imgaussfilt(crop_A, 1,'FilterSize',[3 3]); 
BW = imbinarize(crop_A,'adaptive','ForegroundPolarity','dark','Sensitivity',0.1); 
 BW = abs(int8(BW)-1); 
CC = bwconncomp(BW); 
numPixels = cellfun(@numel,CC.PixelIdxList); 
for i=1:length(numPixels) 
    if (numPixels(i)<=25) 
        BW(CC.PixelIdxList{i}) = 0; 
    end 
end 
[Label,Total]=bwlabel(BW,8); 
marker_margin = 10; 
check_merge = 1; 
while (check_merge == 1) 
    check_merge = 0; 
    s = regionprops(Label,'BoundingBox'); 
    boundingboxes = cat(1, s.BoundingBox); 
    paired_index = []; 
    total_merge = 0; 
    for (i=1:Total) 
        for (j=i+1:Total) 
            check_margin = (boundingboxes(j,1) - boundingboxes(i,1)) - 
boundingboxes(i,3); 
            if (check_margin <= marker_margin) 
                paired_index = [paired_index; [i j]]; 
                total_merge = total_merge + 1; 
                check_merge = 1; 
            end 
        end 
    end 
    if (total_merge > 0) 
        for (k=1:size(paired_index,1)) 
            Label = changem(Label,paired_index(k,1),paired_index(k,2)); 
        end 
        Total = Total - total_merge; 
    end 
end 
s = regionprops(Label,'all'); 
checkloop = size(s,1); 
i=1; 
while (i <= checkloop) 
    for (j=1:size(s,1)) 
        if (s(j).Area == 0) 
            s(j) = []; 
            break; 
        end 
    end 
    i=i+1; 
end 
centroids = cat(1, s.Centroid); 
boundingboxes = cat(1, s.BoundingBox); 
for (jj=1:size(s,1)) 
    idx = s(jj).PixelList; 
    sorted_idx = sortrows(idx,2); 
    check_value = sorted_idx(1,2); 
    counter = 0; 
    sum_x = 0; 
    avg_x = []; 
    for ii=1:length(sorted_idx) 
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        if (check_value == sorted_idx(ii,2)) 
            sum_x = sum_x + sorted_idx(ii,1); 
            counter = counter + 1; 
        else 
            avg_x = [avg_x ; [sorted_idx(ii-1,2) sum_x/counter]]; 
            check_value = sorted_idx(ii,2); 
            counter = 1; 
            sum_x = sorted_idx(ii,1); 
        end 
        if (ii == length(sorted_idx)) 
            avg_x = [avg_x ; [sorted_idx(ii,2) sum_x/counter]]; 
        end 
    end 
    p = polyfit(avg_x(:,1),avg_x(:,2),1); 
    min_x = min(avg_x(:,1)); 
    max_x = max(avg_x(:,1)); 
    x_range = min_x:0.5:max_x; 
    x_range = x_range'; 
    interpolated_x = [x_range x_range*p(1)+p(2)]; 
    s(jj).average_x = avg_x; 
    s(jj).slope = -p(1); 
    s(jj).interpolated_x = interpolated_x; 
end 
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C1.2. MATLAB Code “Image_Analysis” 
Credit to Dr. Wing Keung Cheung (Screen’s Group) 
clear; 
folder_name = uigetdir; 
imagefiles = dir(fullfile(folder_name, '*.jpg')); 
nfiles = length(imagefiles);    
 for ii=1:nfiles 
    currentfilename = imagefiles(ii).name; 
    result(ii).name =  currentfilename; 
    [result(ii).image, result(ii).label, result(ii).all] = 
find_marker(fullfile(folder_name,currentfilename)); 
end 
average_displacement_deviation = zeros(nfiles-1,size(result(ii).all,1)); 
displacement_deviation = zeros(nfiles-1,size(result(ii).all,1)); 
slope_deviation = zeros(nfiles-1,size(result(ii).all,1)); 
angle_deviation = zeros(nfiles-1,size(result(ii).all,1)); 
 for ii=1:nfiles 
    for jj=1:size(result(ii).all,1) 
        min_y(ii,jj) = result(ii).all(jj).interpolated_x(1,1); 
        max_y(ii,jj) = result(ii).all(jj).interpolated_x(end,1); 
    end 
end 
 sorted_min_y = sort(min_y); 
sorted_max_y = sort(max_y); 
 marker_min_y = sorted_min_y(end,:); 
marker_max_y = sorted_max_y(1,:); 
 for ii=2:nfiles 
    for jj=1:size(result(ii).all,1) 
         
        ref_min_y_indices = find(result(1).all(jj).interpolated_x(:,1)== 
marker_min_y(jj)); 
        ref_max_y_indices = find(result(1).all(jj).interpolated_x(:,1)== 
marker_max_y(jj)); 
         
        min_y_indices = find(result(ii).all(jj).interpolated_x(:,1)== 
marker_min_y(jj)); 
        max_y_indices = find(result(ii).all(jj).interpolated_x(:,1)== 
marker_max_y(jj)); 
         
        total_rows = max_y_indices-min_y_indices+1; 
         
        displacement_deviation(ii-1,jj) = 
sum(abs(result(ii).all(jj).interpolated_x(min_y_indices:max_y_indices,2)- 
result(1).all(jj).interpolated_x(ref_min_y_indices:ref_max_y_indices,2))); 
         
        average_displacement_deviation(ii-1,jj) = displacement_deviation(ii-1,jj) / 
total_rows; 
         
        slope_deviation(ii-1,jj) = (result(ii).all(jj).slope - 
result(1).all(jj).slope); 
         
        angle_deviation(ii-1,jj) = (rad2deg(atan(result(ii).all(jj).slope)) - 
rad2deg(atan(result(1).all(jj).slope))); 
    end 
end 
  
average_displacement_deviation 
displacement_deviation 
slope_deviation 
angle_deviation 
  
figure; 
for ii=1:nfiles 
     
     
    subplot(3,nfiles, ii), 
    imagesc(result(ii).image); 
    title(result(ii).name, 'Interpreter', 'none'); 
    colormap('gray'); 
     
    subplot(3,nfiles, ii+(nfiles)), 
    imagesc(result(ii).label); 
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    title('Average X position', 'Interpreter', 'none'); 
     
    hold on 
     
    centroids = cat(1, result(ii).all.Centroid); 
    boundingboxes = cat(1, result(ii).all.BoundingBox); 
     
    plot(centroids(:,1),centroids(:,2), 'r*'); 
     
    for k = 1:size(boundingboxes,1) 
         
        rectangle('position',boundingboxes(k,:),'Edgecolor','y'); 
         
        plot(result(ii).all(k).average_x(:,2),result(ii).all(k).average_x(:,1), '.g') 
         
    end 
    hold off 
     
    subplot(3,nfiles,ii+(2*nfiles)), 
    imagesc(result(ii).label); 
    title('Interpolated Line', 'Interpreter', 'none'); 
     
    hold on 
     
    plot(centroids(:,1),centroids(:,2), 'r*') 
     
    for k = 1:size(result(ii).all,1) 
         
        rectangle('position',boundingboxes(k,:),'Edgecolor','y' 
        
plot(result(ii).all(k).interpolated_x(:,2),result(ii).all(k).interpolated_x(:,1), '-
b') 
         
    end 
     
    hold off 
     
end 
  
figure; 
for ii=2:nfiles 
     
    subplot(nfiles-1,1,ii-1), 
    [m,n]= size(result(1).image); 
    set(gca,'Color','k') 
    set(gca,'Ydir','reverse'); 
    xlim([0 n]); 
    ylim([0 m]); 
    set(gca,'XTick',(0:50:n)); 
    set(gca,'YTick',(0:20:m)); 
    
    [B] = bwboundaries(result(1).label); 
    hold on 
    for k = 1:length(B) 
        boundary = B{k}; 
        plot(boundary(:,2),(boundary(:,1)), 'r', 'LineWidth', 1); 
    end 
     
    [B] = bwboundaries(result(ii).label); 
    for k = 1:length(B) 
        boundary = B{k}; 
        plot(boundary(:,2),(boundary(:,1)), 'b', 'LineWidth', 1); 
    end 
     
    figure_number = ii-1; 
    title(['Overlaid Interpolated Line (Ref [red] vs Set ',num2str(figure_number),' 
[blue])']); 
     
    hold on 
     
    for k = 1:size(result(ii).all,1) 
                
plot(result(ii).all(k).interpolated_x(:,2),result(ii).all(k).interpolated_x(:,1), '-
b') 
         
    end 
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    for k = 1:size(result(1).all,1) 
                
plot(result(1).all(k).interpolated_x(:,2),result(1).all(k).interpolated_x(:,1), '-r') 
         
    end 
     
    hold off 
     
end 
 
